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Abstract
Transcription and translation are precisely-regulated processes that enable
a cell to react to environmental stimuli by the production of appropriate
sets of proteins. In order to analyze gene expression regulation, two novel
methods have been developed that facilitate aﬃnity puriﬁcation approaches
in combination with quantitative mass spectrometry.
First, the concepts underlying transcriptional control are investigated by
identifying proteins binding to cis-regulatory modules (CRMs) in a sequence-
speciﬁc manner. The method facilitated the determination of proteins specif-
ically binding to DNA sequences with a length of 500 base pairs. Quantita-
tive comparison of the binding pattern of three CRMs active in Drosophila
melanogaster muscle development revealed 72 candidates potentially regu-
lating the activity of these CRMs among thousands of proteins that interact
non-speciﬁcally. In vivo validation of biological activity of several candidates
is in progress and will probably reveal new circuits of Drosophila melanogaster
muscle development.
Second, a novel approach to speciﬁcally enrich and quantify newly synthe-
sized proteins by combining click-chemistry and pulsed SILAC labeling was
developed. This method was introduced as a useful tool to study protein syn-
thesis and the sensitive detection of rapid response to cellular stimulation.
In addition, the method was adapted to the selective and precise quantiﬁ-
cation of secreted proteins. This important subset of mammalian proteins
is currently understudied because of technical limitations in the detection of
low-abundant proteins against a background of serum. In-depth and diﬀer-
ential secretome analysis of various cell lines and primary cells revealed, e.g.,
profound eﬀects of serum starvation on secretome composition. Moreover, a
unique application studying the kinetics of protein secretion was introduced.
The approach will have broad implications in studying the responsiveness of
cells grown under optimal conditions.
Finally, in combination with RNA and protein abundance measurements,
the developed approaches were used to investigate regulatory mechanism
establishing response programs in lipopolysaccharides stimulated mouse ma-
crophages with temporal resolution. These data for the ﬁrst time provide
a comprehensive view on the kinetics of macrophage activation. Transcrip-
tional, tanslational and localization regulation was distinguished and starting
points for further investigation of these mechanisms were proposed.
Zusammenfassung
Die durch Stimulierung aktivierte Proteinsynthese ermöglicht es Zellen ﬂe-
xibel auf Umweltfaktoren zu reagieren und wird von präzise kontrollierten
Mechanismen, der Transkription und der Translation, bestimmt. Im Rah-
men dieser Arbeit wurden Methoden der Proteinanreicherung in Kombina-
tion mit quantitativer Massenspektrometrie zur Analyse der Genexpression
entwickelt.
Transkriptionale Kontrollmechanismen wurden durch die Analyse von
sequenz-speziﬁsch DNA-bindenden Proteinen studiert. Die vorgestellte Me-
thode erlaubt die Verwendung von langen DNA-Sequenzen (500 Basenpaa-
re). Der Vergleich der Interaktionsproﬁle von cis-regulatorischen Modulen
(CRMs), welche die embryonale Entwicklung von Fruchtﬂiegen (Drosophi-
la melanogaster) steuern, ergab - neben tausenden unspeziﬁsch bindenden
Proteinen - 72 potentielle Regulatoren dieses Prozesses. Die in vivo Validie-
rung dieser Kanditaten ist in Arbeit und wird neue Kontrollmechanismen
der embryonalen Entwicklung in diesem Modellsystem aufdecken.
Die zweite, neu entwickelte Methode kombiniert Klick-Chemie und meta-
bolische Proteinmarkierung zur selektiven Anreicherung und Quantiﬁzierung
von neu synthetisierten Proteinen. Die Analyse von aktivierten Mausmakro-
phagen ergab eine hohe Empﬁndlichkeit auf schnelle Änderungen des Pro-
teoms. Zusätzlich wurde die Methode an die selektive und exakte Quantiﬁzie-
rung von sezernierten Proteinen angepasst und ermöglicht nun den Nachweis
einer Proteinklasse, deren Analyse aufgrund der hohen Hintergrundkonzen-
tration an Serumproteinen sehr anspruchsvoll ist. Die vergleichende Sekre-
tomanalyse von verschiedenen Zelllinien und primären Zellen ergab unter
anderem einen hohen Einﬂuss des Serumentzugs auf die Proteinsekretion.
Zusätzlich wurde eine neue Strategie zur Untersuchung der Sekretionskinetik
eingeführt. Mit Hilfe der vorgestellten Methode können zelluläre Reaktionen
unter optimalen Wachstumsbedingungen studiert werden.
Desweiteren wurden RNA- und Proteinabundanzmessungen mit den be-
schriebenen Methoden kombiniert, um die Aktivierungsmechanismen in Li-
popolysaccharid-stimulierten Mausmakrophagen zeitlich aufgelöst zu unter-
suchen. Die Ergebnisse ermöglichen die Unterscheidung von transkriptiona-
ler, translationaler und räumlicher Kontrolle und ergeben erstmalig ein um-
fassendes Bild der Zusammenhänge von RNA- und Proteinkinetik in diesem
Modellsystem. Außerdem wurden Ansatzpunkte zur Erforschung spezieller
Kontrollmechanismen vorgeschlagen.
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Der unermeßlich reichen, stets sich erneuernden Natur gegenüber wird der
Mensch, soweit er auch in der wissenschaftlichen Erkenntnis fortgeschritten
sein mag, immer das sich wundernde Kind bleiben und muß sich stets auf
neue Überraschungen gefaßt machen.
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Chapter 1
Introduction
How can cells change their phenotype as response to an environmental stim-
ulus? What makes it possible for a few cells to develop to a whole organism
with specialized tissues and organelles? By asking these and similar ques-
tions, it was discovered that the functionality of all organisms is based on
macromolecules like DNA, RNA and proteins.
The phenotype of a cell is established and adapted to environmental ef-
fects through interconnected networks of these macromolecular components.
Protein-protein and protein-DNA/RNA interactions regulate and enhance
speciﬁc gene expression to produce transcriptional and translational pro-
cesses to generate the correct response to cellular changes. To understand
the driving forces behind these changes, comprehensive examination of the
mechanisms establishing the composition and localization patterns of the
cellular pool of proteins (proteome) is necessary.
Investigating the composition of the proteome is challenging due to the
high complexity and dynamic range of protein abundance within the cellular
pool of protein. Hence, the ability to detect low abundant proteins with
potentially interesting biological functions, such as transcription factors, is
limited. Furthermore, in contrast to other macromolecules such as DNA,
proteins have a much higher diversity in their chemical properties (e.g. sol-
ubility) and cannot be ampliﬁed.
In light of these challenges, mass spectrometry-based methods have been
established as extremely powerful tools for protein identiﬁcation and quan-
tiﬁcation in complex mixtures. In combination with separation techniques
such as gel electrophoresis, isoelectric focusing, or multidimensional chro-
matography it is possible to identify and quantitatively compare thousands
of proteins from whole cell or tissue lysates [1;2]. Current instruments are
capable of detecting more than 10,000 proteins from a complex lysate, rep-
resenting a signiﬁcant depth of coverage of the human cellular proteome [3].
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However, identiﬁcation and quantiﬁcation of all proteins within a cell under
all conceivable conditions cannot provide complete mechanistic insight into
cellular regulation.
The establishment of protein abundance is regulated at several steps dur-
ing gene expression, leading from DNA to mRNA and ﬁnally to the func-
tional protein. Transcription factors can regulate the temporal and spatial
activity of gene expression by selective binding to speciﬁc DNA sequences.
This initial step towards the synthesis of a protein is orchestrated by global
cis-regulatory networks of interacting cis-regulatory modules (CRMs). Cis-
regulatory modules are regions in the genome that contain clusters of binding
sites that regulate the transcription of certain genes. The activity of a CRM
is deﬁned by the set of bound transcription factors. Therefore, understand-
ing how combinatory binding of transcription factors activates CRMs would
help to predict spatio-temporal gene expression.
Global detection of DNA sequences that bind to a single transcription
factor can be obtained based on recent developments in chromatin immuno-
precipitation methods in combination with microarrays and DNA sequenc-
ing [4–7]. However, the detection of all proteins binding to a single genomic
region is challenging due to the low abundance of transcription factors and
the wide variety of proteins that bind DNA non-speciﬁcally. In vitro DNA
aﬃnity puriﬁcation from nuclear extracts has been applied to short DNA se-
quences using mutated sequences in order to detect non-speciﬁcally binding
proteins [8]. Since CRMs are on average 270 base pairs long the mutation of
one or several DNA sites would not prevent binding of all speciﬁc proteins.
Therefore, a robust method for the investigation of proteins binding to longer
DNA sequences is necessary to gain insights into transcriptional regulation.
Following transcription a multitude of interconnected processes deﬁne the
ﬁnal protein abundance, such as mRNA processing and location, the balance
between protein synthesis and degradation and post-translational modiﬁca-
tions. Within the last century, immense progress in the ﬁeld of genomics and
transcriptomics yielded in the production of high-content data sets gath-
ering insights into cellular responses towards perturbation. However, these
approaches only shed light on a subset of the information required to obtain a
comprehensive picture of cellular regulation, as they omit contributions from
protein translation. Hence, combinatory examination of protein synthesis,
degradation and localization in tandem with genomic and transcriptomic
data are essential to distinguish between transcriptional and translational
regulation.
The potential for unbiased, high-throughput data acquisition positions
mass spectrometry as a powerful tool to address these questions on protein
level. However, for comparison of multiple cellular conditions more sophis-
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ticated experimental designs are required. Thus, quantitative labeling pro-
tocols based on stable isotope labeling facilitating examination of protein
turnover and synthesis have been established. These approaches overcome
limitations of established low-throughput pulse labeling methods that re-
quire radioactive isotopes, by measuring protein synthesis rates of thousands
of proteins in parallel. Contrarily, stable isotope labeling approaches are still
hampered by a low temporal resolution. Due to the restricted dynamic range
of the mass spectrometer, a minimal incorporation eﬃciency of 5-10% for the
stable isotope is neccessary for proper quantiﬁcation of protein synthesis [9].
This can be eluded by aﬃnity puriﬁcation of the proteins of interest,
which is a routine method for the detection of other low-abundant protein
classes, such as proteins with post-translational modiﬁcations [10]. Recently,
the enrichment and selective detection of newly synthesized proteins was fa-
cilitated by pulse labeling with non-canonical amino acids bearing functional
groups [11;12]. Combination of this enrichment approach with stable isotope
labeling methods will allow the quantitative analysis of proteome dynamics,
providing insight into the regulation of protein synthesis after stimulation.
Another currently understudied ﬁeld in proteomics that addresses protein
localization regulatory circuits is the cellular secretome. Fundamental pro-
cesses that overarch multiple cell types, or even organs, such as metabolism
and immunity, rely on eﬀective transmission of signaling proteins that are
secreted to elicit a response in a paracrine or autocrine fashion. In addition,
extracellular proteins can regulate adhesive and migratory properties of cells,
that are themselves modulated by a range of secreted proteases and protease
inhibitors. Indeed, in many diseases secreted proteins can create the condi-
tions that are favorable for the disorder, e.g., promotion of cancer metastasis.
This was highlighted by analyses demonstrating the secretome to be a proven
source of disease biomarkers [13;14]. Therefore, knowledge of the qualitative
and quantitative composition of this important set of proteins is crucial to
understand the biology of cellular interaction as well as stimulation response.
In spite of its potential to obtain biologically valuable information, secre-
tome analysis is not routinely applied in proteomics studies. This is primarily
due to the high-dynamic range of protein abundance present in complex ex-
tracellular mixtures, such as human plasma, or cell cultures supplemented
with 10% of bovine serum, that make mass spectrometric analysis challeng-
ing. This problem can be partially addressed through extensive protein
and/or peptide fractionation strategies that enable the mass spectrometer
to detect low-abundant factors. In spite of immense eﬀords, often only few
secreted proteins are detected.
Alternatively, cells can be proliferated under serum-free conditions to
omit the high background of serum proteins [15]. However, serum deprivation
3
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aﬀects expression and phosphorylation levels of multiple proteins [16–19] and
could therefore have unpredictable eﬀects on protein secretion. As such, a
method for the eﬀective enrichment of secreted proteins from the high back-
ground of serum could resolve the current limitations in secretome analysis.
1.1 Objective of the thesis
To overcome the described challenges in these ﬁelds of proteomics, the aim of
this thesis was to develop robust methods for the detection and quantiﬁcation
of newly synthesized and secreted proteins as well as DNA-binding proteins.
Initially, an approach for the detection of proteins binding to long DNA
sequences is demonstrated (chapter 3). Moreover, the newly developed tech-
nique was applied to the detection of proteins speciﬁcally binding to CRMs
active during drosophila melanogaster muscle development.
The subsequent chapters describe the development and evaluation of a
quantitative method to compare levels of newly synthesized proteins under
diﬀerent conditions and its application to intracellular and extracellular mea-
surement of protein synthesis.
The reproducible enrichment and quantiﬁcation of secreted proteins tack-
les the described challenges in this ﬁeld of proteome research (chapter 5).
The broad applicability to diﬀerent biological questions and systems is de-
monstrated and a novel approach in secretome analysis is introduced.
In chapter 6 these methods were applied to a time-course analysis of
macrophage activation. This model system was used to demonstrate how the
integration with mRNA and protein abundance data can shed light on the
regulatory mechanism controlling gene expression and protein localization
during innate immune response.
Advantages and limitations as well as possible applications of the pre-
sented approaches are discussed in chapter 7.
4
Chapter 2
Regulatory Mechanism
Establishing Cellular Protein
Homeostasis
The phenotype of a cell is to a great extent deﬁned by its protein compo-
sition. Here not only the identity of proteins is important but also their
amount, localization and activity. Most importantly, the protein pool is not
static. Proteins are constantly synthesized and degraded, allowing the cell to
quickly respond to environmental variations by adapting its protein compo-
sition and therefore its phenotype. To perpetuate cellular functionality the
protein amount, deﬁned by the interplay of protein synthesis and degrada-
tion (protein turnover), as well as protein localization and activity need to
be tightly controlled and adjusted to environmental variations. The follow-
ing chapter will give an overview on the current knowledge about regulatory
mechanisms of gene expression, protein turnover and secretion and how these
processes can be investigated. Mechanisms inﬂuencing protein activity will
not be covered, since - although equally important - they are less relevant
for the work presented in this thesis.
In addition, this chapter covers the regulation of innate immunity with
the focus on macrophages and Toll-like receptor 4 signaling as a model sys-
tem to study proteome dynamics. The activation of the immune system
after challenging an organism with pathogens is driven by complex tightly
connected response programs. Due to the extreme changes in protein ex-
pression during this process, it is well suited for the investigation of protein
synthesis, degradation and secretion.
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2.1 Regulation of gene expression
Protein synthesis is regulated at various steps during gene expression (ﬁg. 2.1).
The genetic information is stored in the DNA, being kept in the nucleus of
a cell. DNA is transcribed to mRNA, which is transported from the nucleus
to the cytoplasm, where translation into proteins takes place. Each of these
steps is tightly controlled to ensure the production of the proteins needed at
a certain time.
DNA RNA
transcript
mRNA mRNA protein inactive
protein
transcriptional
control
RNA
processing
control
RNA
transport
control
translation
control
protein
activity
control
nuclear pore
nuclear envelope
NUCLEUS CYTOSOL
Figure 2.1: Schematic representation of gene expression and its regulation. Tran-
scriptional control mechanisms are highlighted in purple, while post-transcriptional
control points are shown in yellow. (Adapted from “Essential cell biology” [20].)
The mechanisms regulating gene expression can be roughly distinguished
into transcriptional and post-transcriptional control (ﬁg. 2.1). Transcrip-
tional control is achieved by concerted transcription factor binding and mech-
anisms regulating DNA accessibility as well as mRNA processing, while
translation and establishment of protein localization and activity are post-
transcriptional processes. The correlation between RNA and protein abun-
dance can help to estimate the contribution of these two levels regulating
the ﬁnal protein amount. The correlations reported in the literature vary de-
pending on the experimental setup, the investigated organism and the applied
statistical approach between 0.3 and 0.7 [21–32]. These numbers demonstrate
the high contribution of post-transcriptional control to gene expression. In
the next sections transcriptional and post-transcriptional regulation mecha-
nism relevant for this thesis, will be discussed.
2.1.1 Transcriptional regulation
During transcription the genetic code stored in the DNA is transfered to
mRNA based on complementary base pairing supported by RNA polymerase
II. This process is divided into four steps: recruitment of RNA polymerase II
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to promoters, transcription initiation, elongation and termination [33]. Pro-
moters are DNA sequences at the beginning of a gene bearing common se-
quence elements such as TATA boxes and the initiator sequence as well as
speciﬁc transcription factor binding sites. In concert, these binding sites
recruit the so called general transcription machinery to the transcriptional
start site (TSS). The general transcription factor machinery is composed of
the mediator complex and the general transcription factors which assemble
into a pre-initiation complex. General transcription factors together recog-
nize core promoters, assemble the transcription start site by e.g. unwinding
of the DNA double strand, recruit RNA polymerase II and support the tran-
sition from transcription initiation to elongation. In addition, for certain
genes the binding of transcription factors to a distant site in the DNA strand
called cis-regulatory module (CRM) may be required. These CRMs are on
average 270 base pair long DNA stretches composed of multiple transcrip-
tion factor binding sites [34]. Here, signals provided by multiple transcription
factors are integrated, leading to inhibition or activation of transcription re-
sulting in speciﬁc spatio-temporal gene expression. The recent discovery of
nearly 300,000 mouse cis-regulatory sequences illustrates their importance in
gene regulation [35].
The establishment and regulation of the mentioned processes is far more
complex than expected thirty years ago. Novel methodologies have revealed
detailed insights into gene regulation, leading to four concepts that in concert
govern gene expression [36].
First, the organization of nucleosomes and their modiﬁcation states are
well deﬁned. Genes are stored in the nucleus by wrapping the chromosomal
DNA around histone octamers containing two copies of histones H2A, H2B,
H3 and H4 forming the nucleosomes [37]. This compact structure inhibits
transcription initiation [38]. The closed chromatin formation is often marked
by speciﬁc histone modiﬁcations, e.g., methylation of histone H3 at lysine 9
(H3K9), methylation at H3K27 and dimethylation of H3R2 [39;40]. Genome-
wide analysis of nucleosome positions revealed that promoters of most genes
reside in nucleosome-free regions, with equal distance to the transcription
start site [41].
Second, chromatin remodeling is coupled to promoter assembly of the
general transcription factors and RNA polymerase II. Transcription initia-
tion involves the rearrangement of structure, position, or composition of nu-
cleosomes facilitated by four families of chromatin remodeling complexes [42].
Conversely, nucleosome reorganization by the Imitation SWItch (ISWI) fam-
ily of remodelers can repress transcription [43].
Third, the phosphorylation states of RNA polymerase II are connected to
chromatin modiﬁcation states during transcription [36]. Changing phospho-
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rylation pattern at the RNA polymerase II CTD repeat selectively govern
the recruitment of proteins involved in histone modiﬁcations, elongation,
termination and mRNA processing at diﬀerent stages during the transcrip-
tion cycle [44]. In addition, the 20-40 amino acids long histone tails, which
reach from the core histones to the surrounding solvent, bear highly dy-
namic post-translational modiﬁcations including ubiquitinylations, methy-
lations and acetylations, also called “histone marks” [45]. They change the
structure of chromatin due to alterations in electrostatic properties or inter-
nucleosomal contacts and/or serve as binding sites for regulatory proteins.
RNA polymerase II phosphorylations and histone marks constitute a highly
connected network together regulating the process during transcription. E.g.
trimethylation of H3K4, which is associated with active genes [46], requires
H3K14 acetylation [47] which is established by acetyltransferases that colocal-
izes with RNA polymerase II.
Finally, regulatory networks of sequence-speciﬁc transcription factors gov-
ern the transcription of genes. Cis-regulatory elements bound by speciﬁc
transcription factors or transcription modulators regulate transcriptional pro-
grams. They can induce or repress transcription or assist binding of the basal
transcription machinery [36;48]. The direct interaction of these proteins bind-
ing to a distant site in the genome with the general transcription machinery
is established by a loop formation of the DNA. Thereby, sequence-speciﬁc
regulators orchestrate multiple processes during transcription by the recruit-
ment of chromatin remodeling complexes, general transcription factors, chro-
matin modifying complexes and RNA polymerase II via the Mediator com-
plex [36]. Possible transcription induction mechanisms are, e.g., the recruit-
ment of chromatin remodeling proteins that increase the accessibility of TSS
or the recruitment of speciﬁc kinases phosphorylating RNA polymerase II
and thereby stimulate elongation. CRM regulation is characterized by the
dependence of CRM activation on the concentration of transcription factors,
by cooperative transcription factor binding and the dominance of repressive
inputs over activating ones [49]. Concerted regulation of gene expression is
established by the integration of diﬀerent network motifs, like the parallel
induction of several genes by the same transcription factor (“single-input”
motif), the integration of multiple signaling pathways to drive transcription
of one gene (“multiple-input” motif) or autoregulation of transcription fac-
tors [50].
Additional mechanisms regulating gene expression that have emerged very
recently are pausing of RNA polymerase II after initiation [51] and regulation
by antisense transcripts and cryptic unstable transcripts (CUTs) from inter-
genic regions [52;53].
The further investigation of the mechanisms governing the described con-
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cepts as well as their interactions will lead to the elucidation of regulatory
networks controlling gene expression, the ﬁrst step towards the synthesis of
proteins.
2.1.2 Analysis of transcription factor binding sites
As described, the regulation of gene expression is partly deﬁned by transcrip-
tion factors binding in concert to speciﬁc DNA elements called cis-regulatory
modules thereby initiating or inhibiting gene transcription. The detection of
all proteins binding to a CRM should help to understand how transcription
of a gene is controlled.
Transcription factors have domains speciﬁcally binding to certain DNA
motifs. Although in the era of whole genome sequencing, it should be possi-
ble to develop computational algorithms that scan this data for transcription
factor binding motifs, the detection of transcription factor targets remains
challenging [54]. Firstly, the transcription factor binding motif needs to be well
deﬁned. Since these motifs often have a “loose” consensus, large collections
of binding sites are needed to deﬁne a motif. Secondly, due to the enormous
search space, deﬁned by the genome size, in comparison to the rather short
motifs and their “loose” consensus these approaches often detect a high per-
centage of biologically not functional binding sites. Improvements have been
achieved by accounting for the fact that transcription factor binding sites
often cluster together and by the experimental validation of CRM activity
data [55].
A more direct method is chromatin immunoprecipitation in combination
with DNA arrays (ChIP-Chip) [4] or DNA sequencing (ChIP-Seq) [5–7]. Here,
in vivo DNA-protein complexes are preserved by crosslinking using formalde-
hyde, followed by DNA fractionation and the enrichment of a selected tran-
scription factor using an antibody against the transcription factor of interest.
After crosslink reversion the bound DNA is subjected to microarray or DNA
sequencing analysis to detect transcription factor binding sites across the
complete genome. The need for a speciﬁc antibody as well as the fact that
only binding sites for one transcription factor are detected in one experiment
represent the main disadvantages of this approach.
An alternative to chromatin immunoprecipitation are protein binding mi-
croarrays [56;57]. Here, microarrays are spotted with a large number of poten-
tial DNA-binding sites and incubated with the puriﬁed DNA-binding protein
of interest, bearing an epitope tag, which can be detected with a ﬂuorescence-
labeled antibody speciﬁc for the epitope tag.
All previously mentioned methods require the knowledge of the identity
of the transcription factor to be used as a “bait”. To detect transcriptional
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active sites for unknown transcription factors either methods altering the
chromatin structure, like DNaseI hypersensitivity measurement, or methods
manipulating deﬁned DNA segments are used. Extreme sensitivity to enzy-
matic digestion marks functional regions in non-coding sequences, including
transcription factor binding sites [58]. Hypersensitivity has been associated
with acetylated histones H3 and H4 and methylated H3 at lysine 4 [59], which
reduce the aﬃnity of DNA for the nucleosome [60]. Still, the transcription
factor binding to the detected sites is not identiﬁed.
For the identiﬁcation of unknown transcription factors binding to a DNA
sequence of interest mass spectrometry in combination with nucleic acid aﬃn-
ity capture [61;62] should be a powerful tool. Here, a “bait” DNA sequence is
used for in vitro enrichment of DNA-binding proteins from nuclear extracts.
The identiﬁcation of speciﬁc DNA-binding proteins is challenging in a
single-step DNA-aﬃnity isolation [63] caused by the low abundance of tran-
scription factors that bind to speciﬁc promoters, accounting only for <0.01%
of the total cellular proteins [64]. Therefore, large amounts of cultured cells
are necessary to achieve suﬃcient amounts for mass spectrometric detec-
tion (10,000- to 100,000-fold enrichment). Moreover, non-speciﬁc binding of
positively charged proteins to the DNA backbone represents an abundant
contamination in DNA aﬃnity isolates masking low abundant speciﬁc DNA-
binders. Non-speciﬁcally binding proteins can be discriminated from speciﬁc
binders by quantitative mass spectrometry using mutated control DNA se-
quences in parallel for enrichment.
This method has been applied to the detection of DNA- and RNA-binding
proteins by diﬀerent groups addressing various biological questions [65–69],
such as the identiﬁcation of six4 as the trex-binding factor in the muscle
creatine kinase enhancer [70] and the detection of RBP-J as a Methyl-CpG
binding protein [71]. Due to the need for a mutated control DNA all this ap-
proaches use short DNA fragments (∼40 base pairs), which very well exceed
the length of a transcription factor binding site. The combinatorial binding
of multiple transcription factors to longer DNA sequences (e.g. in the range
of CRMs) can therefore not be assessed by this approach.
In an alternative approach applying mass spectrometry Dejardin et al.
used a speciﬁc nucleic acid probe against telomeres to isolate genomic DNA
with associated proteins after crosslinking of protein-DNA complexes, fol-
lowed by identiﬁcation using mass spectrometry [72]. Thereby they are able
to investigate in vivo DNA-protein interactions. However, it is yet to be
demonstrated for genomic loci that exist at lower copies per cells. In ad-
dition, the detection of crosslinked peptides represents one challenge of this
method.
In conclusion, ChIP based approaches are extremely powerful for the
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genome wide identiﬁcation of DNA bound to one protein, while quantita-
tive mass spectrometry based approaches can be used to detect previously
unknown DNA-binding proteins to short DNA sequences. Due to the large
number of non-speciﬁc DNA-binding proteins these approaches are restricted
to short DNA sequences that have deﬁned protein binding sites. In the course
of this thesis this challenge has been addressed by the implementation of a
quantitative proteomic approach comparing the DNA-protein interactomes
of multiple CRMs against each other. This way, a diﬀerentiation between
non-speciﬁc and sequence-speciﬁc DNA binding was possible.
2.1.3 Regulation of protein synthesis and degradation
As depicted in section 2.1 transcriptional regulation can deﬁne the ﬁnal pro-
tein amount only to a certain extent, because it represents just one part of
the process of gene expression. It has been estimated that approximately
one third of all genes are translationally controlled [73]. Hence, the additional
investigation of protein synthesis and protein degradation (protein turnover)
helps to understand how global protein abundance is established and regu-
lated. Here, protein synthesis has been much deeper investigated in the last
decades than protein degradation.
Protein synthesis or translation, which is well characterized and described
in general textbooks [74], comprises the ribosomal decoding of information en-
crypted in mRNA into the amino acid sequence of a protein in the cytoplasm
of a cell. Each amino acid is encoded by nucleotide triplets being recognized
by the complementary anticodon triplet of a transfer RNA (tRNA). Each
tRNA carries a special amino acid, that can be added to the C-terminal end
of the polypeptide chain. The translation process, carried out by large mul-
tiprotein complexes, the ribosomes, is divided into four phases: initiation,
elongation, translocation and termination. During initiation the start codon
(AUG) is recognized by a unique initiator tRNA molecule, resulting in the
binding of the small ribosomal subunit, which is supported by initiation fac-
tors. Protein synthesis starts after binding of the large ribosomal subunit.
During elongation mRNA triplets are translated in 5’-to-3’ direction by bind-
ing of complementary aminoacyl-tRNA in four steps. After aminoacyl-tRNA
is bound, the peptide bond can be formed. This is followed by two ribosome
translocation steps. These reactions are controlled and driven by elongation
factors, which use GTP hydrolysis to provide energy. Hence, the ribosome
moves along the mRNA until it reaches a stop codon. Here binding of release
factors results in the termination of translation and release of the polypetide
chain.
Regulation of translation is achieved by several diﬀerent mechanisms
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Figure 2.2: Mechanism regulating translation (yellow) and methods to address
diﬀerent levels of regulation (red). (Adapted from Maier et. al. [31].)
(ﬁg. 2.2). First, the translation rate of proteins can be inﬂuenced by physical
properties of the mRNA. Prokaryotic mRNA for example contains a so called
Shine Dalgarno (SD) sequence upstream of the start codon [75]. This sequence
is complementary to the 3’ end of 16S rRNA in the ribosome, therefore rep-
resenting a ribosomal binding site. The strength of ribosomal binding to
this sequence inﬂuences the translation rate, being lower for weak ribosome
binding. The Kozak sequence has a similar function in eukaryotes [76].
In addition, condition-dependent physical properties like secondary or
tertiary mRNA structure can inﬂuence the accessibility of ribosomal binding
sites. The structure of rpoH in Escherichia coli for example is temperature
dependent resulting in diﬀerent translation rates for the corresponding pro-
tein at diﬀerent temperatures [77]. The mRNA translation repression of the
cobalamin-transport protein (btuB) in Escherichia coli by high coenzyme
B12 concentration is another example, this time highlighting the inﬂuence of
small metabolites on protein synthesis [78].
An additional mechanism regulating transcription is the binding of re-
pressive proteins to the translational start site (ﬁg. 2.2). Similarly, regulatory
small RNA in prokaryotes or microRNA in eukaryotes can aﬀect evolution
and stability of mRNA as well as translation eﬃciency [79]. The enhancement
of ribosome binding is for example achieved when small RNA binding pro-
hibits secondary mRNA structures that block ribosome binding [80]. Trans-
lation is blocked by small RNAs binding to the SD sequence of mRNA [79].
An increase of mRNA stability can be achieved by shielding RNAse cleavage
sites [79;81;82].
Translation eﬃciency, deﬁned as the number of molecules per mRNA and
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time, is furthermore maximized by a mechanism called “codon bias” (ﬁg. 2.2).
Here, the triplet codes for one amino acid are used with diﬀerent frequency.
Highly expressed genes usually have a large codon bias [83;84], which can be
measured using the codon adaptation index (CAI) [85]. This method can help
to evaluate the abundance distribution in a data set.
Ribosome occupancy, which is the number of ribosomes bound to and
translating one mRNA, has a big impact on translational eﬃciency (ﬁg. 2.2).
It can be measured by obtaining polysome proﬁles with sucrose gradient
centrifugation [86], aﬃnity tag puriﬁcation followed by microarray analysis
and/or northern blotting [87] or deep sequencing of mRNA fragments that
are protected by ribosomes [73]. Ribosome occupancy and ribosome density
have been estimated to contribute to approximately 5% to the total variation
between mRNA and protein abundance [88]. Therefore, the parallel measure-
ment of ribosome occupancy and mRNA and protein abundance improves
the correlation between mRNAs and proteins [73].
An important mechanism establishing protein abundance is protein degra-
dation, which in combination with protein synthesis determines the half-life
of a protein (ﬁg. 2.2). Protein degradation is inﬂuenced by protein stability,
which can be partly estimated using the N-end rule [89]. Some N-terminal
amino acids are speciﬁcally recognized by chaperones, which unfold proteins
for proteasomal degradation. Therefore, the N-terminal amino acid deter-
mines the stability of proteins. Another sequence motif inducing protein
instability is the PEST motif, which is rich in proline, glutamic acid, serine
and threonine residues [90]. In addition, certain post-transcriptional modiﬁ-
cations like ubiquitinylation mark proteins for degradation.
Translation eﬃciency can furthermore be regulated during translation
initiation or elongation (ﬁg. 2.2). One example is the phosphorylation of
translation initiation [91–93] or elongation factors [94]. Translational eﬃciency
is inﬂuenced by the sequence surrounding the stop codon [95;96]. In addition
mRNA could either not be translated or the corresponding protein could
escape from detection, due to the secretion.
In conclusion, protein synthesis and degradation are regulated by com-
plex interconnected mechanisms highly inﬂuenced by internal and external
conditions. Therefore, the global measurement of these processes would help
to explain regulatory principles of gene expression. At the same time, it
may provide a mechanistic link between speciﬁc external events and their
consequences at the level of the proteome.
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2.1.4 Measuring protein synthesis and degradation
Protein synthesis and degradation are often measured by pulse-labeling with
radioactive or stable isotopes. Therefore, cells or even complete organisms are
grown with isotope labeled nutrients, e.g., amino acids like 35S-methionine [97],
glucose or nitrogen, resulting in the labeling of all newly synthesized proteins.
Hence, the relative amounts of labeled and unlabeled proteins can be used to
calculate the turnover of a protein. Conversely, labeling of cells or organisms
with isotopes for a certain amount of time, followed by a medium switch to
the natural isotope, allows to calculate protein degradation rates based on
the decrease of isotopic label. When combined, double labeling strategies
enable the parallel measurement of protein synthesis and degradation [98;99].
The detection of radioactive isotopes with audioradiography reveals the
averaged protein synthesis rate of the total proteome. The combination of
radioactive labeling with protein separation using 2D gel electrophoresis en-
ables the measurement of individual protein half-lifes [97–99]. Here, the half-life
for each gel-spot can be calculated separately while the protein identiﬁca-
tion is performed using mass spectrometry. An alternative option is the
enrichment of proteins using antibody-based techniques, followed by audio-
radiography. Both methods require single protein samples after separation,
meaning no overlap of gel-spots or highly speciﬁc antibodies, which is diﬃcult
to achieve considering the complexity of the proteome.
Protein degradation can be assessed by chemical inhibition of eEF2-
mediated ribosome translocation with cycloheximide followed by a western
blot time course analysis. The disadvantage of this method is the possible
perturbation of cellular function by cycloheximide, e.g., induction of cellular
stress [100].
Although limited in throughput, these traditional techniques revealed
basic principles of protein synthesis and degradation regulation. Modern
methods aim to assess protein turnover on a global scale. They can be
subdivided into approaches using genetic tags and those that don’t.
Genetic tagging approaches utilize either aﬃnity or ﬂuorescent tags. Aﬃn-
ity tags can be used for aﬃnity puriﬁcation followed by western blotting as
read out, as performed for 4000 tandem aﬃnity protein (TAP) tagged yeast
strains [101]. Bleaching experiments with ﬂuorescent tags enable the extrap-
olation protein half lifes [102]. Khmelinskii et al. recently introduced fusions
of two single-color ﬂuorescent proteins that mature with diﬀerent kinetics
called “tandem ﬂuorescent protein timers” (tFTs), which were used to ana-
lyze protein turnover and mobility in living cells [103]. A careful investigation
of the results retrieved with these methods is necessary since the expression
of tagged proteins could inﬂuence protein structure, activity, localization and
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stability. In addition, genetic manipulation of cell lines or organisms is time
and cost intensive and would be diﬃcult to be applied for many cell lines
and even more diﬃcult for systems that cannot be genetically manipulated.
Most non-tagging approaches adapt isotopic labeling strategies by using
stable instead of radioactive isotopes, in combination with high resolution
mass spectrometry for protein identiﬁcation and measurement of protein
synthesis and degradation [104–112]. Diﬀerent sources of stable isotopes can
be used, including deuterated water [111] and stable isotope labeled amino
acids containing 2D, 13C, 15N or a combination thereof [106;112].
In standard stable isotope labeling methods, which aim to compare pro-
tein abundances between two samples, the cells are completely labeled with
the stable isotope. After collection, mixing and lysis of the diﬀerentially la-
beled and treated cells, the proteins are digested into peptides, which are
submitted to nanoLC-MS/MS. Each peptide is now represented by a heavy
and light peak, coming form the diﬀerent samples. The peak area ratios are
used to calculate the relative abundance of the protein of interest. Nowadays,
the stable isotope labeling with amino acids in cell culture (SILAC) method
is most often used for this purpose [113] (ﬁg. 2.3a).
In contrast to this but similar to radioactive labeling, for protein turnover
studies the cells are just labeled for a certain time with the stable isotopes [106]
(ﬁg. 2.3b). When using stable isotope labeled amino acids this approach is
called dynamic SILAC. An adaption of this method is pulsed SILAC [112]
(ﬁg. 2.3c). Here, in a triple labeling strategy changes in protein synthesis in
response to cellular perturbation are compared. Starting with two equal cell
populations the cell growth medium is exchanged to growth medium either
containing medium-heavy or heavy stable isotope labeled amino acids. In
parallel, a perturbation can be applied to either of the two cell populations.
After the desired incubation time the cells are mixed and subjected to sample
preparation for mass spectrometry. The measured mass spectra will contain
three peaks. While the light peak represents a combination of peptides de-
rived from “old” proteins of both samples, the medium-heavy and heavy peak
correspond to the peptides of newly synthesized proteins in each of the two
samples and can be used for relative quantiﬁcation of protein synthesis.
Due to the restricted dynamic range of the mass spectrometer, a minimal
incorporation eﬃciency of 5-10% for the stable isotope is necessary to obtain a
suﬃcient signal-to-noise ratio for proper quantiﬁcation of protein synthesis [9].
Hence, short incubation times are not applicable and transient changes in
protein synthesis, e.g., rapid stimulation responses, cannot be investigated.
The signal-to-noise ratio could be improved by depleting “old” proteins,
since those represent the major part of the sample. A depletion of “old”
proteins would allow the subjection of higher sample amounts to the mass
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Figure 2.3: Mass spectrometry based methods applied for the quantiﬁcation of
newly synthesized proteins or protein turnover. a) Quantiﬁcation of protein abun-
dance changes using SILAC [113]. b) Protein turnover measurement by dynamic
SILAC [106]. c) Quantiﬁcation of diﬀerences in protein synthesis measured with
pulsed SILAC [112]. d) Identiﬁcation of newly synthesized proteins after enrich-
ment. Stable isotope labeling enables the distinction between newly synthesized
proteins and background [11]. e) Quantiﬁcation of diﬀerences in protein synthesis
using isobaric tags for relative and absolute quantiﬁcation (iTRAQ) for peptide
labeling [114;115].
spectrometric analysis, increasing the signals derived from newly synthesized
proteins.
2.1.5 Labeling of newly synthesized proteins with non-
natural amino acids
For the depletion of “old” proteins a method to tag newly synthesized pro-
teins would be needed. A perfect tag would be selectively and eﬀectively
incorporated into newly synthesized proteins and should ideally have no ef-
fect on protein structure or function. Furthermore, a functional group is
necessary, which is bioorthogonal and allows the enrichment of the tagged
proteins. This means it should not interfere with naturally occurring func-
tional groups and reactions. Furthermore, its incorporation should allow
experimental setups similar to stable isotope labeling.
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Azidohomoalanine (AHA), homopropargylglycine (HPG) and homoallylglycine
(HAG) bear reactive groups that can be functionalized using bioorthogonal chem-
istry.
These requirements are perfectly fulﬁlled by analogues of naturally occur-
ring amino acids, called non-canonical amino acids (ncAAS) (ﬁg. 2.4). The
mis-incorporation of amino acids in the polypeptide strain during protein syn-
thesis is prevented due to the selectivity of aminoacyl-tRNA synthetases [116].
Therefore, non-canonical amino acids can be incorporated into proteins only
if their structure is similar enough to the naturally occurring amino acid, to
satisfy the proofreading mechanism of the according aminoacyl-tRNA syn-
thetase. Since the incorporation of the non-canonical amino acids is often
disfavored relative to the naturally occurring amino acid [117], a depletion of
the natural amino acid is necessary.
Selenomethionine was the ﬁrst non-canonical amino acid incorporated
into newly synthesized proteins in 1956 [118] (ﬁg. 2.4) and it has been used ex-
tensively for phase determination in structural biology [119]. Today hundreds
of non-canonical amino acids are known, but only a few can be directly incor-
porated without the need for genetical engineering approaches. Among them
the methionine analogues azidohomoalanine (AHA), homopropargylglycine
(HPG) and homoallylglycine (HAG) bear reactive functional groups that do
not appear in the natural environment of the cell, being azide, alkyne, or
alkene side chains, respectively (ﬁg. 2.4). Experimental conditions can be
adjusted to inﬂuence the percentage of natural amino acid replaced by the
analogous one. The nearly quantitative replacement of methionine has been
reported for AHA [120], while 85% of methionine were substitued by HPG
in Escherichia coli [117]. Obviously, only proteins containing the replaced
amino acid (e.g. methionine) and that are expressed can be labeled. La-
beled proteins are coupled to reagents containing aﬃnity enrichment groups
or ﬂuorecent dyes applying bioorthogonal chemical reactions, opening cues
for detection and visualization of newly synthesized proteins (ﬁg. 2.5). In
this setup non-canonical amino acids are useful tools in molecular biology.
Azides and alkynes, which are absent in mammalian cells, can be cou-
pled to each other by the very selective 1,3-cycloaddition under enhancement
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Figure 2.5: Non-canonical amino acids for the detection and visualization of
newly synthesized proteins: ncAAs are incorporated into all newly synthesized
proteins (green) using pulse-labeling. The thereby introduced functional groups
can be modiﬁed with either aﬃnity tags like biotin or agarose resin or with ﬂu-
orescence dyes using bioorthogonal chemistry. The ﬂuorescent label can be read
out after gel electrophoretic separation or in vivo visualize the distribution of
newly synthesized proteins in the cell. Aﬃnity tags can be used for detection by
western blotting (in the case of biotin) and aﬃnity enrichment, to separate newly
synthesized proteins from “old” proteins (blue), followed by mass spectrometric
identiﬁcation. (Adapted from Ngo et al. [120]. The ﬂuorescence image was kindly
provided by Jenny Hansson.)
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by Cu(I) catalysis or by ring strain (so-called click-reaction) [121]. An alter-
native way to functionalize azides is the Staudinger ligation [122], attaching
phosphines or phosphites. Therefore, AHA in contrast to HPG exhibits a
broader bioorthogonal reactivity.
Both non-canonical amino acids have been used to functionalyse newly
synthesized proteins in bacteria [12;114;123] as well as mammalian cells [11;124–126].
Dieterich et al. ﬁrst used AHA in combination with deuterated leucin to
label and enrich newly synthesized proteins from human endothelial cells
(HEK) [11] (ﬁg. 2.3d). They demonstrated that AHA is not toxic during
the applied two hours of incubation and that it does not increase protein
degradation. For enrichment of newly synthesized proteins prior to mass
spectrometric analysis a biotin reagent, containing an alkyne group and a
cleavable linker, was used in combination with streptavidin beads. To exclude
the detection of background binding proteins, only peptides containing AHA
or deuterated leucin were used for the identiﬁcation of newly synthesized
proteins. This approach is called bioorthogonal non-canonical amino acid
tagging (BONCAT).
To circumvent the streptavidin enrichment step Nessen et al. developed
an alkyne bearing resin (azide-reactive cyclooctyne (ARCO) resin) for co-
valent coupling of AHA containing proteins [12]. Here, the reaction can be
performed without Cu(I) catalysis, since the cyclic alkyne is activated by
ring strain. Again a cleavable linker allowed the release of newly synthesized
proteins after stringent washing.
In an alternative approach Kramer et al. labeled the AHA containing
proteins, derived from very short pulse labeling of Escherichia coli, with
tris(2-carboxyethyl)phosphine using Staudinger ligation [114]. This induces a
time shift during peptide chromatography, allowing the separation of AHA
containing peptides from others. For the quantiﬁcation of perturbations in-
duced by changing the growth temperature they combined this approach
with isobaric tags for relative and absolute quantiﬁcation (iTRAQ) labeling
of the peptides, a reagent used for relative quantiﬁcation in mass spectrom-
etry (ﬁg. 2.3e). In an additional report they used this method to quantify
the changes in protein synthesis after switching from aerobiosis to anaerobio-
sis [115]. The comparison of total protein expression changes with the detected
changes in protein synthesis revealed a higher contribution of protein synthe-
sis to the resulting protein abundance levels [115]. Protein degradation had a
minor inﬂuence on protein abundance in their system.
To assess genome-wide nucleosome dynamics in Drosophila melanogaster
cells Deal et al. used AHA labeling to enrich newly synthesized histones,
followed by the identiﬁcation of bound DNA [127]. Hereby, they found the
highest nucleosome turnover over active genes, epigenetic regulatory elements
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and replication origins.
Notably, Hinz et al. incorporated recently AHA in living zebraﬁsh larvae,
without measurable eﬀects on zebraﬁsh larvae behavior [128]. They used this
method to visualize and measure the amount of newly synthesized proteins
across the larva.
In conclusion, the incorporation of non-canonical amino acids represents
a useful tool to selectively introduce tags into newly synthesized proteins.
Coupling these tags to reagents using bioorthogonal chemistry for enrich-
ment or visualization enables the investigation of protein synthesis dynamics,
which will improve our understanding of gene regulation. In this technique,
the selective capturing of the newly synthesized proteins from a background
of “old” proteins is advantageous in comparison to other strategies for the
quantiﬁcation of newly synthesized proteins.
2.2 Regulation of protein secretion
Subsequent to synthesis proteins can be translocated in the cell, establishing
the ﬁnal protein amounts in cellular compartments. This includes protein
secretion to transport proteins to the extracellular space. Here, secreted pro-
teins, such as cytokines, chemokines and hormones, exhibit central functions,
like intercellular communication, which is crucial to maintain homeostasis in
every multicellular organism. The cellular secretome does not only include
actively secreted proteins, but also extracellular matrix proteins and proteins
shed from the cell surface [13]. This important set of proteins is encoded by ap-
proximately 10% of the human genome regulating multiple cellular processes
like cell-to-cell signaling, immunity, migration and metabolism.
Secreted proteins exit the cell via diﬀerent pathways. Proteins released
by the classical secretion pathway are mostly regulated on the level of gene
expression, while the regulation of unconventional secreted proteins is often
independent of gene expression regulation [129].
2.2.1 Classical secretion
The majority of proteins is externalized via the classical secretion path-
way [130]. Here, proteins containing an N-terminal hydrophobic signal se-
quence are secreted in a ER/Golgi-apparatus dependent manner.
Proteins bearing a signal peptide are translated into the lumen of the en-
doplasmatic reticulum guided by the signal peptide recognition particle [131]
(ﬁg. 2.6). Following post-transcriptional processing and quality control, they
are packed into cargo vesicles coated with coat protein complex II (COPII)
20
CHAPTER 2. REGULATORY MECHANISM ESTABLISHING CELLULAR
PROTEIN HOMEOSTASIS
COPII
COPI
Ribosomes
Plasma membrane
Endoplasmatic 
reticulum
cis-Golgi
trans-Golgi
Retrograde
transport
Anterograde
transport
Cytoplasm
Extracellular space
Signal recognition particle
Figure 2.6: Schematic representation of the classical secretion pathway.
at specialized membrane domains, called ER exit sites (mammals) or tER
sites (yeast or drosophila melanogaster) and directed towards the Golgi-
apparatus [132]. The transport vesicles fuse to form new cis-Golgi vesicles,
which then move towards the trans-face of the Golgi stack [133]. After passing
the Golgi-apparatus, where they are modiﬁed, processed and sorted, cargo
proteins are directed into vesicles and transported towards the cell mem-
brane. Vesicular transport across Golgi cisterna as well as back to the ER
is mediated by COPI coated vesicles [134]. Next, the carrier vesicles fuse with
the membrane, releasing the proteins into the extracellular space [135]. Vesi-
cles can be continuously transported to the plasma membrane, resulting in
the constitutive secretion of the containing proteins. Alternatively, proteins
can be stored in vesicles, called secretory granules, and membrane fusion
and protein release to the extracellular space needs to be induced by an ex-
tracellular stimulus [136]. Fusion events during vesicular transport are medi-
ated via SNAREs (soluble N-ethylmaleimide-sensitive fusion protein (NSF)
accessory protein (SNAP) receptors). Therefore, trans-SNARE complexes
are formed between vesicular SNAREs (v-SNARE) and target SNAREs (t-
SNARE), e.g., at the membrane when they are close to each other [137].
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2.2.2 Unconventional secretion
Unconventional or non-classical secretion encompasses all pathways that do
not follow the classical ER-Golgi-route of secretion. Secretion of proteins
continuing along these pathways is not aﬀected by brefeldin A, which causes
rapid fragmentation of the Golgi-apparatus [138]. Although unconventional
secretion has been mainly shown for proteins not bearing a signal peptide,
recently Golgi-independent routes of secretion for signal peptide containing
proteins have been reported.
Unconventional secretion of signal peptide containing proteins
Signal peptide containing proteins can bypass the Golgi-apparatus. This was
shown for CD45 [139], ovine Mx1 [140] and CF transmembrane conductance reg-
ulator (CFTR) [141]. COPII-coated vesicles can either directly fuse with the
plasma membrane or with lysosomes or endosomes which are directed towards
the membrane. Alternatively, cargo proteins can be packed into COPII in-
dependent vesicles, following transport to the plasma membrane. Currently,
the function of these export routes is not clear, but possibly processing of
oligosaccharide chains or proteolytic cleavage events are prevented, resulting
in a diﬀerent biological activity of the secreted proteins [142].
Unconventional secretion of cytosolic or nuclear proteins
Several proteins not bearing an N-terminal signal sequence are established
secretory proteins, e.g., Mif, Galectins, Il-1beta, Ybx1 [143–147]. The diverse
routes of secretion they follow are not fully dissolved yet, but it has been
shown that unconventional secretion is often triggered by cellular stress, such
as inﬂammation or starvation [148]. At least four mechanisms, which can be
classiﬁed into vesicular and non-vesicular pathways, have been proposed.
First, the translocation of proteins through the membrane can be per-
formed without the involvement of vesicles (ﬁg. 2.7). Examples for pro-
teins following this pathway are FGF1 [149], HIV Tat [150] and annexin A2 [151].
Transporter proteins, like ATP binding cassette (ABC) transporter, can as-
sist the externalization of the protein. One example is ABCA1, which is in-
volved in the secretion of multiple proteins like IL-1beta [152] and HSP70 [153].
In addition, phosphoinositide phosphatidylinositol-4,5-bisphosphate has
been described to initiate FGF2 translocation towards the membrane, fol-
lowed by heparan sulphate proteoglycans (HSPGs) mediated secretion [142].
Just recently, the oligomerisation of FGF2 resulting in the formation of li-
pidic membrane pores was demonstrated as the mechanism driving FGF2
secretion [154].
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Figure 2.7: Schematic representation of possible unconventional secretion path-
ways: 1) Translocation of proteins across the plasma membrane. Adaptor
molecules could be involved. 2) Secretion via secretory lysosomes. 3) Secretion
through microvesicle shedding. 4) Secretion of exosomes. Question marks high-
light that the involvement of transmembrane transporter molecules is not resolved
for all unconventional secreted proteins, yet. (Adapted from Nickel et al. [142].)
One vesicle-dependent pathway facilitates the externalization of cytosolic
and nuclear proteins by secretory lysosomes (ﬁg. 2.7). Secretory lysosomes
share functions of lysosomes and secretory granules, being acidic and contain-
ing proteases but also performing regulated secretion [155]. IL-1beta and its
transforming caspase (caspase 1) have been proposed to follow this secretion
route [156;157].
The shedding of microvesicles from the extracellular side of the plasma
membrane is a second vesicle dependent secretion pathway [142] (ﬁg. 2.7).
Finally, multivesicular bodys can be formed by endosomes [142] (ﬁg. 2.7).
These release the intra-endosomal vesicles to the extracellular space, which
are known as exosomes. They have been reported to contain multiple cy-
tosolic or nuclear proteins [158]. Engulfment of phagophore membrane bound
Acyl-CoA binding protein by endosomes has been demonstrated as a selective
autophagy dependent mechanism for multivesicular body formation, followed
by secretion of this protein [159;160].
Recently, recycling endosome mediated secretion of tissue transglutami-
nase has been demonstrated, possibly representing an alternative unconven-
tional secretion pathway [161].
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2.2.3 Secretome analysis
Although the secretome contains compared to the total proteome a rather
small fraction of proteins, its analysis is challenging. To generate real in vivo
data the analysis of bioﬂuids would be the direct approach. The diﬃculties
here are the highly complex background, (e.g., 12 orders of magnitude in
protein concentration in human plasma [162]) as well as possible rapid degra-
dation of secreted proteins by proteinases upon release or during sample
processing [163]. Therefore, a common approach is to use culture media after
conditioning with a cell type of interest for secretome analysis. This method
allows non-invasive sample collection. Moreover, many cell lines representing
several cellular phenotypes are available, e.g., diﬀerent stages of cancer pro-
gression [15]. On the other hand, the retrieved results need to be evaluated
in vivo afterwards, since in the real organism several diﬀerent cell types are
localized together, possibly inﬂuencing each other.
Conditioned media can be analyzed using either antibody-based appro-
aches, like ELISA assays and microarrays, or using mass spectrometry, both
representing complementary approaches [164]. While ELISA needs to be per-
formed separately for each protein, microarrays and mass spectrometric de-
tection methods are large-scale approaches. For microarrays selective anti-
bodies against all proteins of interest, bound to a solid support, are incubated
with one or two ﬂuorescent labeled samples. Fluorescence signal intensities
are used as read out. The big advantage of microarrays is the possibility to
measure diﬀerent kinds of data in parallel. These could be protein abun-
dance [165], the existence of diﬀerent isoforms [166] or protein modiﬁcations [167]
as well as biological activity like protein-protein interactions. Unfortunately,
these data can only be acquired using microarrays if a binder with appropri-
ate speciﬁcity and aﬃnity for the protein of interest is available, representing
the biggest limitation of this approach.
In contrast, mass spectrometry is an unbiased method, allowing in theory
the detection of all proteins present in a sample. In the real experiment this
is limited by the measurable dynamic abundance range. Since most cells
are grown using media supplemented with bovine serum (10%), the serious
challenge of secretome analysis using mass spectrometry lies in the detection
of low-abundant secreted proteins (ng/ml range) against a background of
1000s of high-abundant serum proteins (mg/ml). It has been shown that,
even when reducing the concentration of serum to 0.5%, the detection of se-
creted proteins is complicated [15]. An additional contamination to be dealt
with are cells that die during collection, resulting in the detection of many
intracellular proteins [168]. Hence, mass spectrometric analysis of conditioned
media is done in either of two ways. First, cells can be conditioned under
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optimal conditions in the presence of serum in the growth media, necessitat-
ing extensive protein and/or peptide fractionation strategies to enable the
mass spectrometer to detect low-abundant factors. Isotope labeling strate-
gies have been used to distinguish cellular from serum proteins. Examples
are the labeling of newly synthesized proteins with radioactive isotopes, fol-
lowed by gel electrophoresis and autoradiographic visualization of secreted
proteins [169], as well as approaches using stable isotopes, like SILAC [170], but
this does not increase the sensitivity. An increase in sensitivity has been
achieved by protein equalization using Proteominer beads [171].
Alternatively, a widely used approach is to keep cells under serum-free
conditions, thereby reducing analytical interference and facilitating the detec-
tion of secretory proteins [15]. Although serum starvation as an experimental
condition has been used to synchronize cells and to study cellular stress and
apoptosis [16], it has several consequences that are unintended and essentially
disregarded in secretome analysis. For instance, even a short period (hours)
of serum deprivation aﬀects expression and phosphorylation levels of mul-
tiple proteins [16–19]. Hence, huge eﬀorts are necessary to optimize washing
procedures to eﬃciently reduce serum protein contamination in conditioned
medium, but at the same time circumventing cell damage or perturbation of
the physiological properties of the cells of interest [172–174].
In conclusion, the current methods for secretome analysis suﬀer from the
high background of serum proteins contained in the cell growth medium.
Therefore, a method would be needed which allows the selective enrichment
of proteins from full cell growth medium. Very recently, the secretome protein
enrichment with click sugars (SPECS) method has been reported. All newly
synthesized and glycosylated proteins are pulse-labeled with non-canonical
sugars bearing an azide functionality, which was used for the enrichment
of glycosylated proteins from cell growth medium [175]. Since 66% of all se-
creted proteins are glycosylated, this method adresses a high proportion of
the secretome but not all secreted proteins.
Prediction of protein secretion
As described, secretome analysis is complicated by multiple sources of con-
taminations, like serum proteins or cells dying during collection [168]. While
serum proteins can be distinguished from cellular proteins using stable iso-
tope labeling approaches, the other source of contaminations cannot fully be
excluded. Hence, a quality assessment for the acquired data is necessary.
The special characteristics of secreted proteins allow to a certain extend the
computational prediction of secreted proteins.
Classically secreted proteins bear an N-terminal signal peptide, which
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targets the transcription of secreted proteins into the endoplasmatic retic-
ulum [176]. The approximately 15-30 residues long signal peptide is cleaved
oﬀ during membrane translocation. Although there is no common sequence,
all signal peptides contain an N-terminal region (n-region), often bearing
positively charged residues, an at least six residue long hydrophobic region
(h-region) and a C-terminal region (c-region). The c-region is made up by po-
lar uncharged residues showing some conservation at the -3 and -1 positions
relative to the cleavage site [177]. These special features are used to predict the
secretion probability for a protein applying machine learning methods and
modeling approaches, such as in the popular and powerful tool SignalP [178].
Since unconventional secreted proteins do not bear a signal peptide their
prediction is more complicated. Programs like SecretomeP [179] assume that
secreted proteins share certain characteristics, like amino acid composition,
frequency of amino acid pairs or protein disorder [177]. Since rather low num-
bers of unconventional secreted proteins have been detected so far, these
approaches suﬀer from the need of reliable training sets for machine learning
algorithms to predict protein secretion and are therefore not as reliable as
approaches predicting conventionally secreted proteins.
In summary, the prediction algorithms for conventional secreted proteins
are reliable due to the very speciﬁc properties of the signal peptide. Con-
trarily, the small number of proven unconventional secreted proteins and the
multitude of possible unconventional secretion pathways, which are at the
time not fully uncovered, complicates the development of prediction meth-
ods for these group of proteins. Hence, the existing approaches need to be
applied with care.
2.3 Activation of macrophages
The process of protein secretion as described in the previous section is highly
important for intercellular signaling of the immune system. Here, secretion of
signaling proteins ensures the activation of immune cells after exposure with
infectious agents. Among the ﬁrst actors after infection are macrophages,
which were used as model system in this thesis. Therefore, the mechanism
activating macrophages will be discussed here.
Inﬂammation, the self-regulating defense mechanism protecting the host
from invading pathogens, is divided into innate immunity and adaptive im-
munity. While innate immunity, which is mainly executed by myeloid cells,
is initiated immediately after pathogen recognition, adaptive immunity rep-
resents the second line of defense. Here, lymphocytes establish an antigen-
speciﬁc recognition system enabling the organism to remember pathogens
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after initial contact and to respond stronger at secondary infection with the
same pathogen.
While innate immunity was originally thought to be composed of non-
speciﬁc responses and phagocytosis, it is now well accepted that it orches-
trates adaptive immunity and recognizes pathogen associated molecular pat-
terns (PAMPs) with unexpected speciﬁcity [180]. The innate immune system
is composed of physical and chemical barriers, like the epidermis and mucosal
surfaces with antimicrobial secretions as well as specialized cells recognizing
pathogens and activating defense responses [181].
In cooperation with the other cells of the immune system, macrophages,
which are derived from monocytes entering damaged tissue [182], establish
innate immune responses towards invading pathogens. Their spectrum of
functionalities comprises the phagocytosis of cellular debris and patogens,
the recognition of PAMPs by specialized receptors, the secretion of molecules
and proteins activating other immune cells and the presentation of antigens
to lymphocytes. To execute several of these functions macrophages need to
be activated by PAMPs or substances secreted by other immune cells.
Activated macrophages similarly to T-cells develop into distinct pheno-
types. Here, classically activated macrophages (M1 macrophages) and al-
ternatively activated macrophages (M2 macrophages) are well established
(ﬁg. 2.8) [183]. While initially M1 cells were deﬁned as pro-inﬂammatory cells
and M2 macrophages were thought to exhibit functions in humoral immu-
nity and repair [184], it has been shown that subsets of M2 macrophages are
involved in wound healing and the regulation of inﬂammation [185]. The de-
velopment of the diﬀerent macrophage types is deﬁned by their stimulation
with diﬀerent substances and proteins employing diﬀerent types of pattern
recognition receptors. The thereby activated signaling cascades that tightly
regulate the induction of speciﬁc transcription factors, result in the diﬀeren-
tial expression of many cytokines and receptors by these cells (ﬁg. 2.8). The
diﬀerentiation between macrophage phenotypes is maintained by feedback
loops, selectively repressing transcription of genes speciﬁc for the alterna-
tive macrophage type [186]. Transcription factors inducing genes responsible
for M1 phenotype are AP1, NF-κB, STAT1 and IRF5, while STAT6, IRF4,
CREB, C/EBPβ and PPARγ regulate M2 speciﬁc genes [186]. The ongoing
debate about the deﬁnition of macrophage types is represented by the recent
discovery of a new type of activated macrophages called Mox macrophages,
exhibiting a diﬀerent phenotype with decreased phagocytotic and chemotac-
tic capacity and an overrepresentation of NRF2-mediated expression of redox-
regulatory genes (ﬁg. 2.8) [187]. Tumor-associated macrophages (TAMs) [188],
an additional macrophage phenotype, are often considered as M2 macropha-
ges, but similarly to Mox exhibit gene expression pattern distinct from M1
27
CHAPTER 2. REGULATORY MECHANISM ESTABLISHING CELLULAR
PROTEIN HOMEOSTASIS
M1 M2
MOX
Ym1, FIZZ1, ARG1, CCL22,
CCL17, IL1ra, IL1R2, IL10, SR, GR
iNOS, IL1α, IL1β, TNFα, IL12,
NOS2, CXCL1, CXCL2, CXCL9,
CXCL10, CXCL11
VE
GF
, H
O1
, C
OX
2,
IL1
β, 
NR
F2
, A
RE
VEGF, HO1, COX2,
IL1β, NRF2, ARE
Ox
PA
PC
OxPAPC
resting
HealingHost defense
Redox / antioxidant activity
Fungi/ helminths,
CSF1, IL4, IL13
IFN
γ, 
GM
-C
SF
,
LP
S
STAT1, IRF5,
AP1, NF-κB
STAT6, IRF4,
CREB, C/EBPβ,
PPARγ
Figure 2.8: Types of activated macrophages: Resting macrophages can be acti-
vated into M1 or M2 macrophages by various stimuli (shown on arrows). Tran-
scription factors regulating gene expression in response to these stimulations are
depicted inside the macrophage types. M1 and M2 macrophages can both be
transformed to Mox macrophages by oxidized 1-palmitoyl-2-arachidonoyl-sn-3-
phosphorylcholine (oxPAPC). The diﬀerent macrophage types can be distinguished
by the expression of speciﬁc genes (highlighted in respective colors). (Adapted from
Shalhoub et al. [180].)
or M2 macrophages [183;189].
Mammals infected with gram-negative bacteria develop severe syndromes
including septic shock, the major reason for morbidity and mortality. Most
of these eﬀects can be mimicked by lipopolysaccharides (LPS) injection [190].
Lipopolysacharides are glycolipide components in the cell wall of gram-ne-
gative bacteria which are recognized by macrophage Toll-like receptor 4
(TLR4), inducing downstream signaling cascades which lead to M1 macro-
phage phenotype [185]. These processes have been intensively investigated us-
ing LPS stimulation of macrophage cell lines as model system. A few hours af-
ter LPS induction macrophages cannot induce many pro-inﬂammatory genes
in response to a second LPS stimulation [191], while others can be restimu-
lated (e.g. IL10). This diﬀerent stage of macrophage activation is referred
to as endotoxine tolerance [192], resulting in the alteration of the gene ex-
pression program towards an M2 macrophages like phenotype. Endotoxine
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tolerance is a mechanism within the inﬂammatory process representing its
self-regulatory properties. The precise regulation of LPS responses is impor-
tant to preserve host defense while avoiding organ failure or death.
2.3.1 Signaling downstream of TLR4 activation
This regulation is ensured by multiple signaling cascades activated after LPS
associates with Toll-like receptor 4 [193]. The three main pathways involved in
signaling downstream of TLR4 activation are NF-κB signaling and mitogen-
activated protein kinases (MAPKs) signaling, which induce the production
of pro-inﬂammatory genes [193], as well as signaling regulated by IFN regu-
latory factors (IRFs) [194–196], especially IRF3 [186], which stimulate Interferon
production (ﬁg. 2.9).
For the recognition by TLR4, LPS binds to LPS-binding protein (LBP),
followed by the association with the coreceptor CD14 [197]. Now, LPS is trans-
ferred to the accessory molecule MD2, which is associated to the extracel-
lular domain of TLR4, resulting in TLR4 oligomerisation [198] and activation
of downstream signaling due to the recruitment of cytosolic TIR domain-
containing adaptor molecules [199], e.g., MyD88, MyD88 adaptor-like protein
(Mal), TRIF, TRIF-related adaptor molecule (TRAM) (ﬁg. 2.9). Based on
the adapter molecules the signaling pathways employed by TLR4 are divided
into MyD88-dependent pathways and MyD88-independent pathways. The
MyD88-dependent pathway involves binding of Mal and MyD88 to TLR4,
while in the MyD88-independent pathway TRAM and TRIF bind the recep-
tor [200].
The mechanism by which TLR4 regulates two competing pathways has
just recently been resolved by Kagan et al. [201]. They propose the initial
activation of MyD88-dependent signaling at the plasma membrane followed
by endocytosis of the TLR4 complex and TRAM/TRIF dependent signal
transduction from early endosomes, where easier access to the adaptor pro-
tein Tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) is
achieved [201].
In MyD88-dependent signaling after MyD88/TLR4 association multiple
phosphorylation and ubiquitinylation events of recruited proteins, like IRAK
family members [202;203], TRAF6 [204], TAK1 and NEMO [205], enable the inde-
pendent induction of an IKK complex involving pathway as well as MAPK
signaling [205] (ﬁg. 2.9).
While MAPK signaling leads to the induction of gene expression down-
stream of Transcription factor activator protein 1 (AP1) [206] (ﬁg. 2.9), the
IKK complex (IKKα, IKKβ, NEMO) phosphorylates IκB the NF-κB in-
hibitor, marking it for degradation. Following degradation of IκB, NF-κB is
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Figure 2.9: Toll-like receptor 4 signaling pathway.
released and translocates to the nucleus. Here, it activates the transcription
of downstream genes.
The MyD88-independent pathway downstream of TLR4 is mediated by
TRIF and TRAM and therefore also known as TRIF-dependent signaling
pathway [207]. Here, TRAF3 and TANK transmit signaling to IKK-related
kinases TBK1 and IKK [208–211], which directly phosphorylate IRF3 and
IRF7 (ﬁg. 2.9). Phosphorylation results in the formation of homo- and
heterodimers that are translocated to the nucleus to activate downstream
signaling [212;213]. In addition, IRFs, AP1 and NF-κB associate to a multi-
transcription factor complex called enhanceosome to induce INF-γ tran-
scription [214]. Moreover, TRIF-dependend signals are transmitted by RIP1,
TRAF6 and TAK1 leading to the activation of NF-κB and MAPK signal-
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ing [215] (ﬁg. 2.9).
In concert, the described pathways drive the precise regulation of gene
expression resulting in the time-resolved induction of various genes down-
stream of LPS induction. This ensures the exact ﬁne tuning of inﬂammatory
responses conducted by macrophages, including the production of cytokines,
chemokines and arachidonic acid metabolites, as well as the production of
reactive nitrogen species and the reorganization of the cytoskeleton [216;217].
Thereby, the polarization of the innate and adaptive immune responses as
well as the protection from invading pathogens is achieved.
2.3.2 Analysis of activated macrophages
Macrophage activation with LPS has been recently explored in several large-
scale transcriptomic and qualitative or quantitative proteomic studies ex-
ploring diﬀerent aspects of TRL4 signaling. E.g., Ramsey et al. combined
mRNA expression analysis using microarrays with transcription factor bind-
ing site motif scanning to investigate primary macrophages after stimulation
with diﬀerent substances including LPS. Thereof, they inferred a network of
associations between transcription factor genes and clusters of co-expressed
target genes [218]. Similarly, stimulation responses of macrophages to com-
binations of non-TLR4 ligands with LPS were used to elucidate pathway
interactions by customized mRNA expression arrays [219]. It was found that
IFN-γ and LPS cross-regulated the transcriptional response induced by each
other.
By applying systems biological approaches Litvak et al. predicted and
conﬁrmed a regulatory network between the three transcription factors NF-
κB, C/EBP Omega and ATF3 that discriminates between transient and per-
sistent Toll-like receptor 4-induced signals [220].
Investigating the changes in protein expression levels of a mouse cell line
as well as primary macrophages using iTRAQ labeling Swearingen et al.
detected 36 proteins [221]. In the most comprehensive proteome wide quanti-
tative study using SILAC labeling Du et al. revealed signaling and regulatory
networks that systematically operate in the early response to LPS [222].
While many of the mentioned studies investigated the temporal proﬁles
of mRNA expression, all of the data sets on protein level only focus on one or
two time points after stimulation. This represents the lack of a comprehensive
time-resolved investigation of protein abundance diﬀerences in response to
LPS stimulation.
Furthermore, only Swearingen et al. integrated transcriptomic and pro-
teomic data to diﬀerentiate between transcriptional and post-transcriptional
events, revealing 75% of similarity between the two data sets [221]. Bhatt et
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al. adressed this question using a diﬀerent approach. They performed RNA
sequencing of fractionated transcripts in a time-course study of lipid A (the
functional compound of LPS) stimulated macrophages, elucidating a high-
resolution map of coding and non-coding transcripts at three diﬀerent cellular
locations (chromatin-associated, nucleus, cytoplasm) [223]. In the chromatin
fraction a high percentage on unspliced transcripts was found, suggesting
that splicing often occurs after completion of transcription. In addition, the
time-resolved transcription proﬁles were submitted to transcription factor
motif enrichment, elucidating the temporal regime of transcription activa-
tion in response to stimulation [223]. Although this study gave impressive
insights into regulation of mRNA processing as well as mRNA abundance
and localization, regulatory processes on the level of translation were missed.
Weintz et al. and Sharma et al. published tremendous changes of the
phosphoproteome upon LPS treatment [224;225], thereby addressing a diﬀer-
ent level of post-transcriptional regulation. The combination of phosphopro-
teomics and transcriptomic data at two time points after stimulation revealed
novel signaling modules as well as the cytoskeleton as key target in LPS reg-
ulated phosphorylation. Furthermore, several transcription factors involved
in TLR4 signaling were found to be phosphorylated [224].
In two alternative approaches Patel et al. and Dhungana et al. focused on
speciﬁc aspects of diﬀerential protein localization after LPS treatment [226].
Patel et al. enriched microtubule associated proteins from LPS and IFNγ
stimulated macrophages and identiﬁed 94 regulated proteins [226;227]. This
diﬀerential binding pattern demonstrates the rapid modulation of the micro-
tubule cytoskeleton in macrophages, essential to perform immune functions.
Thereby, activated macrophages rapidly increase in size, as well as their
phagocytic, secretory and migratory activity.
Dhungana et al. focused on proteins recruited to macrophage rafts in
response to LPS stimulation for 5 or 30 minutes [227]. Selective activation of
the proteasome in macrophage rafts and its inactivation outside of rafts was
detected using unsupervised network analysis of the detected proteins. These
studies demonstrate the extensive relocation of proteins in response to LPS
stimulation.
A central process to signal to, attract or activate other cells of the immune
system in response to stimulation of macrophages is the secretion of a variety
of proteins including cytokines, representing a diﬀerent aspect of protein
translocation. This central process in inﬂammatory response has to the best
of my knowledge not yet been investigated in a comprehensive and time-
resolved manner.
Several of these studies used macrophage stimulation as a model system to
investigate basic principles of gene expression, post-transcriptional or protein
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localization regulation. Thereby, they elucidated a wide variety of mech-
anisms orchestrating inﬂammatory responses. While post-transcriptional
processes involved in mRNA localization and splicing have been partly ad-
dressed, a full view on this regulatory processes can only be achieved by
the integration of mRNA expression and protein synthesis data looking at
diﬀerent time points after LPS stimulation. Furthermore, the integration of
this data with protein localization data like secretome analysis would dis-
close the sequence of events leading to macrophage activation, as well as the
mechanism underlying this process.
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Identiﬁcation of DNA-binding
Proteins
The identiﬁcation of proteins binding to cis-regulatory modules (CRMs) in
a sequence speciﬁc manner can help to explore the mechanisms underlying
transcriptional control. CRMs are DNA sequences with transcription factor
binding sites which are clustered into modular structures, like promoters,
enhancers, silencers, boundary control elements and other modulators (see
chapter 2.1). Combinatorial and dynamic transcription factor binding to
CRMs results in speciﬁc expression patterns. The identiﬁcation of the pro-
teins binding to a CRM is a necessary prerequisite to understand how its
activity is controlled and, thereby, how its target genes are regulated.
Zinzen et al. [34] used ChIP-on-chip analysis to determine the genome-wide
binding proﬁles of ﬁve transcription factors active in Drosophila melanogaster
mesoderm development and it was shown that combinatorial binding can be
predictive of spatio-temporal CRM activity. They found a signiﬁcant amount
of “plasticity” in terms of transcription factor binding to CRMs, meaning that
signiﬁcant diﬀerences in combinatorial transcription factor binding can give
rise to virtually identical spatio-temporal CRM activity. Conversely, this
study also showed that nearly identical transcription factor binding patterns
for the ﬁve studied transcription factors can yield large diﬀerences in CRM
activity. Therefore, additional proteins must play a role in the activation
of these CRMs. Hence, in order to identify hitherto unknown interactors
impinging on myogenisis, the binding repertoire of selected CRMs active
at diﬀerent times and in diﬀerent tissues during Drosophila melanogaster
development was probed.
The DNA-binding proteins were aﬃnity puriﬁed from whole embryo nu-
clear extracts with streptavidin conjugated magnetic beads binding the DNA
sequence of interest containing a biotin linker and an enzyme restriction site
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Figure 3.1: Experimental design for the detection of DNA-binding proteins:
Streptavidin beads, bound to three diﬀerent biotinylated DNA sequences (i.e. spe-
ciﬁc CRMs) bearing an enzymatic restriction site (light blue) and a spacer (black),
are incubated with Drosophila melanogaster nuclear embryo extracts. Proteins are
eluted from the beads followed by trypsin digestion. To distinguish speciﬁc (red
and green) from non-speciﬁc (blue) binding, proteins bound to the diﬀerent DNA
sequences were quantitatively compared. Therefore, peptides are labeled with sta-
ble isotopes by dimethylation of peptide N-termini and lysines. After combination
of the peptide samples, their complexity is reduced by OFF-Gel isoelectric focusing
to increase the number of protein identiﬁcations. Finally, the samples are analyzed
by nanoLC-MS/MS. The peak areas of the diﬀerentially labeled peptides are now
used to calculate the relative abundance of the proteins bound to the diﬀerent
DNA sequences.
as described by Mittler et al. [8]. The bound proteins are released from the
beads and analyzed by quantitative mass spectrometry using the stable iso-
tope labeling by peptide dimethylation technique [228] (ﬁg. 3.1). This ap-
proach does not only reveal the transcription factor binding to the chosen
DNA sequence, but does also disclose proteins interacting with these tran-
scription factors. Thereby transcription factor associated proteins possibly
assisting them in their regulatory functions can be detected.
3.1 Method optimization
The described method has been used previously in several studies, all of
which use short double stranded DNA sequences (∼40 bp) for the enrichment
of binding proteins [65–71]. Using this approach a sequence mutated at the
binding site can serve as a control to detect non-speciﬁc binding proteins. In
contrast, actual CRMs are generally thought to be several hundred base pairs
long [34]. Hence, the simple mutation of one or two nucleotides would not be
suﬃcient to prevent speciﬁc binding of all potential interactors. In addition,
the binding sites to be mutated are not known. To distinguish between
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speciﬁc and non-speciﬁc binding the interaction patterns of diﬀerent CRMs
were compared. This approach should thereby allow to ignore non-speciﬁc
DNA-binding proteins, but transcription factors interacting speciﬁcally and
with equal aﬃnity to all tested CRMs would also be missed. The application
of this method to CRMs active at very diﬀerent times and in diﬀerent tissues
should increase the chance that the identiﬁed diﬀerential binders may have a
real impact on mesodermal gene regulation and mesoderm development. To
avoid skewing the assay unnecessarily by using CRMs of diﬀerent length, all
used CRMs were adjusted to 500 base pairs to cover all potential transcription
factor binding sites by Robert Zinzen.
Since 500 base pair long DNA sequences are not commercially available,
they were produced by PCR ampliﬁcation, using a biotinylated primer for
the forward strand. Thereby, biotinylated double stranded DNA sequences
are made in one step. Three methods for the concentration of the DNA af-
ter PCR were compared: DNA extraction form agarose gels, DNA puriﬁca-
tion with Qia-Quick PCR puriﬁcation kit and phenol-chloroform-extraction.
Phenol-chloroform extraction yielded more than twice as much DNA as the
other methods and no contaminations were detected in the resulting DNA
samples by gel electrophoresis and was therefore used in further experiments
(ﬁg. B.10).
To enrich for speciﬁc DNA-binding proteins the biotinylated DNA se-
quences were bound to streptavidin beads, followed by incubation with Dro-
sophila melanogaster embryo nuclear extracts for three hours. Since the
DNA-protein complexes are not covalently linked very mild washing con-
ditions were applied. This was achieved by using four times the protein
binding buﬀer and once the buﬀer necessary for enzymatic cleavage of the
DNA sequence. It was found that this last washing step already releases
bound proteins, resulting in losses of speciﬁcally binding proteins (ﬁg. 3.2).
Furthermore, after enzymatic digestion the DNA could not be detected on
an agarose gel, while DNA cleaved from beads that were not incubated with
nuclear extracts was well recovered (ﬁg. 3.3).
To overcome this problem, diﬀerent combinations and incubation times
of SmaI and DNAseI were tested, but did not improve the protein release.
Possibly the restriction enzyme recognition site was masked by proteins from
the extract. In addition, SmaI cleavage in the protein binding buﬀer did not
work, even when tested in solution. Therefore, the ﬁfth bead washing step,
shown to release proteins (ﬁg. 3.2), could not be prevented.
Finally, alternative methods for protein release were explored. Very short
boiling in 0.1% or 1% SDS seemed to be most eﬀective, since boiling of the
beads after elution does not result in additional protein release (ﬁg. 3.4).
Both methods resulted in a similar contamination with streptavidin. Hence,
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M tinC C M
Wash 1 Wash 2 Wash 3 Wash 4 Wash 5 Elution 1 Elution 2 Elution 3
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Figure 3.2: Release of proteins from DNA-protein complexes during washing pro-
cedure: Silver stained gels of washing buﬀers and eluates after protein enrichment
using CRM tinC (tinC) or control beads not bearing a DNA sequence (C). For
washing step 1-4 (Wash 1-4) the protein binding buﬀer was added, while washing
step ﬁve (Wash 5) employed the nuclease restriction buﬀer. While after initial
release of less tightly bound proteins during washing step one the protein amount
released during washing decreases, washing step ﬁve results in a higher release of
proteins. The elution steps one and two (Elution 1 and 2) contain proteins subse-
quently released by one hour of SmaI digestion and elution step three (Elution 3)
is the supernatant after a ﬁnal overnight incubation with SmaI.
for the ﬁnal experiment 1% SDS was used to release the bound proteins.
The resulting SDS containing protein sample was puriﬁed and digested using
the ﬁlter aided sample preparation (FASP) method, which can accommodate
high SDS concentrations [229].
In summary, changes in the published protocol were necessary to adapt
the in vitro DNA-protein interaction assay to long DNA sequences. Since the
enzymatic restriction site in the DNA sequence seems to be blocked by bound
proteins, DNA release was only achieved by boiling in SDS. The thereby
introduced background of proteins binding non-speciﬁcally to streptavidin
beads was addressed by using a quantitative proteomics approach.
3.2 Comparison of proteins binding to cis-
regulatory modules
Next, the optimized protocol was applied to the quantitative comparison
of proteins bound to three CRMs, active at diﬀerent times and in diﬀerent
tissues during Drosophila melanogaster development (table 3.1). The CRMs
were incubated with Drosophila melanogaster embryo nuclear extract derived
from two to ten hours old embryos, approximately covering stages 4 to 13
during embryo development.
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1 2 3 4 5 6 7 8 9
1  CRM 965, proteins bound and cleaved
2  CRM 404, proteins bound and cleaved
3  Blank, proteins bound and cleaved
4  CRM 965, supernatant after binding DNA to beads
5  CRM 404, supernatant after binding DNA to beads
6  CRM tinC, no proteins bound and cleaved
7  CRM 965, before bead binding
8  CRM 404, before bead binding
9  Marker 100kB ladder
Figure 3.3: DNA release from streptavidin beads by enzymatic digestion: While
the DNA is well recovered from beads before incubation with nuclear extract (lane
6), only minor or no recovery of DNA cleaved after incubation was detected (lane
1,2).
1 2 3 4M M 1 2 3 4 M M
1  Boiled beads CRM tinC
2  Boiled beads blank
3  SDS elution CRM tinC
4  SDS elution blank
M Marker
0.1 % SDS 1 % SDS
Figure 3.4: Elution of DNA-protein complexes by boiling in SDS: Recovery
of proteins is similar for both SDS concentrations tested. In addition, protein
composition released from DNA bound beads is highly similar to that from control
beads. This highlights the need for a quantitative approach to distinguish between
speciﬁc and non-speciﬁc binding.
To exclude any inﬂuence of the selected labels on the quantiﬁcation re-
sults, two biological independent experiments with diﬀerent labeling schemes
were processed (table 3.2). As many as around 2800 proteins were quantiﬁed
in each experiment. This high number can be explained by the very mild
washing conditions, resulting in the non-speciﬁc binding of proteins, not only
to the DNA sequence but also to DNA-bound proteins.
The 2565 proteins, quantiﬁed in both biological replicate samples, were
subjected to functional annotation clustering using DAVID [230]. The strongest
enriched clusters contain GO terms associated with “transcription regula-
tion”, “nucleotide-binding” and “chromatin organization”, representing well
known functionalities of DNA-binding proteins (table B.1). Notably, as many
as 338 proteins are assigned to the GO term “transcription regulation”. Other
clusters like “ribonucleoprotein” or “RNA processing” may be due to highly
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CRM Stage Tissue
CRM 633 5-8 Unspeciﬁed early mesoderm
bap3 10 onwards Visceral mesoderm
tinC late Cardiac mesoderm
Table 3.1: Investigated CRMs: Stages and tissues give the temporal and spatial
activity of these CRMs.
light int heavy μg DNA mg protein quantiﬁed proteins
Replicate 1 633 bap3 tinC 15 8.3 2854
Replicate 2 tinC 633 bap3 15 8.3 2777
Table 3.2: Experimental design and number of quantiﬁed proteins. The stable
isotope labeling scheme for the two independent biological samples as well as the
amounts of double stranded DNA and total protein in the nuclear extracts per
CRM are given (int: intermediate).
abundant nuclear proteins non-speciﬁcally binding to the chosen DNA se-
quences (table B.1). In addition, two well known DNA-binding domains are
highly enriched in the data set: Zinc ﬁnger, PHD-type [231] and Zinc ﬁnger,
C2H2-like [232] (table B.1).
The quantitative analysis of the data revealed 35 and 26 proteins binding
stronger to the CRMs 633 and bap3, respectively, as well as 17 proteins
binding stronger to the CRM tinC than to either of the other two. The by
far strongest enriched cluster retrieved by functional annotation clustering
for the in total 72 diﬀerentially binding proteins contained terms associated
with “transcription regulation” and “DNA-binding” (ﬁg. 3.5). 48 proteins are
grouped into this cluster including 14 proteins with the biological function
“transcription factor activity”.
Figure 3.6 displays the measured binding ratios for all diﬀerentially bind-
ing proteins. For example, Pannier (pnr), which is involved in the regulation
of cardiac speciﬁcation and diﬀerentiation [234], strongly binds to the tinC
CRM, which is active in the cardiac mesoderm. Secondly, Biniou (bin),
which plays a key role in the development of the visceral mesoderm and the
derived gut musculature [235], interacts strongly with bap3, a CRM active in
the visceral mesoderm [236]. These two proteins show the expected binding
pattern, thereby validating the presented approach.
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Transcription regulation, DNA-binding
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Development and morphogenesis
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Gland development
Embryonic morphogenesis
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Figure 3.5: Functional annotation clustering for all diﬀerentially binding pro-
teins.
The strongest diﬀerence (16-fold enrichment) was detected for CG32772 1,
a protein with a zinc ﬁnger domain and DNA binding activity, which has not
yet been extensively studied. Similar to CG32772 the interaction of lin-
52, hb, sqz and Rox8 to the CRM 633 is more prominent compared to the
other CRMs tested (ﬁg. 3.6). A second protein exhibiting strong diﬀerences
in CRM binding is Cyclic-AMP response element binding protein B at 17A
(CrebB-17A), which is a transcriptional activator [237]. It strongly binds to
the CRMs 633 and bap3, but seems to be excluded from tinC (ﬁg. 3.6).
Similar patterns are detected for Hrb27C, Hrb87F, lark, bin and Ssb-c31a.
In contrast, CG2990, Chi, ewg, pnr and so tightly interact with tinC but to
a lesser degree with CRM 633 or bap3 (ﬁg. 3.6). Preferential bap3 binding
was detected for Kr-h1, wor, Su(H), mod(mdg4), hang and baf. Wor is a
zinc ﬁnger protein closely related to snail and esg. Therefore, the strong
binding of wor and esg to bap3 could represent interaction with a snail
binding site, which might be required for keeping this CRM inactive early in
development [238]. Decreasing amounts of protein binding from CRM 633 via
tinC to bap3 were measured for nub, pdm2, Rbf2 and vvl (ﬁg. 3.6), possibly
representing diﬀerences in either numbers or aﬃnity of the binding sites for
these proteins.
Since all tested CRMs are active at diﬀerent times in diﬀerent mesoder-
mal tissues the binding of these candidate proteins to the CRMs could point
1All detected proteins will be mentioned by using the associated gene symbol. Associ-
ated protein names are collected in appendix D.
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Figure 3.6: Proteins binding diﬀerentially to the investigated CRMs: Log2-fold-
changes are shown in bar plots. Proteins more strongly bound to CRM 633 or bap3
exhibit positive log2-fold-changes, while proteins more strongly bound to tinC
have negative log2-fold-changes. Blue dots highlight proteins with mesodermal
expression in four to eight hour old embryos based on chromatin data (Berkeley
Drosophila Genome Project) [233]. Genes highlighted in red were validated by in
situ staining (ﬁg. 3.7). Gene names appearing twice represent diﬀerent isotopes
of proteins distinguished by mass spectrometric identiﬁcation. In both cases the
binding patterns are similar.
to regulatory interactions and especially to activating roles if the candidate
proteins themselves are expressed in the mesoderm. Alternatively, no expres-
sion of a protein in the mesoderm could point towards an inhibitory function
of a protein on mesodermal active CRMs. Mesodermal transcription in four
to eight hour old embryos was detected using chromatin data for 59 of the 72
signiﬁcant proteins (Berkeley Drosophila Genome Project) [233]. These pro-
teins could thereby activate the CRM they bind to, while the proteins not
expressed in the mesoderm could act as repressors.
13 proteins were selected for further validation (ﬁg. 3.6). For selected pro-
teins a fold-change of at least three and and likely DNA-binding motifs were
required. In situ staining against the corresponding genes of seven proteins
determined their expression at the same time and place where the strongly
bound CRM is active, e.g., CRM 633 in the early mesoderm. Therefore, they
could feasibly be activators of their bound CRM.
The three proteins excluded from the mesoderm (pdm2, esg, CG32772 )
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Figure 3.7: In situ staining of selected proteins at three diﬀerent stages during
Drosophila melanogaster development. The protein of interest is shown in green,
the pan-mesodermal marker (Mef2 ) in red and DAPI in blue. (Genes expressed
at the same time and in the tissue, where the CRM they preferentially bind to is
active, are highlighted in red. Genes excluded from mesoderm are highlighted in
blue. Both represent candidates potentially regulating the respective CRMs.)
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could have inhibitory function on the CRM they strongly bind to. One of
them is Escargot (esg), which is known to be a repressor inhibiting transcrip-
tion from promoters containing E2 boxes activated by bHLH proteins [239].
Thus, esg is a very promising candidate possibly inhibiting bap3 activity.
Similarly, CG32772 was excluded from the early mesoderm, where CRM 633
is active. Since it has been shown to strongly bind to this CRM it could
inhibit it in other tissues and at diﬀerent times.
The last three proteins were not detected by in situ staining (hang, big-
max, Eip75B). This means they are probably not expressed within the in-
vestigated times. Since they were detected by mass spectrometry they are
expressed at diﬀerent time points covered by the nuclear extracts prepared
from two to ten hour old embryos. Therefore, they could still impinge on the
activity of the enhancers they bind.
Based on the described results further validation using loss of function
mutants, deﬁciency mutants or RNAi repression as well as overexpression
constructs of selected proteins are in progress. The impact of the loss or
overexpression of this proteins on muscle development will be determined.
3.3 Conclusion and outlook
Here, an in vitro DNA aﬃnity capture approach was for the ﬁrst time suc-
cessfully applied to the detection of thousands of potential CRM binding
proteins. Unlike previously published approaches that used around 40 base
pair long DNA sequences, the method was adapted to the determination
of proteins binding to DNA sequences as long as 500 base pairs. Hence,
emerging challenges were the detection of hundreds to thousands of non-
speciﬁcally binding proteins and the shielding of the enzymatic restriction site
for DNA release. These challenges were addressed by adaptions of the proto-
col. Firstly, non-speciﬁcally binding proteins were distinguished from speciﬁc
binders by a quantitative proteomic strategy applying restrictive statistics.
Secondly, DNA release was facilitated by SDS elution.
The disadvantage of this method is on the one hand the contamination
of samples with SDS, repressing peptide ionization in the mass spectromet-
ric measurement and on the other hand the elution of contaminating bead
binding proteins as well as streptavidin. However, SDS was removed from
the samples prior to analysis by a special protein digestion protocol involv-
ing extensive buﬀer exchange. Presuming equal background binding to the
beads for the diﬀerent CRMs tested, the quantitative approach leads to the
exclusion of these proteins from further analysis.
The detected proteins are highly enriched in proteins with functions con-
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nected to DNA binding activity, like transcriptional regulation or cell cycle
regulation. Quantitative comparison of the proteins bound to three CRMs
active at diﬀerent times during Drosophila melanogaster embryo develop-
ment and in diﬀerent tissues, revealed 72 proteins potentially involved in the
regulation of these CRMs.
A ﬁrst validation conﬁrmed the expression of 7 out of 13 tested proteins
at the right time and place in the embryo. Additional three proteins which
are excluded form the tissue where the bound CRM is active, could repress
their target CRMs in other tissues and at diﬀerent times. Based on these
results further validation using loss of function mutants, deﬁciency mutants,
RNAi mediated repression as well as overexpression constructs of selected
proteins are in progress.
A more comprehensive view could be gained by including additional
CRMs active at similar stages or tissues. Thereby, combinatory binding
patterns driving the activity of CRMs in certain tissues could be elucidated.
In addition, nuclear extracts from more reﬁned developmental states could be
used. E.g., the embryo collection times could be adjusted to the developmen-
tal stages when CRMs are active, which may allow a better understanding
of the activating and repressive regulatory interactions that determine CRM
activity. The challenge here would be the quantitative proteomic compari-
son of CRMs active at diﬀerent stages. The use of diﬀerent nuclear extracts
in one experiment could complicate the detection of non-speciﬁcally binding
proteins.
In summary, extensive DNA-binding proﬁles of three CRMs were com-
pared for the ﬁrst time, resulting in the detection of candidates poten-
tially regulating the activity of these CRMs. These candidates were distin-
guished from thousands of non-speciﬁcally binding proteins by quantitative
proteomics. Since the comparison was performed in vitro, in vivo validation
of biological activity is in progress and will probably reveal new circuits of
Drosophila melanogaster muscle development.
The disadvantage of the applied approach is that the in vitro retrieved
data not necessarily represent the in vivo binding pattern. Therefore, a care-
ful validation of potential interactions in vivo is needed. For the elucidation
of in vivo binding activity DNA sequences tagged with an enrichment func-
tionality could be introduced (e.g. by transfection in cell culture systems)
and DNA-protein complexes could be stabilized by crosslinking approaches.
The challenge of such an approach is the enrichment suﬃcient amounts of
bound proteins for mass spectrometric detection.
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Quantiﬁcation of Newly
Synthesized Proteins
Transcription and translation are regulated at several diﬀerent steps during
gene expression, ultimately resulting in the synthesis of new proteins. Know-
ing which proteins are synthesized at a speciﬁc time will aid in unraveling
the temporal dynamics of the proteome. In addition, this information will
help to understand the regulatory gene expression responses to environmen-
tal stimuli. Since newly synthesized proteins represent a small subset of the
total cellular protein pool, eﬃcient strategies that facilitate their enrichment
are necessary. This can be achieved using non-canonical amino acids that
are selectively incorporated in newly synthesized proteins. In this chapter,
a methodology based on the use of non-canonical amino acids coupled with
click-chemistry to enrich for newly synthesized proteins is described. Using
this method in combination with stable isotope labeling with amino acids
in cell culture (SILAC), quantitative analysis of lipopolysaccharides (LPS)
stimulated mouse macrophages (RAW 264.7) was performed. Moreover, to
establish the best experimental setup, alternative approaches to quantify
changes in protein synthesis were compared.
4.1 Capturing newly synthesized proteins
For the selective enrichment of newly synthesized proteins, a non-natural
amino acid that is an azido-analogue of methionine, called azidohomoalanine
(AHA) is utilized. By supplementing culture medium depleted of methionine,
AHA will be metabolically incorporated into newly synthesized proteins by
translationally active cells. Using a copper-catalyzed 1,3-cycloaddition, the
AHA labeled proteins are coupled to either an alkyne reagent with a biotin
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group or an alkyne-activated agarose resin (ﬁg. 4.1).
new
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Figure 4.1: Enrichment of newly synthesized proteins: AHA is incorporated into
all newly synthesized proteins in cultured cells using methionine-free medium. The
azido-group can be used to couple any alkyne, either bearing a biotin or coupled
to an agarose resin (X), which both can be used for the selective enrichment of
newly synthesized proteins or in case of biotin for detection by western blot.
The biotin group can be used for aﬃnity puriﬁcation or detection of newly
synthesized proteins by western blot. The alkyne-activated agarose resin is
beneﬁcial for aﬃnity puriﬁcation, because the covalent capture of newly syn-
thesized proteins permits usage of stringent washing conditions, reducing
non-speciﬁc interactions. In addition, NeutrAvidin is omitted, which rep-
resents an abundant contamination after on-bead digestion of the captured
proteins.
The incorporation of AHA into t-RNA is slower than the introduction
of methionine [122]. This could perturb cellular functions, leading to star-
vation or cell death. To investigate the potential eﬀects on viability AHA
treated RAW 264.7 cells were compared with those cultured in the presence
of methionine. From this, no signiﬁcant diﬀerences between RAW 264.7 cells
cultured in either condition was observed (ﬁg. 4.2a).
To further investigate the potential eﬀects of substituting AHA for me-
thionine, translation characteristics were measured using polysome proﬁling.
Examination of ribosome occupancy revealed a translation index of 0.62 com-
pared with 0.81 for RAW 264.7 cells treated for two hours with AHA and
methionine, respectively (ﬁg. 4.2b). Based on these data, a 25% reduction
in the rate of translation can be estimated. Since the aim of this study was
to compare protein synthesis under two diﬀerent conditions, this reduction
in global protein synthesis should aﬀect the cells which are compared in a
similar way and should therefore not inﬂuence the results of the experiment.
This hypothesis is further tested in section 4.2.
To assess the metabolic incorporation rate, RAW 264.7 cells were treated
for 5 to 30 minutes with AHA with sampling every 5 min. Cells grown in
methionine containing medium were used as controls. Dot blot analysis of
cellular protein extracts demonstrates the successful tagging of AHA contain-
ing proteins with the alkyne-biotin reagent (ﬁg. 4.3a). Furthermore, newly
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Figure 4.2: Viability and translation rate in AHA treated mouse macrophages:
a) Viability of RAW 264.7 macrophages after 2 h and 4 h of AHA treatment
determined with the trypan blue viability test: No signiﬁcant decrease in viability
was detected using a Student’s t-test (p-value>0.01). b) Polysomen-proﬁling of
RAW 264.7 cells after 2 h of AHA treatment (AHA1, AHA2). Cells grown in
methionine containing medium were used as control (Met).
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Figure 4.3: Incorporation of AHA into newly synthesized proteins: a) Dot blot
(anti-biotin antibody) after treatment of RAW 264.7 cells with AHA for diﬀer-
ent times and labeling of AHA containing proteins with biotin containing alkyne.
Incorporation of AHA can already be detected after 5 min of treatment. Two
dilutions of each sample were blotted (as indicated next to the ﬁgure) and each
of the samples was blotted twice. b) Inhibition of protein synthesis: Western blot
(anti-biotin antibody) after AHA treatment of RAW 264.7 cells with (1) or without
(2) cycloheximide for 2 h. (Cells treated with methionine were used as negative
controls (3).) AHA is selectively incorporated into newly synthesized proteins that
span a broad protein mass range.
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synthesized proteins were detected in all samples with increasing amounts
from 5 to 30 minutes, demonstrating the rapid and progressive incorporation
of AHA. When protein synthesis was blocked using cycloheximide, no stain-
ing of biotin is observable by western blot, further validating the selective
incorporation of AHA into newly synthesized proteins (ﬁg. 4.3b).
After metabolic labeling with AHA, cellular proteins were aﬃnity puri-
ﬁed on NeutrAvidin agarose beads. As expected, all biotinylated proteins
were bound to the beads and subsequently removed from the beads during
enzymatic digestion (ﬁg. 4.4). The detected newly synthesized proteins span
a broad mass range, demonstrating the unbiased incorporation of AHA. The
14.6
66 - 77
55
44
36
29
24
20
17
AH
A:
 su
pe
rna
tan
t
AH
A:
 bo
un
d t
o r
es
in
AH
A:
 W
as
h 1
AH
A:
 re
sin
 af
ter
 di
ge
sti
on
Me
t: i
np
ut
Me
t: b
ou
nd
AH
A:
 in
pu
t
EM
BL
 M
ark
er
pre
sta
ine
d s
tan
da
rd
bio
-B
SA
 8 
ng
97
Figure 4.4: Enrichment of AHA containing proteins: RAW 264.7 cells were
treated with AHA for 2 h and lysed. AHA containing peptides were coupled to
an biotin-alkyne using click-chemistry and enriched. The western blot highlights
the eﬃcient enrichment of AHA containing proteins with NeutrAvidin beads and
the successful release of newly synthesized proteins from the beads by trypsin
digestion.
analysis of these samples using mass spectrometry revealed contamination
with NeutrAvidin, which is introduced by the on-bead digestion. To omit
this problem, several approaches were tested. First, the puriﬁcation was
performed using magnetic steptavidin beads instead of NeutrAvidin agarose
beads. However, this approach did not result in any reduction in the amount
of contaminating peptides. Elution of the proteins by boiling them in SDS-
PAGE loading buﬀer resulted in a strong NeutrAvidin band on the gel. An
insuﬃcient number of proteins was identiﬁed when monomeric avidin beads
in combination with biotin elution were used for enrichment, suggesting sig-
niﬁcant losses during the protocol. This problem was overcome by adding a
peptide separation step based on oﬀ-gel isoelectric focusing (OFF-Gel IEF).
The use of IEF fractionation increased the number of identiﬁed proteins
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tremendously, leading to the detection of low-abundant regulated proteins,
like NF-κB and AP1 transcription factor family members (e.g. Rel and Fos).
An additional solution was provided by the recent commercialization of an
alkyne-agarose resin, allowing covalent capture of newly synthesized proteins
and on bead enzymatic digestion without NeutrAvidin contamination.
In summary, AHA incorporation into newly synthesized proteins was ef-
fective, selective and rapid. RAW 264.7 cells are viable for at least four
hours in presence of AHA. However, during this period a reduced translation
rate was observed. Lastly, newly synthesized proteins were quantitatively
enriched using NeutrAvidin beads. An additional peptide fractionation step
after on-bead digestion compensated for the high background of NeutrA-
vidin derived peptides. However, the use of alkyne-activated agarose beads
will fully omit this problem.
4.2 Quantiﬁcation of newly synthesized pro-
teins - a comparison of approaches
Having established an eﬃcient method to capture newly synthesized pro-
teins, I aimed to quantify diﬀerences in protein synthesis between two condi-
tions. Hence, the combination of AHA labeling with a quantitative approach
was necessary. The labeling protocol for AHA lends itself well to combina-
tion with another metabolic approach referred to as SILAC. Quantitative
SILAC experiments utilize metabolic incorporation of isotopically labeled
amino acids, typically arginine and lysine. To establish the best experimen-
tal setup, four alternative methods to quantify changes in protein synthesis or
total protein abundance after LPS stimulation of mouse macrophages (RAW
264.7) were compared (ﬁg. 4.5). To detect diﬀerences in protein synthesis
LPS treated RAW 264.7 cells were compared to untreated controls at two
diﬀerent times after LPS addition in two biologically independent samples
(ﬁg. 4.6).
Changes in total protein abundance were measured using the default
SILAC approach [240;241]. Fully SILAC labeled cells (e.g. heavy) were pulse
labeled with AHA during LPS treatment for two or three hours. For com-
parison, a parallel population of control cells bearing the alternative SILAC
label (e.g. light) were only pulse labeled with AHA (ﬁg. 4.5a). After the
desired treatment time the cells were combined and lysed. The samples were
directly digested and the resulting peptide mixtures fractionated using IEF
prior to analysis using nanoLC-MS/MS. For relative quantiﬁcation of total
protein abundance the light and heavy peak areas of the same peptides were
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Figure 4.5: Quantiﬁcation strategies for newly synthesized proteins or all cellular
proteins: a) Full SILAC labeling for relative quantiﬁcation of all cellular proteins.
b) Pulsed SILAC for the relative quantiﬁcation of protein synthesis. c) Full SILAC
combined with AHA labeling and enrichment of newly synthesized proteins for the
relative quantiﬁcation of protein synthesis. (Biotin-alkyne in combination with
NeutrAvidin beads was used.) d) Pulsed SILAC combined with AHA labeling and
enrichment of newly synthesized proteins for the relative quantiﬁcation of protein
synthesis. (Alkyne-activated agarose beads were used.)
used. 3400 and 3397 proteins were quantiﬁed after two and three hours of
LPS stimulation, respectively (ﬁg. 4.6a,b). Signiﬁcant diﬀerences (FDR 1%
and fold-change >2) in total protein amount were detected for 17 and 7
proteins in response to two and three hours of LPS treatment, respectively
(ﬁg. 4.6a,b).
Previously, pulsed SILAC (pSILAC) was described for the quantiﬁcation
of changes in protein synthesis [112]. To compare this approach with that in-
troduced here, the pSILAC protocol as described in chapter 2.1.4 was applied
(ﬁg. 4.5b), followed by the same sample processing as for the fully SILAC
labeled samples. Triple labeling was achieved by using 13C6-arginine and
d4-lysine as medium-heavy labels or 13C615N4-arginine and 13C615N2-lysine
as heavy labels (ﬁg. 4.5b). Now, for each peptide three peaks are expected.
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Figure 4.6: Comparison of the diﬀerent approaches: Log2-fold-changes of two
biological replicates comparing LPS treated cells against untreated control cells
are plotted for two treatment times (120 min and 180 min). a, b) Comparison of
changes in total protein abundance using full SILAC. c, d) Comparison of protein
synthesis using full SILAC and biotin for enrichment. e, f) Comparison of protein
synthesis using pSILAC. g, h) Comparison of protein synthesis using pSILAC and
alkyne-activated agarose beads for enrichment. Colored dots highlight proteins
with signiﬁcant changes. Red: FDR 1% and fold-change >2; orange: FDR 1%;
blue: FDR 5%; grey: quantiﬁed with high standard deviation and therefore ex-
cluded from signiﬁcance test. The correlations between replicates (R) as well as
the number of proteins quantiﬁed in both replicates (black) and the number of
signiﬁcant proteins (FDR 1% and fold-change >2) (red) are shown.
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Here, the light peak is derived from all peptides of “old” proteins and the
medium-heavy and heavy peaks represent the newly synthesized proteins in
the corresponding condition and can therefore be used for relative quantiﬁ-
cation of protein synthesis. Although, as many as 4936 and 4356 newly
synthesized proteins were quantiﬁed after two and three hours of LPS stim-
ulation, respectively, no statistical signiﬁcant diﬀerences in protein synthesis
(FDR 1% and fold-change >2) were detected (ﬁg. 4.6e,f).
Next, full SILAC and AHA labeled samples was subjected to newly syn-
thesized protein enrichment using the biotin-alkyne in combination with Neu-
trAvidin beads (ﬁg. 4.1). Following extensive washing the proteins were
submitted to on-bead digestion. The peptide mixtures were subsequently
fractionated and measured using nanoLC-MS/MS (ﬁg. 4.5c). The expecta-
tion is that the resulting peptide spectra contain only peptides derived from
newly synthesized proteins. Quantitative comparison of protein synthesis
using the SILAC labels was achieved for 2045 and 3095 proteins at two and
three hours after LPS stimulation, respectively (ﬁg. 4.6c,d). Eight and three
proteins were diﬀerentially synthesized (FDR 1% and fold-change >2) after
stimulation (ﬁg. 4.6c,d).
Finally, pulsed SILAC was combined with AHA labeling and stimulation
(ﬁg. 4.5d). After the combination of diﬀerentially labeled cells and cell ly-
sis, newly synthesized proteins were covalently coupled to alkyne-activated
agarose beads. Peptide fractionation and measurement was performed as
before. Again, the light peak represents the peptides derived from “old” pro-
teins, but is expected to be mainly absent, since those proteins did not in-
corporate AHA and are therefore removed during enrichment. The medium-
heavy and heavy peaks are used for relative quantiﬁcation of protein synthe-
sis revealing synthesis rations for 5466 and 5359 proteins after two and three
hours of LPS stimulation, respectively (ﬁg. 4.6g,h). In addition, as many as
189 and 246 proteins showed signiﬁcantly diﬀerent protein synthesis (FDR
1% and fold-change >2) when comparing LPS treated samples to untreated
controls (ﬁg. 4.6g,h).
Table 4.1 highlights the advantages of the applied strategies. It should be
noted that the diﬀerences in newly synthesized proteins are established by a
combination of protein synthesis and degradation. For convenience they are
referred to as “protein synthesis” in this thesis.
The comparison of the tested experimental setups reveals, that similar
numbers of proteins were quantiﬁed in the two approaches using full SILAC
labeling (ﬁg. 4.6a-d). However, approximately 2000 more proteins were quan-
tiﬁed using the pSILAC approaches (ﬁg. 4.6e-h). Two possible explanations
are the use of more advanced instrumentation for the pSILAC experiments,
or the higher amount of starting material used. The amount of starting
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fullSILAC pSILAC fullSILAC/AHA pSILAC/AHA
all proteins quantiﬁed + - - -
NSP quantiﬁed - + + +
selective labeling of NSP∗ - + - +
depletion of “old” proteins - - + +
covalent capture of NSP - - - +
Table 4.1: Advantages of the diﬀerent approaches (NSP: newly synthesized pro-
teins; ∗Additional labeling of newly synthesized proteins with stable isotopes gives
further conﬁdence that a protein is truly newly synthesized and not a contamina-
tion.)
material in the full SILAC experiments was deﬁned by the on-bead diges-
tion, which resulted in a high background of NeutrAvidin derived peptides,
limiting the relative amount of original sample, to be loaded on the HPLC
column. Only low correlations between biological replicates, ranging form
0.03 to 0.43, were calculated for those samples, explaining the low numbers
of proteins with signiﬁcant diﬀerences between the compared samples. In ad-
dition, low abundant proteins with diﬀerential expression or synthesis were
possibly missed due to the lower numbers of quantiﬁed proteins.
The correlations between biological replicate samples for pSILAC are with
0.05 and -0.33 even lower (ﬁg. 4.6e-f). Although proteins with high standard
deviation were excluded, no signiﬁcant proteins could be detected applying
the mentioned parameters. Increasing the false discovery rate to 5% recovers
36 signiﬁcant proteins after three hours of LPS treatment, but did not im-
prove the detection at two hours (ﬁg. 4.6e-f). These results again demonstrate
the limitation of stable isotope labeling approaches for the measurement of
protein synthesis after short isotope incorporation times. Hence, this method
is not well suited for the investigation of rapid responses to LPS stimulation.
A tremendous improvement was achieved when pSILAC was combined
with AHA labeling and enrichment (ﬁg. 4.6g-h). Despite similar numbers of
quantiﬁed proteins the correlation between biological replicates increased to
0.84 and 0.86. As highlighted before, as many as 189 and 246 diﬀerentially
synthesized proteins could be detected for two hours and three hours of LPS
treatment, respectively. The depletion of peptides derived from “old” pro-
teins, represented by the light peak in each peptide spectrum, improves the
signal-to-noise ratio for medium-heavy and heavy signals, which are used for
the quantiﬁcation of protein synthesis. This is especially important for short
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labeling times, as applied here, resulting in a low relative amount of newly
synthesized proteins compared to “old” proteins. Therefore, the light signal
will be much more intense than the signals used for quantiﬁcation.
To conclude, for the measurement of rapid changes in protein synthe-
sis after LPS stimulation of mouse macrophages the combination of AHA
incorporation with pSILAC labeling was best suited. Enrichment of low
abundant newly synthesized proteins using alkyne-agarose beads increased
the signal-to-noise ratio of the mass spectrometric measurement, resulting in
a high sensitivity for the detection of stimulation responses. The advantage
of pSILAC labeling compared to full SILAC is the selective labeling of newly
synthesized proteins, introducing a possibility to discriminate between newly
synthesized proteins and non-speciﬁcally binding proteins.
Since a lower translation rate for AHA treated macrophages was observed
(ﬁg. 4.2), the impact of AHA on protein synthesis was evaluated. The com-
parison of protein synthesis diﬀerences determined with pSILAC to changes
measured after AHA and pSILAC labeling and enrichment reveals corre-
lations of 0.45 and 0.69 for two hours and three hours of LPS treatment,
respectively. At both time points only a few proteins show induced synthesis
in AHA treated samples, while no change was detected in untreated samples
(ﬁg. 4.7). Therefore, a major impact of AHA on protein synthesis for the
investigated treatment times can be excluded.
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Figure 4.7: Comparison of quantitative results from AHA treated and untreated
samples. In both approaches LPS treated macrophages were compared to un-
treated cells after two and three hours of stimulation. pSILAC was used for quan-
tiﬁcation. In AHA treated samples newly synthesized proteins were enriched.
Since the enrichment strategy depends on the replacement of methion-
ine by AHA, the detection of proteins enriched in this amino acid could be
favored. Therefore, distributions of identiﬁed proteins in only pSILAC and
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pSILAC combined with AHA enrichment samples were compared to each
other and to the complete proteome, as deﬁned by the database used for
protein identiﬁcation (ﬁg. 4.8).
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Figure 4.8: Distribution of protein properties of detected newly synthesized pro-
teins: a) average hydrophobicity, b) isoelectric point (pI), c) molecular weight, d)
sequence length, e) methionine frequency, f) relative methionine frequency nor-
malized by sequence length. The “complete proteome” was deﬁned by all proteins
contained in the database used for protein identiﬁcation.
Although, a bias in the proteomic data sets is detected for most of the
investigated protein characteristics, this was similar for the AHA enriched
and not enriched samples. Hence, the detection bias is rather a property
of the mass spectrometric detection method, as described in literature [242],
than of the selected enrichment protocol. This is highlighted by the ob-
served trend against the detection of proteins with low numbers of methion-
ines (ﬁg. 4.8e). This bias disappears when using the relative number of
methionines normalized for sequence length (ﬁg. 4.8f). This is indicative of
the well-known underrepresentation of small proteins in mass spectrometric
analyses [242] (ﬁg. 4.8d) and causes a similar detection bias towards proteins
with low numbers of methionines here.
In summary, it was shown that on-bead digestion of newly synthesized
proteins from NeutrAvidin beads is disadvantageous, since it produces a high
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background of NeutrAvidin derived peptides, complicating protein quantiﬁ-
cation. AHA incorporation followed by enrichment with alkyne-activated
agarose beads in combination with pSILAC for the quantiﬁcation of newly
synthesized proteins outperforms pSILAC for short labeling times. Further-
more, although AHA treatment reduces the translation rate, it does not
cause major diﬀerences in the changes detected after LPS treatment of mouse
macrophages during the investigated time frame. In addition, AHA labeling
and enrichment of newly synthesized proteins does not introduce a protein
detection bias.
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Chapter 5
Quantitative Secretome
Analysis
Secreted proteins constitute a large and biologically important subset of
mammalian proteomes involved in cellular communication, adhesion and mi-
gration. Yet, secretomes are understudied because of technical limitations
in the detection of low-abundant proteins against a background of serum
used to sustain cell culture. The method described in the previous chap-
ter was adapted for the selective enrichment and quantiﬁcation of secreted
proteins irrespective of a complex protein background. The approach solves
several problems in todays secretome analysis, meaning that cells can be
grown in the presence of serum, while preserving the capacity to identify a
large repertoire of low-abundant secreted proteins. In addition, the method is
quantitative enabling accurate secretome comparisons of diﬀerent cell types,
or of cells before and after stimulation. Its utility in the in-depth and diﬀer-
ential analysis of secretomes will be demonstrated and a unique application
studying the kinetics of protein secretion upon cellular stimulation will be
introduced. The method gives access to a poorly covered but biologically
important part of the proteome, contributing to an increased understanding
of cellular communication and responsiveness and with a strong potential in
biomarker discovery.
5.1 Accurate quantiﬁcation of secreted pro-
teins in complete culture media
The key aspect of the approach is the combined metabolic pulse-labeling of
proteins with SILAC amino acids (pSILAC) [112;243], as well as azidohomoala-
nine (AHA), an azide-bearing analogue of methionine [11]. Pulse-labeling with
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AHA allows the selective and covalent capture of newly synthesized proteins
to an alkyne-activated resin via click-chemistry (ﬁg. 4.1) and permits strin-
gent washing conditions. The SILAC label serves to quantify protein levels
in the ensuing mass spectrometric analysis, at the same time providing a
mark to distinguish new from pre-existing proteins (ﬁg. 5.1).
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Figure 5.1: Quantitative analysis of cell secretomes. By combined pulse label-
ing with AHA and stable isotope-labeled amino acids, secreted proteins can be
enriched from the high protein background of cell growth media and are quan-
tiﬁed using mass spectrometry after on-bead digestion and (optionally) peptide
fractionation.
First, the beneﬁt of AHA labeling and protein enrichment in combina-
tion with pSILAC, compared to pSILAC alone, to identify secreted proteins
in the background of complete cell growth medium, i.e. in the presence of
10% bovine serum, was assessed. At the same time, it was explored if this
approach can be used for in-depth and quantitative diﬀerential secretome
analysis. Therefore, two cell lines (PC3 cells, prostatic adenocarcinoma cells
initiated from a bone metastasis, and WPMY-1 cells, a myoﬁbroblast stro-
mal cell line derived from healthy prostate) were pulse-labeled with AHA and
SILAC amino acids for 24 hours in two biologically independent experiments
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with reversed SILAC labels. Conditioned media of oppositely SILAC-labeled
cells were combined (i.e. medium-heavy PC3 and heavy WPMY-1 and vice
versa) and half of each sample was then used for enrichment of newly syn-
thesized proteins and on-bead digestion (as in ﬁg. 5.1). The remaining part
was concentrated and directly subjected to trypsin digestion, thereby omit-
ting the enrichment step. In the enriched sample, 684 human proteins were
quantiﬁed, showing a very high reproducibility between biological replicates
(correlation: 0.961) (ﬁg. 5.2a). Without enrichment, only 22 human pro-
teins were quantiﬁed (correlation: 0.025) (ﬁg. 5.2b) amongst a multitude of
bovine serum-derived peptides. This high background results in severely re-
duced signal-to-noise ratios in MS spectra of secretory peptides (ﬁg. B.1),
explaining poor detection and identiﬁcation.
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Figure 5.2: Comparison of secretomes between cell types. Proteins that are
diﬀerentially secreted with statistical signiﬁcance (FDR: 1%) are highlighted in
red. a) Comparison of secretomes of PC3 and WPMY-1 cells in the presence of 10%
serum. Cells were labeled with AHA and SILAC for 24h in biological duplicate,
followed by media collection and enrichment of newly synthesized proteins; b) as
in panel a, but without protein enrichment
The incorporation of AHA into t-RNA is slower than for methionine [122].
To exclude any inﬂuence of AHA-labeling on protein secretion, conditioned
media from cells grown with AHA or methionine were quantitatively com-
pared. Statistical analysis did not result in any signiﬁcantly changing protein
in either PC3 or WPMY-1 for treatments as long as 24 hours, even when
raising the false discovery rate from 1% (as applied in the analyses described
above) to 5% (ﬁg. B.2).
These results demonstrate that AHA labeling and enrichment of newly
synthesized proteins provide a powerful means to capture secreted proteins
from growth media containing 10% serum. In addition, its combination with
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pSILAC labeling allows for highly reproducible protein quantiﬁcation. Pro-
tein ratios are highly accurate as assessed from samples that were combined
in known relative amounts (ﬁg. 5.3). Therefore, it can be concluded that
the vast diﬀerences in secretome composition observed between PC3 and
WPMY-1 cells (ﬁg. 5.2a) accurately reﬂect diﬀerences in secretory activity.
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Figure 5.3: Accuracy of protein quantiﬁcation after labeling and enrichment.
After incorporation of AHA and either “medium-heavy” or “heavy” SILAC amino
acids, diﬀerentially labeled conditioned media were mixed in known ratios. Pro-
teins were quantiﬁed following enrichment and MS analysis as in ﬁgure 5.1. En-
riched samples had a clearly deﬁned distribution of peptide ratios centered at the
dilution values.
5.1.1 Quantitative comparison of secretomes for net-
work analysis
The dataset was then used to explore the nature and diversity of identiﬁed
proteins and to gain a detailed insight how the diﬀerential secretome may ex-
plain the metastatic properties of PC3 cells. In total, 1136 newly synthesized
proteins were identiﬁed in conditioned media of PC3 and WPMY-1 cells.
Of these, 395 are truly secretory (fulﬁlling the criteria of being associated
with UniProt [244] keywords: “Signal” or “Secreted”, or reaching signiﬁcance
in SignalP 4.0 [245]). Functional classiﬁcation of all identiﬁed proteins using
MetaCore [246] revealed 74 ligands, 65 receptors, 62 proteases and 211 other
enzymes. Among the ligands are 11 cytokines and 12 growth factors, as well
as 13 proteins that show cytokine and growth factor activity based on gene
ontology annotation.
Based on the status of the SILAC label, 459 proteins were detected orig-
inating from PC3 cells alone, 325 (71%) of which were truly secretory. This
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outperforms earlier studies identifying 303 (out of 771 proteins, or 39%) [247]
and 77 (out of 139 proteins, or 55%) [248] secretory proteins from PC3 cells
(ﬁg. 5.4). Notably, those studies [247;248] used serum-starved cells and exten-
sive peptide fractionation schemes and were only qualitative (i.e. they did
not use SILAC).
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Figure 5.4: Number of identiﬁed proteins in PC3 cells compared to recent stud-
ies [247;248] (secretion evidence: signal peptide predicted using SignalP 4.0 [245] or
UniProt keyword “Signal” or UniProt keyword “Secreted” [244]) (Proteins identiﬁed
based on at least 2 MS/MS spectra were considered from the presented dataset as
well as the dataset published by Sardana et al. [247].)
As noted above, out of 1136 identiﬁed proteins, 684 could be quantiﬁed
(ﬁg. 5.2a). As many as 601 of these were diﬀerentially secreted between PC3
cells and WPMY-1 cells (FDR: 1%), 200 and 401 of which had elevated secre-
tion levels in PC3 and WPMY-1 cells, respectively. Among the PC3-speciﬁc
proteins, 63 are associated to “prostatic neoplasm” based on the curated
GeneGo database [246], e.g., INHBA, AREG, DKK1 and PSAP. Functional
annotation [230] of the proteins stronger secreted by PC3 cells revealed the
terms “lysosome”, “cell adhesion”, “peptidase activity” and “cell migration”,
reﬂecting processes related to remodeling of the extracellular matrix. Fig-
ure 5.5 highlights some of these aspects in a network of directly interacting
proteins (either physically or functionally). The ﬁgure shows the diﬀerential
secretion of several metalloproteases (MMP1, 2, 3 and 13 ; ADAM10 and
ADAMTS1 ), as well as over 60 of their substrates. This suggests extensive
processing (activation and inhibition) of signaling proteins and cell-surface
proteins, e.g., inhibitory cleavage of CTGF by MMP13 or LTBP1 by MMP2
or activation of AREG and THBS1 by ADAMTS. In addition, PC3 cells
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diﬀer from WPMY-1 cells by speciﬁc patterns of extracellular matrix pro-
teins, over-expressing laminins (that are thought to mediate the migration
of cells into tissues [249]), while many collagens are underrepresented. The
detection of ligand-receptor pairs, including ROBO1 -SLIT2, APP-TGFB2
and SDC4 -CYR61, adds another level of functional connectivity covered by
the presented data set. Five cytokines were quantiﬁed, including two mem-
bers of the IL6-family (IL6 and IL11 ) that are prototypical proteins at the
lowest range of protein abundance [162] rarely detected in proteomic studies.
Furthermore, several proteins conferring metastatic properties to cancer cells
were successfully detected (ADAM10, TNC, SDC1, L1CAM, ALCAM ), as
well as other proteins that may be associated with cancer progression (e.g.
PLOD1, PLOD2, PLOD3, SDC4 ). In the following paragraphs the secretion
proﬁles of these proteins will be discussed in detail.
The metastatic properties of the cancer cell line are reﬂected by many
diﬀerentially secreted proteins that are involved in the remodeling of the
extracellular matrix (ECM). The major protease degrading ECM proteins is
Plasmin. Plasmin is converted from Plasminogen by the two proteases, PLAU
and PLAT, both of which are stronger secreted by PC3 cells (ﬁg. 5.5). In
contrast, the secretion of the Plasminogen activator inhibitor (SERPINE1 )
is reduced in PC3 cells compared to WPMY-1 cells. Although Plasmin was
not identiﬁed in this experiment these secretion pattern suggest an activation
of Plasmin leading to extensive tissue remodeling.
Plasmin activates several Matrix metalloproteases (MMPs) including the
collagenases MMP1 and MMP13, which show enhanced secretion in the can-
cer cell line. Metalloproteinases (ADAMs and MMPs) represent key proteins
in ECM remodeling, which are able to degrade extracellular matrix proteins
as well as bioactive molecules. The direct interaction network derived from
MetaCore [246] (ﬁg. 5.5) displays the diﬀerential secretion proﬁles of metallo-
proteases and their substrates detected in this study. Interestingly, ADAMs,
as well as the majority of their target proteins, are stronger secreted by the
PC3 cell line. Several ADAM proteins including ADAM10, identiﬁed in this
study, are well-known to be involved in cancer formation and progression [250].
In contrast to the ADAM family proteins, the matrix metalloproteinases
and their substrates show diﬀerential secretion patterns. Here, the collage-
nases (MMP1 and MMP13 ) are strongly secreted by PC3 cells, while higher
amounts of MMP2 and MMP3 are secreted by the WPMY-1 cells.
Collagens are the major compounds of the extracellular matrix and im-
portant targets of metallopoteinases and other proteases [251]. Most of the
collagens quantiﬁed in this experiment are stronger secreted by the WPMY-1
cell line, including Collagen I, III, IV and V, which are ﬁbril-forming colla-
gens and Collagen XVI, that is assigned to the FACIT collagen family, the
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members of which are associated to the ﬁbril forming collagens. The col-
lagens stronger secreted by PC3 cells (COL6A1, COL6A2 and COL18A1 )
exhibit alternative functions: Collagen VI is a microﬁbrillar collagen, while
Collagen XVIII belongs to the family of the multiplexins and can be pro-
teolytically processed to Endostatin, a potent antiangiogenic protein. The
speciﬁc functionalities and secretion proﬁles of Collagen VI and XVIII may
suggest a function in cancer progression. The lower amount of ﬁbril forming
collagens present in the supernatant of PC3 cells could be explained either
by an enhanced degradation by the two collagenases (MMP1 and MMP13 )
or the extensive secretion of collagen by ﬁbroblasts since the WPMY-1 cell
line is derived from myoﬁbroblast stromal.
Collagen inter-ﬁbrillar cross-links are made by two groups of enzymes:
Lysyl oxidases (LOX) and Procollagen-lysine,2-oxoglutarate 5-dioxygenases
(PLOD). Crosslinks increase collagen stiﬀness which inﬂuences integrin sig-
naling, resulting in enhanced focal adhesion formation and tumor progres-
sion [252;253]. Furthermore, it was shown that cells tend to move towards
regions of increased stiﬀness [254]. Interestingly, all known PLODs were quan-
tiﬁed in the study and are stronger secreted by the cancer cell line. This is in
line with earlier studies, where increased expression levels of PLOD proteins
were observed in gastric neoplasm [255;256]. Altogether, these results suggest
that increased secretion of PLOD proteins from cancer cells contributes to
cancer progression and regulation of cell migration by the enhancement of
ECM stiﬀness.
Another group of extracellular matrix proteins highly represented in the
dataset are laminins, a family of multidomain-containing heterotrimeric gly-
coproteins. Laminins promote cell adhesion and migration via integrins and
other cell surface receptors [249]. Changes in expression levels and subunit
composition of laminins have been described for several cancer types, espe-
cially for Laminin 5 [257]. Furthermore the expression of many laminins is
restricted to certain cell types [249]. The data reﬂect the same trends with
several laminin subunits stronger secreted by PC3 cells. The only excep-
tion is Laminin subunit alpha-1 (LAMA1 ) which is stronger secreted be the
WPMY-1 cells possibly representing a cell-speciﬁc laminin.
The ECM-tethered, matricellular proteins TNC, TNXB and GPC are
stronger secreted by PC3 cells. Tenascin (TNC ) is known for its antiadhe-
sive properties. This could explain its strong secretion in the metastatic cell
line in contrast to ﬁbronectin, which is adhesive and does not show diﬀeren-
tial secretion. Furthermore, TNC, a ligand for laminins, is involved in the
rebuilding processes in prostatic adenocarcinoma especially facilitating the
process of invasion [258].
Several other proteins involved in cell adhesion show an increased secre-
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tion in the cancer cell line, e.g, syndecan-1, syndecan-4, L1CAM, ALCAM
and BCAM. Although it is known that syndecans enhance in cooperation
with integrins adhesion, due to weak interactions with ECM components,
their exact contribution to cell adhesion and migration is still unclear [259].
While Syndecan-1 expression has been linked to aggressive cancer progres-
sion [260], a contribution of Syndecan-4 to prostatic cancer has not been shown
yet.
The enhanced secretion of CAM proteins provides a link to the metastatic
properties of the PC3 cells, since Neural cell adhesion molecule L1 (L1CAM )
as well as CD166 antigen (ALCAM ) are up-regulated in the leading front and
cell-cell junctions of invading tumor, respectively [261]. Basal cell adhesion
molecule (BCAM ), which has been associated to malignant transformation
and tumor metastasis [262], is a receptor for Laminin alpha-5, which is often
highly expressed in cancer cells [249].
In summary, the highlighted examples represent several successfully de-
tected proteins contributing to metastatic properties in cancer cells, as well
as new candidate proteins whose role in cancer progression remains to be
established. Furthermore, the results indicate that the presented method
permits in-depth diﬀerential secretome analysis against the background of
10% serum, identifying hundreds of secretory proteins down to the cytokine
level and quantifying them over three orders of magnitude. The richness and
quantitative nature of these data allows the construction of extensive net-
works that may be used to explain cellular behavior and that will be useful
for biomarker discovery.
5.2 Serum starvation alters protein secretion
For reasons of convenience to minimize interference by background proteins,
serum is often omitted in secretome analysis, based on the assumption that
a short period of starvation (typically 24 h) only minimally aﬀects cellular
behavior. Recent reports have challenged this hypothesis, by showing that
serum starvation rapidly (within hours) aﬀects expression and phosphoryla-
tion levels of multiple proteins [16–19]. Having introduced a method to study
protein secretion in the presence of serum, the eﬀect of serum deprivation on
secretome composition, a question that could not be addressed properly so
far, was investigated. At the same time it was explored if the approach may
be used to gauge immediate eﬀects on secretome composition upon cellular
perturbation. Therefore, ﬁve cell lines of diﬀerent origin as well as primary
hepatocytes (PHC) were pulse-labeled with AHA and SILAC using growth
media with and without serum, followed by protein enrichment and mass
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spectrometry (as in ﬁg. 5.1).
name cell type time quantiﬁed secreted R signiﬁcant
PC3 prostatic cancer 3 h 39 100% 0.87 5
PC3 prostatic cancer 24 h 428 64.7% 0.87 39
WPMY-1 prostate 3 h 95 96.8% 0.79 5
WPMY-1 prostate 24 h 757 26.8% 0.80 54
Hepa1-6 hepatocytes 4 h 173 84.5% 0.90 24
Hepa1-6 hepatocytes 24 h 1202 24.3% 0.82 130
Hepa1c1 hepatocytes 4 h 186 78.5% 0.74 26
Hepa1c1 hepatocytes 24 h 733 38.9% 0.88 105
PHC primary hepatocytes 4 h 103 71.8% 0.69 8
PHC primary hepatocytes 24 h 267 40.5% 0.54 14
RAW 264.7 macrophages + LPS 2 h 244 49.2% 0.65 42
Table 5.1: Cell types tested in serum starved medium: The treatment times, the
number of quantiﬁed proteins, the percentage of truly secreted proteins (secreted),
the correlation between biological replicates (R) and the number of diﬀerentially
secreted proteins (signiﬁcant) are given. (Signiﬁcant proteins were deﬁned by a
FDR: 1% and a minimum fold-change of 2 for LPS stimulated mouse macrophages,
PC3 and WPMY-1 cells, or a FDR: 5% and a minimum fold-change of 2 for all
mouse hepatocytes.)
From 39 up to 1202 proteins were quantiﬁed with high reproducibility
between biological replicates in the diﬀerent cell lines (see table 5.1 and ﬁg-
ures 5.6 - 5.8). As expected, prolonged collection times resulted in increased
numbers of quantiﬁed truly secretory proteins, but was accompanied by a
higher proportion of non-secretory proteins. All of these proteins carried a
SILAC label and thus were synthesized during the AHA incubation step. Al-
though it cannot be excluded that these proteins originate from cells dying
during collection, they might also be externalized by unconventional secre-
tion, e.g., by exosomes. The observed diﬀerence in this “leakiness” between
the investigated cell types can now be evaluated using the presented method,
which would be more diﬃcult without AHA and pSILAC labeling.
Serum deprivation signiﬁcantly inﬂuenced the secretion pattern of up to
130 proteins. Even after short times of serum starvation (2-4 h) 5 to 42
proteins were diﬀerentially secreted by the tested cell types, not only demon-
strating the ability of the method to capture immediate changes in secretome
composition but most importantly highlighting the profound and rapid eﬀect
of serum starvation on protein secretion.
Although only starved for two hours the number of aﬀected proteins in
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Figure 5.6: Comparison of secretomes of prostate cells grown with and without
serum. Proteins diﬀerentially secreted with statistical signiﬁcance (FDR: 1%) and
have a fold-change higher than 2 are highlighted in red. a) Diﬀerential secretion
of proteins from PC3 cells after 3 h serum starvation. b) Diﬀerential secretion of
proteins from WPMY-1 cells after 3 h serum starvation. c) Diﬀerential secretion
of proteins from PC3 cells after 24 h serum starvation. d) Diﬀerential secretion of
proteins from WPMY-1 cells after 24 h serum starvation.
mouse macrophages is as high as for other cell lines after 24 hours. The
viability of RAW 264.7 cells grown without serum was signiﬁcantly reduced
to 74.1%, compared to 84.0% of viable cells when grown in serum-containing
medium (p-value = 0.014). Furthermore, several proteins induced by LPS
stimulation of mouse macrophages are aﬀected by serum starvation (ﬁg. 5.8b),
reﬂecting a reduced eﬃciency of macrophage activation in serum-free medium.
For primary hepatocytes the diﬀerences in secretion in response to serum
starvation are less extreme in comparison to the stable cell lines. The overlap
between the two collection times is, with only two proteins signiﬁcant in both
experiments, very low. Furthermore, only 7 of the 20 diﬀerential proteins
are known secreted proteins. This points to the conclusion that primary
hepatocytes are not as susceptible to serum reduction as stable cell lines.
Many diﬀerentially secreted proteins are involved in central cellular func-
tions such as proliferation, cellular homeostasis, cholesterol homeostasis and
signal transduction. In total 24 of the most strongly changing proteins were
cytokines and growth factors (e.g. CTGF, CCL20, CCL2, IL23a, CXCL1,
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Figure 5.7: Comparison of secretomes of hepatic cells grown with and without
serum. Proteins that are diﬀerentially secreted with statistical signiﬁcance (FDR:
5%) and have a fold-change higher than 2 are highlighted in red. a) Diﬀerential
secretion of proteins from Hepa1-6 cells after 4 h serum starvation. b) Diﬀerential
secretion of proteins from Hepa1c1 cells after 4 h serum starvation. c) Diﬀerential
secretion of proteins from primary hepatocytes after 4 h serum starvation. d)
Diﬀerential secretion of proteins from Hepa1-6 cells after 24 h serum starvation.
e) Diﬀerential secretion of proteins from Hepa1c1 cells after 24 h serum starvation.
f) Diﬀerential secretion of proteins from primary hepatocytes after 24 h serum
starvation.
CXCL10, INHBA, KITLG, SPP1, TGFB1, VEGFA, IL1RN, TNF, IL11,
IL6, DKK1, CXCL5, TGFB2 ), most of which are rarely detected in pro-
teomic studies. The fact that these cytokines can accurately be quantiﬁed,
testiﬁes to the power of the approach.
In addition, both cell type-dependent and independent responses to star-
vation were observed. The Connective tissue growth factor CTGF and the
Plasminogen activator inhibitor 1 (SERPINE1 ) were stronger secreted by
cells grown with serum in all 8 experiments using stable cell lines. Addi-
tional 18 proteins showed diﬀerential secretion in at least two experiments
with cells originating from diﬀerent tissues. Among those, SERPINE1 and
ﬁve additional proteins stronger secreted by cells grown in serum-containing
medium regulate, based on GO annotation, cell proliferation (ADAMTS1,
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Figure 5.8: Comparison of secretomes of stimulated mouse macrophages grown
with and without serum. Proteins that are diﬀerentially secreted with statistical
signiﬁcance (FDR: 1%) and have a fold-change higher than 2 are highlighted in
red. a) Diﬀerential secretion of proteins from LPS treated RAW 264.7 cells after
2 h serum starvation. b) Comparison of serum starvation results to a comparison
of LPS stimulated to unstimulated cells treated for 2 h
CXCL1, CXCL10, FGFBP1, THBS1 ). CTGF as well as the growth factor
CYR61, which was stronger secreted in serum-containing medium of PC3
cells, are members of the CCN protein family. These proteins are described
to be involved in multiple cellular functions including cell adhesion, angio-
genesis, cell diﬀerentiation, cell proliferation, wound healing and tumorigen-
esis [263]. The observed secretion patterns of CNN proteins correspond with
their described stimulative eﬀect on cell proliferation [264]. Thus, the detected
response to serum starvation of these proteins suggests their involvement in
a common response mechanism controlling cell proliferation.
The increased secretion of CSF1, GDF15 and HS3ST1 and the decreased
secretion of PPIA and ALAD in both hepatic cell lines grown with serum
as well as the increased secretion of HSPA6 and SLIT2 in the prostatic cell
lines are examples for tissue speciﬁc responses to serum starvation. In ad-
dition, several proteins were exclusively diﬀerentially secreted in one type of
cells: HSPA5, GLG1, ERP44, NUCB2, HSP90B1, SPP1, LY6E and LMAN2
are examples speciﬁc for mouse macrophages (ﬁg. 5.8a), CCL20, CCL2 and
SCYL2 were only diﬀerentially secreted by Hepa1-6 cells, while TIMP3 was
highly increased only in secretomes of Hepa1c1 cells (ﬁg. 5.7). Speciﬁc for
PC3 is the cytokine IL6 which exhibits the most extreme response after 24 h
(ﬁg. 5.6c). Sakai et al [265] demonstrated recently the inhibition of cell growth
through the modulation of apoptotic and signal transduction pathways after
knocking down IL6 in PC3 cells, demonstrating its functional relevance in
this cell line. The extreme fold-change of IL6 in the experiment suggests
that IL6 would not be detected in PC3 cells by an approach using serum
free medium. Indeed, IL6 as well as IL4L1, another protein exclusively dif-
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ferentially secreted in PC3 cells, were not detected by Sardana et al. [247].
In WPMY-1 cells another cytokine IL11 was six times stronger secreted
by cells grown with serum. IL11, like its close relative IL6, activates STAT3
signaling by binding to the shared receptor IL6ST promoting cell survival,
proliferation and immune response [266]. Thereby, the increased secretion of
IL6 and IL11 in the two cell lines represents the same response to serum
starvation promoted by cell-speciﬁc cytokines.
Exclusively stronger secreted by PC3 cells under serum-free conditions are
LDL receptor (LDLR) and Proprotein convertase subtilisin/kexin 9 (PCSK9 ).
Both proteins are involved in controlling cholesterol homeostasis. PCSK9
binds and degrades LDLR [267]. This provides a potential link between serum
factors and regulation of local LDL availability, which could help clarifying
the role of cholesterol as a risk factor for prostate cancer [268].
In conclusion, the data indicate that serum starvation drastically and
immediately (2-4 h) aﬀects secretion, well within the time-frame of most
secretome studies (24 h). Proteins identiﬁed under such conditions may
represent artifacts that do not reﬂect the cellular state under physiological
conditions.
5.3 Quantiﬁcation of secreted proteins from
primary mouse hepatocytes compared to
cell lines
Next, it was tested if the approach can be used to access secretion diﬀerences
between primary cells and cell lines. It was applied to mouse hepatic cells,
which are widely used in drug metabolism studies. Since it was demonstrated
before that the intracellular proteome of the hepatoma cell line Hepa1-6
diﬀers strongly from that of primary hepatocytes [269], secretory activity of
primary cells compared to two hepatoma cell lines (Hepa1-6 and Hepa1c1)
was assessed. Figure 5.9a-c shows that secretion proﬁles are diﬀerent to such
a degree that the cell lines should not be considered as being representative of
the primary cells. After four hours of in total 58 and 62 quantiﬁed proteins 52
and 36 showed signiﬁcant secretion diﬀerences in the comparisons of primary
hepatocytes to Hepa1c1 and Hepa1-6 cells, respectively. Strikingly, although
the correlation between biological replicates is very high (0.852 and 0.893
ﬁg. 5.9a,b), the correlation is even higher (0.937) when plotting the protein
ratios of both cell lines against each other (ﬁg. 5.9c), indicating that the
secretomes of the two cell lines are highly similar. Extending the collection
time to 24 hours increased the number of quantiﬁed proteins to 612 containing
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as many as 581 diﬀerentially secreted proteins (ﬁg. 5.9d).
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Figure 5.9: Comparison of the secretomes of primary hepatocytes (PHC) and
hepatoma cell lines (Hepa1-6 and Hepa1c1). Proteins that are diﬀerentially se-
creted with statistical signiﬁcance (FDR: 5%) and have a minimum fold-change of
2 are highlighted in red. a) Comparison of Hepa1-6 and PHC secretomes, collected
for 4 h in biological replicate. b) Comparison of Hepa1c1 and PHC secretomes,
collected for 4 h in biological replicate. c) Combination of panels a and b, showing
very good correlation between secretomes of the two cell lines. d) Comparison of
Hepa1-6 and PHC secretomes, collected for 24 h in biological replicate.
7 and 30 proteins were stronger secreted by primary hepatocytes com-
pared to Hepa1-6 cells after 4 or 24 hours, respectively. The 18 proteins
stronger secreted by primary hepatocytes compared to the Hepa1c1 cell line
highly overlap with the ones signiﬁcant in the comparisons to Hepa1-6 cells.
Together, all of these are known to be exclusively or highly expressed in liver,
e.g., Apoa1, Apoa4, Apob, Ahsg, C9, Gc, Itih4 and nine members of the Ser-
pin family (e.g. Serpina1a, a1e, a1b, a1d, a3k, a3m, a3n, f2 and g1 ). Among
them are high-abundant serum proteins (e.g. Transthyretin, Serum albu-
min) which were distinguished from their bovine homologs in serum by the
presence of SILAC labels. The relative protein abundances in the enriched
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primary hepatocyte samples were estimated using the iBAQ approach [21],
revealing several high abundant proteins stronger secreted by the Hepa1-6
cells than by primary hepatocytes, e.g., B2m, Serpine1, Cst3, Cpe, Ppia,
Fn1, Igfbp4, Tinagl1 (ﬁg. 5.10). This indicates that some hepatic properties
are preserved in the cell line and that the isolation and culture conditions for
the primary cells did not globally reduce secretion.
2 3 4 5 6 7 8
2
4
6
8
log10(iBAQ) replicate 1
lo
g1
0(i
BA
Q)
 re
pli
cat
e 2
stronger secreted by PHC stronger secreted by Hepa1-6 no significant difference
PHC 24 h
2 3 4 5 6 7 8
3
4
5
6
7
8
9
log10(iBAQ) replicate 1
lo
g1
0(i
BA
Q)
 re
pli
cat
e 2
Hepa1-6 24 ha b
Figure 5.10: log10(iBAQ) values for primary hepatocytes (a) and the Hepa1-
6 cell line (b) after 24 h highlighting the relative abundances of the quantiﬁed
proteins after enrichment
Slany et al. recently reported the detection of 67 secreted proteins from
human primary hepatocytes using a serum depleted medium [270]. Of these, 27
mouse orthologues were identiﬁed with additional 83 proteins only captured
via the presented approach.
After 24 hours as many as 29 of 38 quantiﬁed proteins involved in immune
response, including 11 cytokines, are stronger secreted by the Hepa1-6 cells,
possibly representing a hepatic function. In addition, functional annotation
enrichment revealed several terms, like “proteinaceous extracellular matrix”,
“cell adhesion”, “lysosome” and “cell migration”, represented by proteins like
Timp2, Hspg2, Dag1, Sparc, Bcam, Lama5, Lamb2, Mmp13, Ctsa and Ctsb
also found, e.g., in PC3 cells, that may reﬂect the cells’ transformed status.
In summary, it was shown that the approach is equally applicable to
primary cells and cell lines, at the same time demonstrating that secretome
proﬁles of Hepa1-6 and Hepa1c1 cell lines are highly similar to each other,
but very diﬀerent from primary cells.
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5.4 Secretion dynamics in activated macro-
phages
Intracellular interaction in response to external events is established by con-
trolled secretion of proteins [271]. Although several studies have compared se-
cretomes in the presence and absence of stimulation [272–274], traditional tools
(with or without SILAC) have not been able to probe the dynamics of such a
response with good temporal resolution. Therefore, the approach combining
pSILAC and AHA was used for time-resolved secretome analysis to gain de-
tailed insight into the timing and magnitude of protein secretion. Speciﬁcally,
the experiment was designed to capture proteins that are newly synthesized
in deﬁned windows after the onset of cellular stimulation, in order to dis-
tinguish immediate from delayed secretory events (ﬁg. 5.11a). As a model
system mouse macrophages (RAW 264.7) stimulated with lipopolysaccha-
rides (LPS) were used, thereby inducing the secretion of proteins involved in
innate immune response. Proteins were labeled with AHA and SILAC amino
acids only in 2-hour time windows at diﬀerent times (0, 6, or 17 hours) after
the addition of LPS, upon which conditioned media was collected (ﬁg. 5.11a).
Collectively, across these time points, as many as 500 proteins were iden-
tiﬁed and quantiﬁed, including 12 cytokines, 33 receptors, 25 proteases and
99 other enzymes. This highlights that very short collection times (2 hours)
suﬃce to monitor large numbers of relevant signaling proteins. The abun-
dance of proteins after enrichment, estimated from an iBAQ analysis [21],
spans four orders of magnitude, with Tnf, Ccl4 and Ccl9 among the high
abundant proteins and Ccl5, Il6ra and H2-T23 in the low abundance range
(ﬁg. 5.11b). The measured protein ratios correlate very well with previously
published RNA expression data [219] of LPS-stimulated macrophages during
the same time windows (correlation: 0.66, 0.80, 0.83) (ﬁg. 5.12a-c). These
results indicate the relevance of the protein secretion proﬁles.
Compared to untreated controls, 97 proteins were diﬀerentially secreted
upon LPS treatment in at least one of the sampled time points, of which
>90% are bona ﬁde secretory proteins (ﬁg. 5.13). This set includes estab-
lished cytokines in LPS response, such as Tnf, Il6, Ccl2, Ccl4, Ccl5, Ccl9,
Cxcl10, Il23a, and is highly enriched for gene-products downstream of NF-
κB (pValue: 4.7 e-73) and AP1 (pValue: 3,5 e-84), two transcription factors
known to act downstream of LPS and TLR4 signaling (ﬁg. 5.14). In addi-
tion, 58 diﬀerentially secreted proteins can be directly connected to immune
response (Supplementary Table 3). Collectively, this conﬁrms the speciﬁcity
of the experiment in capturing the expected set of proteins and, to the best
of my knowledge, constitutes the ﬁrst comprehensive secretome analysis of
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Figure 5.11: Kinetics of protein secretion from LPS-stimulated mouse
macrophages. a) Experimental design: Mouse macrophages were stimulated with
LPS for 2, 8 and 19 hours. For each time point, 2 hours before the collection
of conditioned media the medium was substituted to a medium containing AHA,
SILAC amino acids and LPS. This allows the capture and identiﬁcation of pro-
teins speciﬁcally synthesized and secreted in the indicated 2 hour time windows. b)
Scatterplot of log10(iBAQ) values for LPS treated macrophages (2 h) used to es-
timate the relative abundance of the detected proteins. For each abundance range
examples for diﬀerentially secreted proteins that are either known to be involved
in immune response (top) or have not been assigned to immune function (bottom)
are provided. c) Heatmap of log2-fold-changes for proteins showing diﬀerential se-
cretion with statistical signiﬁcance in at least one experimental time point. (0-2 h:
FDR: 5%, 6-8 h: FDR: 1%, 17-19 h: FDR: 10%). The bar next to the heatmap
indicates the functionality of the detected proteins.
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Figure 5.12: Comparison to RNA expression data: The measured protein ra-
tios of secreted proteins after LPS stimulation correlate very well with previously
published RNA expression data for proteins involved in immune response [219],
therefore representing positive controls for the measured secretion kinetics.
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Figure 5.13: Number of truly secreted proteins of LPS stimulated mouse
macrophages for all quantiﬁed proteins (a) and diﬀerentially secreted proteins (b)
In the next step the time-resolved changes of the 97 diﬀerentially secreted
proteins upon LPS-stimulation were analyzed (ﬁg. 5.11c). Within two hours
all signiﬁcant proteins are induced after stimulation. This includes several
cytokines, whose secretion was strongly maintained at all time points (Tnf,
Cxcl10, Ccl2 and Ccl4 ) with a peak between six and eight hours. Other
cytokines (Ccl9, Ccl5 ) and receptors (Ldlr, App, Nrp2, Cd14 = LPS co-
receptor) respond to LPS treatment with a delay, being strongly increased
at 6-8 hours before dropping oﬀ slightly at 17-19 hours.
Some proteins are exclusively induced at the ﬁrst time point. This in-
cludes the growth factors Tgfb1, Vegfa and Pdgfb that are known to be both
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Figure 5.14: Interaction network for diﬀerentially secreted proteins after LPS
stimulation of mouse macrophages, centered around NF-κB and AP1. Only those
proteins are displayed that were diﬀerentially quantiﬁed and that are known to
be expressed downstream of the transcription factors NF-κB and AP1 or directly
interacting with other proteins of the network. The large coverage of the network
indicates broad activation of the TLR4 - NF-κB - AP1 axis, known to be induced
upon LPS stimulation. Red and blue circles indicate increased and decreased
secretion, respectively, in each of the time windows. NF-κB and AP1 were added
to the network, although, being localized in the nucleus, they were not detected
in the study.
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secreted by and act on macrophages [275–277]. Their secretion proﬁle thus
seems to indicate that they participate primarily in immediate macrophage
activation. Interestingly, the Il6-receptor also shares this pattern, while its
ligand Interleukin 6 (Il6 ) was only observed after six hours. This is in very
good agreement with observations that Il6, although part of the initial im-
mune response, follows Tumor necrosis factor (Tnf ) secretion at ∼6 hours of
exposure to LPS [278]. In the data secretion of Il6 coincides with the appear-
ance of Il23a, Ccl5, C2, Edil3 and Cd83, possibly indicating similar routes
of secretion.
Interestingly, the presented data uncover 28 proteins whose secretion is
repressed over time compared to the untreated control. This observation
raises the exciting possibility that inhibited secretion of factors that are in-
volved in signaling and ECM remodeling (Lfng, Plau, Cst3, Dag1, Adam15,
Iﬁ30 ) may be part of the LPS response. Interestingly, Macrophage colony-
stimulating factor 1 receptor (Csf1r), the receptor for M-CSF that plays
an important role in promoting the release of pro-inﬂammatory cytokines,
shares this proﬁle. Therefore, its progressive decrease in secretion suggests a
feedback mechanism moderating the inﬂammatory response. In fact, several
of the identiﬁed factors have both pro- and anti-inﬂammatory characteristics,
including Il6 [279]. The interplay of secreted factors (cytokines, receptors, pro-
teases) combined with their individual secretion proﬁles imposes an intricate
mechanism for context-dependent tuning of the immune response.
Another group of proteins strongly involved in the regulation of inﬂam-
matory responses are proteases and their inhibitors. In total, ten proteases
and eight endopeptidase inhibitors were diﬀerentially secreted, displaying
various secretion patterns over time. The two proteases Urokinase-type plas-
minogen activator (Plau) and Tissue-type plasminogen activator (Plat) are
examples for the time-resolved regulation of protease activity in response to
LPS treatment. Their inhibitor Plasminogen activator inhibitor 1 (Serpine1 )
displays increased secretion over the complete time frame (2-19 hours), prob-
ably causing the down-regulation of Plau at the two later time points. Plat
was stronger secreted in response to LPS between zero and two hours but
was not detected afterwards.
Other examples are the two endopeptidase inhibitors Cystatin-C (Cst3 )
and Cystatin-F (Cst7 ) that show decreased secretion at prolonged LPS stim-
ulation. While Cst3 is known to be involved in defense response [280], Cst7
is not assigned to any GO term related to inﬂammatory response, although
it was shown that Cst7 inhibits Dipeptidyl peptidase 1 (Ctsc) in several im-
mune cells [281]. The decreased secretion of Cst7 may prevent the inhibition
of Ctsc, which is stronger secreted itself between six and eight hours after
LPS stimulation.
77
CHAPTER 5. QUANTITATIVE SECRETOME ANALYSIS
Due to their proteolytic properties, proteases of the ADAM family are
important regulators of inﬂammation [282;283]. Of the three regulated ADAM
proteins, Adam8 is known to decrease inﬂammatory response by the cleavage
of TNF receptor [284]. The observed increase in secretion of Adam8 from 0 to
19 hours could indicate a repression of TNF-mediated defense response after
prolonged LPS stimulation.
Among the proteins whose secretion was reduced at 17 hours, three
proteins were in fact induced at two hours (Gpnmb, Lfng, Arsb). While
Transmembrane glycoprotein NMB (Gpnmb) is known to reduce inﬂamma-
tory responses by modulating Il6 levels and NO production [285], Beta-1,3-N-
acetylglucosaminyltransferase lunatic fringe (Lfng) may be connected to the
LPS response indirectly. Lfng is a membrane-bound enzyme that modiﬁes
the Notch1 receptor disrupting Jag1 -binding, which activates Notch signal-
ing [286].
Interestingly, Protein jagged-1 (Jag1 ) secretion is elevated in response
to LPS over the full 19 hours (ﬁg. 5.11b). Recently, Notch-dependent up-
regulation of Notch target genes was shown to be delayed after LPS stimu-
lation [287]. Based on the observations this delay could be explained by the
disruption of Jag1 binding at early time points promoted by Lfng, while the
repression of Lfng could permit Notch1 activation by Jag1 at later times.
No previous evidence was found in the literature for Arsb as well as Edil3,
Sil1, Sumf1, Glg1, Mpeg1 being involved in LPS response.
Altogether, these selected examples illustrate the eﬀective application of
the described approach to the investigation of cellular responses over time.
The capacity of the method to detect high numbers of secreted proteins from
very short collection windows makes it extremely powerful to study kinetics
of protein secretion.
5.5 Compendium of secreted proteins
Next, by assembling all data acquired in this study, the coverage of the
human secretome was investigated. In the human proteome, 3831 proteins
were deﬁned as being secretory (see methods for deﬁnition). In the combined
experimental data, 665 of these (17%) were identiﬁed which represents a
large proportion, especially when considering that only six cell types were
investigated. These proteins span a wide variety of functionalities, of which
hydrolases and signaling molecules make up the biggest part by absolute
numbers, followed by receptors, extracellular matrix proteins, cell adhesion
molecules and proteases (ﬁg. 5.15a).
Since the presented method relies on the presence of AHA (and thus me-
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Figure 5.15: Compendium of secreted proteins identiﬁed across all experiments in
this study. a) Protein functions of secreted proteins based on PANTHER classiﬁca-
tion [288;289]. b) Distribution of methionine frequencies in the theoretical secretome
(3831 proteins, black line) and experimentally detected proteins (665 proteins, red
line) indicates that the method is not biased against proteins with low-methionine
counts. c) Distribution of methionine frequencies after removal of the signal se-
quence in the theoretical secretome (black line) and experimentally detected pro-
teins (red line). The peak at 0 methionines per 100 amino acids represents the 199
proteins not containing a methionine after signal peptide or N-terminal methionine
cleavage d) Classiﬁcation of commonly and uniquely identiﬁed proteins across all
cell lines used. Almost half of all secreted proteins (276) were uniquely identiﬁed
in one cell type and are associated with GO-terms reﬂecting the cells’ biological
functionality. The numbers in brackets indicate the enrichment score derived by
functional annotation clustering using DAVID [230].
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thionine) in target proteins, the dataset of 665 secretory proteins was used
to evaluate a potential bias against proteins sparse in methionines. The
methionine-frequency distribution was shifted slightly to higher values com-
pared to the theoretical human secretome (ﬁg. B.3c,d). However, this can
be fully explained by a similar shift in protein size distribution, which is in
line with the well-known underrepresentation of small proteins in mass spec-
trometric analyses [242] (ﬁg. B.3a,b). Normalization of methionine-frequency
for protein length results in overlapping density curves of experimental and
theoretical data (ﬁg. 5.15b,c) demonstrating that the method is not biased
against proteins with low numbers of methionines. The peak at 0 methion-
ines per 100 amino acids (ﬁg. 5.15c) represents the 199 (5%) proteins that
do not contain a methionine after cleavage of the signal sequence or after
removal of the starting methionine and that therefore are in principle not
detectable by the presented method.
Finally, the frequency of protein identiﬁcation across the experiments
was determined in order to assess the size and composition of cell-speciﬁc
secretomes. (ﬁg. 5.15d). While some proteins were identiﬁed in all seven cell
types and treatments, 42% of the 665 secreted proteins were only identiﬁed
in one cell type (ﬁg. 5.15d). Interestingly, GO-analysis of these cell-speciﬁc
secretomes revealed terms with clear connections to the cellular functionality,
like “response to wounding” and “complement and coagulation cascades”
for primary hepatocytes, or “inﬂammatory response” for activated mouse
macrophages. This demonstrates that the charted secretomes provide unique
signatures of the cells that were investigated and reinforces the idea that the
secretome is a careful reﬂection of the cell’s identity.
In summary, the pulse-labeling of proteins with azide-containing amino
acids facilitates the eﬃcient isolation of newly-synthesized proteins from com-
plex background via click-chemistry. These proteins can then be quantiﬁed
by virtue of the concurrent labeling with isotope-coded amino acids. When
used in combination, it was demonstrated that these tools can be used eﬀec-
tively for the quantitative and in-depth comparison of secretome composition
and to probe for proteome changes induced within a very short time window
in stable cell lines as well as primary cells. Many hundreds of proteins of
diverse functionalities that can be used to explain diﬀerences in cellular phe-
notypes have been uncovered. A particularly powerful and unique application
of the method is in studying the kinetics of secretory activity. The ability
to derive temporal proﬁles for each of the secreted proteins has added novel
insights to the heavily studied activation of mouse macrophages.
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Proteome and Transcriptome
Kinetics in Activated Mouse
Macrophages
Transcription and translation are processes tightly controlled at diﬀerent
steps during gene expression. To understand how a biological system re-
sponds to environmental variation at a molecular level, time-dependent chan-
ges of both processes need to be investigated. Therefore, the methods de-
scribed in the two previous chapters were used in combination with RNA
expression data to gain insight into the kinetics of gene and protein expres-
sion during mouse macrophage activation. Mouse macrophages (RAW 264.7
cells) were stimulated with lipopolysaccharides (LPS), thus activating signal-
ing pathways downstream of the Toll-like receptor 4 (TLR4) that are involved
in the modulation of the host inﬂammatory response. This system was in-
vestigated recently in several qualitative or quantitative proteomic studies
exploring diﬀerent aspects of TLR4 signaling [222;224–227]. All studies focus
either on the early or the late response to LPS stimulation or just detect
changes in mRNA expression in a time course after stimulation [218;219;223].
By measuring proteins newly synthesized during LPS stimulation at diﬀer-
ent time points, the sequence of events leading to macrophage activation can
be reconstructed. Macrophages as ﬁrst actors in the innate immune response
use the secretion of speciﬁc proteins (cytokines) to attract and activate other
immune cells. To include this important set of proteins into the study, the
secretomes of activated macrophages were analyzed.
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6.1 LPS stimulation of mouse macrophages
6.1.1 Experimental design
To create a comprehensive picture of macrophage activation, changes in pro-
tein synthesis were measured and compared to total protein abundance and
RNA abundance changes at three time points after LPS stimulation (ﬁg. 6.1).
The time points were selected to cover immediate responses to stimulation
(one hour) as well as delayed ones (two hours and three hours). Thereby,
events establishing the activated status of macrophages should be revealed.
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Figure 6.1: Workﬂow for the investigation of proteome and transcriptome kinetics
in mouse macrophages.
The measurement of protein synthesis was performed as described in
chapter 4.2 using AHA incorporation and alkyne-activated agarose beads for
enrichment in combination with pSILAC labeling. In parallel, the medium
collected from the same cells was used for secretome analysis as described
in chapter 5.1. Full SILAC labeling was applied to assess changes in total
protein abundance. RNA abundance changes were measured by aﬃmetrix
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gene expression arrays.
6.1.2 Results - an overview
The numbers of quantiﬁed and signiﬁcantly changing proteins are summa-
rized in table 6.1. Notably, already after 20 min of AHA incorporation as
many as 4852 newly synthesized proteins and 32 newly synthesized and se-
creted proteins were quantiﬁed, again demonstrating the rapid incorporation
of AHA as well as the eﬃciency of the enrichment approach.
protein abundance protein synthesis secretome RNA abundance
20 min 4042 (0) 4852 (0) 32 (0)
60 min 3508 (2) 4914 (35) 65 (24) 7972 (79)
120 min 3355 (17) 5389 (189) 325 (41) 7972 (380)
180 min 3357 (7) 5268 (246) 182 (95) 7972 (424)
480 min 5297 (366)
Table 6.1: Number of quantiﬁed proteins in diﬀerent data sets at investigated
times after LPS stimulation. The number of proteins signiﬁcantly changing in
response to LPS treatment are given in brackets in red (FDR 1% and fold-change
>2).
In total, 9131 proteins and 11660 RNAs were detected, with an overlap
of 7972. To ensure that just expressed RNAs are considered, only these 7972
RNA expression values were used in the following analysis.
Diﬀerent amounts of newly synthesized proteins in the LPS treated sam-
ple compared to the untreated control were detected for 35, 189 and 246
proteins after one, two or three hours, respectively (table 6.1). On RNA
level approximately two times more signiﬁcant changes were found. Here,
79, 380 and 424 RNAs were diﬀerentially expressed at the same times af-
ter stimulation (table 6.1). An increasing number of signiﬁcantly changing
proteins over time has been detected on secretome level, too, ranging from
24 proteins after one hour to 41 and 95 proteins after two and three hours
of LPS stimulation. The increased numbers of signiﬁcant proteins over time
represent delayed eﬀects of LPS stimulation, as well as continued RNA or
protein synthesis, increasing abundance and therefore the chance to detect
diﬀerences.
The proportion of changing secreted proteins compared to the total num-
bers of quantiﬁed secreted proteins is much higher than for the other data
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sets. This points to a strong impact of LPS on macrophage secretion.
Signiﬁcant changes in protein abundance were detected for 2, 17 and
7 proteins after one, two or three hours of LPS stimulation, respectively.
These smaller numbers of signiﬁcant proteins in comparison to the signiﬁcant
newly synthesized proteins can be explained by three facts. First, since less
proteins were quantiﬁed, low abundant proteins were most probably missed.
Second, due to enrichment of newly synthesized proteins minimal changes are
detected that were missed when comparing total protein abundances. And
third, a parallel increase or decrease in protein synthesis and degradation
could lead to constant total protein levels while the levels of newly synthesized
proteins vary.
Combining all data sets for 782 proteins signiﬁcant diﬀerences in at least
one of the performed experiments were detected. Since no information for
total protein or RNA abundance is available, the data set measuring the
protein synthesis after eight hours of stimulation was not included.
To assess the contribution of the protein synthesis data sets to the detec-
tion of signiﬁcant proteins, the proportions of signiﬁcant proteins compared
to all quantiﬁed proteins were calculated (ﬁg. 6.2). Therefore, signiﬁcant as
well as quantiﬁed proteins were combined over all investigated time points.
While 8.6% of the detected proteins showed a signiﬁcant change in response
to LPS stimulation, this number was slightly lower when exclusively looking
at the changes of intracellular protein synthesis (5.0%). As many as 31.5% of
the quantiﬁed secreted proteins were detected at diﬀerent levels (ﬁg. 6.2a).
This number increases further, when the secretome analysis at prolonged
times after stimulation (presented in chapter 5.4) are included (35.0%) or only
proteins with secretion evidence are considered (33.1%). When combining
both criteria, more than half of the truly secreted proteins are diﬀerentially
secreted (ﬁg. 6.2b).
The participation of several detected signiﬁcantly changing proteins in
immunity and response to LPS stimulation is well described. This includes
the members of the NF-κB and AP1 transcription factor complexes (Rel,
Nfkb1, Nfkb2, Relb, Junb, Fosl1, Fosl2, Jun, Fos, Jund, Fosb), the LPS re-
ceptor CD14 and several cytokines induced in response to LPS stimulation
(Tnf, Il6, Ccl2, Ccl4, Ccl5, Ccl9, Cxcl10 ).
Next, it was evaluated how many proteins with established functions in
immunity were detected by the method presented in this thesis. Therefore,
the numbers of signiﬁcant proteins involved in immune response were com-
pared to the total numbers of detected proteins participating in this process.
Signiﬁcant changes were observed for 19.1%, 35.1% and 38.3% of all de-
tected proteins involved in immune response, regulated downstream of LPS
stimulation or transcriptionally regulated downstream of LPS stimulation,
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Figure 6.2: Contribution of protein synthesis data sets to the detection of ex-
pected proteins: For the diﬀerent approaches all time points are combined and
the percentage of signiﬁcant proteins compared to all quantiﬁed proteins is given
for a) all detected proteins; b) all proteins with secretion evidence; c) all proteins
with a connection to immune response; d) all proteins regulated downstream of
LPS based on MetaCore annotation [246] (total number in MetaCore: 587); e) all
proteins with transcription regulated downstream of LPS based on MetaCore an-
notation [246] (total number in MetaCore: 373). For the third column the datasets
presented in chapter 5.4 are included to demonstrate that the investigation of
prolonged LPS stimulation times increases the percentage of expected proteins.
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respectively (ﬁg. 6.2c-e). Again, the secretome data sets contribute to a
higher extend to these numbers.
In addition, functional classiﬁcation of the signiﬁcant proteins was per-
formed to gain an overview of biological functionalities of LPS responding
proteins. Within most protein classes around 7 to 10% of the proteins de-
tected in the complete data set were regulated in response to LPS treat-
ment (ﬁg. 6.3). Exceptions are receptor ligands (36%), receptors (19%) and
transcription factors (14%), representing important protein classes regulating
inﬂammatory responses.
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Figure 6.3: Distribution of functionalities of the detected and the signiﬁcant
proteins. Functional assignment was performed using MetaCore [246]. The total
number of detected proteins assigned to each class is given left of the bars.
The attempt to determine a temporal sequence of events induced or re-
duced in response to LPS stimulation based on functional annotation enrich-
ment using the signiﬁcant proteins at diﬀerent time points was not successful,
since the retrieved functional terms were highly similar. Hence, functional
classiﬁcation was performed for groups of proteins with similar synthesis or
abundance kinetics, which will be discussed in section 6.2.1.
In summary, 782 proteins are aﬀected by LPS stimulation of mouse
macrophages for up to three hours. These proteins are enriched in functional
classes important for immune response. Considering the limited time-frame
investigated and the restriction to one cellular system, a high percentage
of proteins expected to be inﬂuenced by LPS stimulation were detected. A
much higher proportion of detected proteins in the secretome data sets are
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regulated, resulting in a high relative contribution of the secretome data to
the detection of known and novel proteins.
6.2 Comparison of the kinetics of RNA abun-
dance, protein abundance, protein syn-
thesis and secretion
Previous studies comparing mRNA abundance to protein abundance report
a wide range of correlation values highly dependent on the applied methods
and the model system under investigation [21;25;290–292]. Hence, experimental
design as well as the model system inﬂuence the degree of agreement between
these types of data. It could be proposed, that certain systems are stronger
inﬂuenced by post-transcriptional regulation than others, resulting in lower
correlation values.
The correlations between changes in RNA abundance and newly synthe-
sized proteins are within the reported range (around 0.4-0.6) (ﬁg. 6.4). No-
tably, similar correlations are observed when comparing, e.g., protein syn-
thesis to total protein abundance changes or protein synthesis to protein
secretion. In spite of similar correlation values, the determined rations of
a subset of proteins do not correlate when comparing changes in secretion
to intracellular protein synthesis or RNA abundance (ﬁg. 6.4). These pro-
teins are only regulated in the secretome. These are possibly diﬀerentially
synthesized proteins that are immediately externalized in response to LPS
stimulation. Alternatively, LPS treatment could induce gene expression in-
dependent secretion routes or extensive transmembrane protein cleavage.
In addition, correlation values increase when comparing RNA abundance
changes to changes in protein synthesis at a later time point (time diﬀer-
ence approximately 1-2 hours) (ﬁg. B.4). E.g., one hour after stimulation a
correlation of 0.47 was determined while the correlation between RNA ex-
pression at one hour and protein synthesis at two or three hours was 0.57
or 0.61, respectively. For increased time shifts, like seven hours, this eﬀect
disappears.
In other words, the comparison of the measured changes in protein and
RNA species reveals expected correlation values. Bad correlations of single
proteins can be partly explained by a delay between RNA expression and
protein synthesis. Furthermore, a subset of proteins show a signiﬁcant change
in secretion, which cannot be explained on the RNA level and is therefore
probably gene expression independent.
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Figure 6.4: Comparison of log2-fold-changes determined for the diﬀerent protein
and RNA species. (PS: protein synthesis; PA: protein abundance)
6.2.1 Comparison of protein synthesis to RNA abun-
dance dynamics
A more speciﬁc comparison of changes in protein synthesis and RNA abun-
dance could help to distinguish between transcriptional and translational reg-
ulation. Hence, all signiﬁcant proteins were grouped into categories based on
the comparison of kinetics of RNA abundance and protein synthesis changes
(ﬁg. 6.5). 24 proteins are quickly induced in response to LPS stimulation
(category A). Among them, three proteins (Tnf, Nfkbiz and Ier3 ), although
not signiﬁcant, show a slight increase in protein synthesis already 20 min
after LPS stimulation, thereby representing the ﬁrst line of action in defense
response. Notably, while Radiation-inducible immediate-early gene IEX-1
(Ier3 ) is thought to be a negative feedback inhibitor of NF-κB [293], NF-
kappa-B inhibitor zeta (Nfkbiz) has been described to inhibit but also pro-
mote NF-κB dependent transcription [294;295].
As predicted using the correlation plots (ﬁg. B.4) a delay in protein syn-
thesis compared to RNA abundance changes can be observed for 40 proteins
(category B in ﬁgure 6.5). Low translation rates or inhibited translation
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Figure 6.5: Categorization of all signiﬁcant proteins based on the comparison
of protein synthesis against RNA abundance kinetics. The heatmap displays all
signiﬁcant proteins. The number of proteins in each category is given in brackets.
The categories are further grouped based on the determined kinetics. Lineplots
illustrate the average log2-fold-changes in each category. (The numbers on top of
the columns in the heatmap give the time after LPS stimulation.)
could cause this delay in protein synthesis.
Proteins in ﬁve categories exhibit changes in RNA abundance without a
detectable eﬀect on protein synthesis, or change in protein synthesis with-
out a signiﬁcant diﬀerence in RNA abundance (categories C, G, H, J, K in
ﬁgure 6.5). This discrepancy can be explained by proteins not detected in
one of the data sets. Other proteins respond in a delayed fashion, exhibiting
the regulation pattern after prolonged time intervals. This was evaluated
for 35 proteins being induced only after eight hours of LPS stimulation (e.g.
Nfkbib, Cd44, Cebpd, Itpkb, Ccrl2 ). For 15 proteins in these categories RNA
abundance changes are reﬂected in the secretome, meaning that the major
amount of induced newly synthesized protein is immediately externalized
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(category C, H). Synthesis of the remaining proteins could be repressed or
a fast degradation of the newly synthesized protein could prevent induction
on the protein level. For several proteins induced on protein level, but not
signiﬁcantly changing in RNA abundance, a slight increase or decrease on
RNA level was detected (category G, J in ﬁg. 6.5). Therefore, it could be
proposed that even minor changes in RNA abundance result in a signiﬁcant
diﬀerence in protein synthesis for these proteins.
The 14 categories deﬁned in ﬁgure 6.5 were further assigned to groups
that show increased protein synthesis or RNA abundance already after one
hour of LPS stimulation, termed “early induced” , or at later time points
(two or three hours after stimulation), termed “late induced”. A third group
(“reduced”) contains all categories with reduced protein synthesis or RNA
abundance after stimulation. Of the three categories not ﬁtting into this
scheme, two exhibit opposing kinetics and in one signiﬁcant changes were
only detected in the secretome.
The majority of proteins in the “induced” categories can be connected to
functions in immune response and LPS signaling based on the applied criteria
(i.e. regulation downstream of LPS, AP1 or NF-κB described in the Meta-
Core database [246] or any GO term containing “immune”, “defense response”
or “inﬂammatory response”). Among the strongest induced proteins several
cytokines (Tnf, Ccl2, Ccl4, Csf3, Cxcl10 ), transcription factors (Atf3, Fosl1,
Junb), the NF-κB inhibitors Nfkbid and Nfkbiz as well as Tristetraprolin
(Zfp36 ), which mediates Tnf RNA decay [296], can be found. In addition many
proteins not ﬁtting the described criteria have been associated to established
LPS response programs. Examples are the Dual speciﬁcity phosphatases
(Dusp2, Dusp4, Dusp5 ), which will be discussed in chapter 6.3.4 and Proto-
oncogene serine/threonine-protein kinase pim-1, that has been described to
regulate proliferation and apoptosis and to be induced by cytokines [297].
In addition to these established inﬂammatory proteins, several induced
proteins have not been associated to immune response yet and are therefore
novel candiatates with possible functions downstream of LPS induction. Ex-
amples are Rgl1, Lamc1, Flnb, Cpeb4, Dusp16, Hmga2, Homer1 and Vps37c
induced with delayed kinetics after LPS treatment (ﬁg. 6.5 category F) as
well as 17 proteins that exhibit a delay in protein synthesis compared to RNA
abundance changes (category B in ﬁgure 6.5), such as Slc4a7, Arl5b, Csrnp1,
Ell2, Tgm2, Hexim1, Phlda1 and Ehd1.
Of note, a minor proportion of the proteins exhibiting “reduced” kinet-
ics ﬁts to the mentioned criteria for involvement in inﬂammatory responses
(ﬁg. 6.5).
Functional annotation clustering of “early induced” and “late induced”
groups reveals expected terms for inﬂammation and response to LPS stimu-
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lation, like “inﬂammatory response”, “toll-like receptor signaling pathway”,
“regulation of cytokine production”, “apoptosis” and “MAPK signaling path-
way” (table 6.2). Although the received functional terms are similar, subtle
distinctions can be recognized. While several “early induced” proteins are in-
volved in processes necessary for a rapid induction of immune response (e.g.
“regulation of cytokine production”, “MAPK signaling pathway” and “regu-
lation of phosphorylation”), most of the “late induced” proteins regulate long
term immunity, represented by the terms “immune system development”,
“cell activation” and “adaptive immune response” (table 6.2).
EARLY INDUCED
6.12 cell death
4.09 inﬂammatory response
3.21 cytokine
2.82 positive regulation of cytokine production
2.73 TLR signaling pathway/ regulation of cytokine production
2.70 MAPK signaling pathway
2.41 positive regulation of developmental process
2.32 regulation of apoptosis
2.10 negative regulation of molecular function/ regulation of phosphorylation
LATE INDUCED
5.16 immune system development/ cell activation
2.85 defense response
2.74 response to organic substance
2.29 cell activation/ adaptive immune response
2.04 plasma membrane part
2.00 Chemokine signaling pathway/ TLR signaling pathway
REDUCED
4.34 chromosome/ chromosome organization
3.44 cell cycle
2.77 nucleosome
1.98 nucleoplasm/ transcription factor complex
1.98 nucleus/ transcription regulation
1.92 GTPase regulator activity
Table 6.2: Functional annotation clustering for proteins induced early or late or
being reduced after LPS stimulation. Numbers in the ﬁrst column are enrichment
scores provided by the functional annotation clustering algorithm in DAVID [230].
In the second column functional terms representative for all terms in the cluster
are provided.
20 signiﬁcant proteins were mapped to the Toll-like receptor (TLR) sig-
naling pathway, the main pathway activated by LPS stimulation of mouse
macrophages (ﬁg. B.5), resulting after Benjamini correction in a p-value of
4.5x10−6. The majority of these proteins are proteins transcribed down-
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stream of TLR signaling. Only a few proteins involved in the signal trans-
duction of this pathway were diﬀerentially expressed or synthesized. This
can be explained by the fact that most of the signal transduction is per-
formed via phosphorylation dynamics, which is not assessed by the applied
methods. Alongside with downstream eﬀector genes several transcription
factors involved in TLR signaling are diﬀerentially synthesized or expressed,
including several members of the NF-κB, AP1 and IRF families.
Functional annotation clustering for all proteins with reduced abundance
or synthesis results in very diﬀerent enriched terms (table 6.2). Those are
rather associated to “chromosome organization” and “transcription regula-
tion”, as well as “cell cycle”, pointing to a repression of speciﬁc transcrip-
tional programs and the reduction of proliferation, which has been reported
earlier [298;299]. The reduction of several proteins involved in cell cycle progres-
sion (e.g. Cdk2, Cdc25a, Cdc25b, Orc5 ) in combination of the induction with
some of its inhibitors (e.g. Mdm2, Myc, Ccnd1 ) are visualized in the KEGG
pathway map (17 mapped genes, corrected p-value: 3.1x10−3)(ﬁg. B.6).
Notably, 225 proteins only exhibit reduced kinetics on RNA level, while
no changes on protein level have been detected (category K in ﬁgure 6.5).
Among them several proteins are associated to the chromosome (functional
annotation clustering score: 4.2), including most of the detected histones
(Prim1, Dsn1, H1f0, Chek1, Rfc4, Xpo1, Hist1h1a, Hist1h4a, Hist2h2ab,
Hist2h2aa1, Hist2h3b, Ncapd3, Hist1h2bf ). In addition, 7 proteins exhibit
“GTPase regulator activity” (score: 2.0)(Fgd4, Rasa3, Racgap1, Wdr67,
Ect2, Hmha1, Vav3 ) and 9 proteins are associated to the functional term
“cell cycle” (score: 1.8)(Chek2, Dsn1, Racgap1, Rassf2, Anln, Chek1, Kif11,
Ncapd3, Rbl1 ).
To provide a more detailed view of macrophage activation, some cate-
gories with interesting synthesis and abundance kinetics will be discussed in
the next paragraphs.
Two “early induced” categories exhibit interesting RNA abundance dy-
namics, being induced after one hour of stimulation but showing balanced
RNA levels after prolonged stimulation (category D and E in ﬁgure 6.5,
ﬁg. 6.6). While for one category the protein synthesis is induced (ﬁg. 6.6a),
no changes in protein synthesis have been detected for the second category
(ﬁg. 6.6b).
The pattern of the ﬁrst of the two categories can be explained by an in-
duced RNA and protein synthesis after LPS stimulation, followed by RNA
degradation at prolonged times, while the protein remains stable. Seven of
the 20 proteins in this group (ﬁg. 6.6a) are transcription factors, including
Btg2, Jun, Fos and all detected Early growth response proteins (Egr1, Egr2
and Egr3 ). A possible interpretation for the detected kinetics are nega-
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Figure 6.6: Protein categories with early induced RNA and balanced RNA levels
after prolonged stimulation: a) Heatmap of log2-fold-changes of proteins assigned
to the category D in ﬁgure 6.5 b) Heatmap of log2-fold-changes of proteins assigned
to the category E in ﬁgure 6.5
tive feedback loops, which are used to maintain low levels of transcription
factors in the cell [300] and to increase the response time of transcriptional net-
works [301]. Negative feedback loops can include a downstream target of the
transcription factor, but for several transcription factors, including Fos [302],
a negative autoregulation was demonstrated [300].
An alternative mechanism could be the induction of RNA degradation
by another induced protein. One example for this is the stimulation of RNA
degradation by Tristetraprolin (Zfp36 ), which is strongly induced in response
to LPS (category A in ﬁgure 6.5). RNA degradation by Tristetraprolin has
been demonstrated for a wide range of proteins including Serine/threonine-
protein kinase PLK3 (Plk3 ) [303] and Immediate early response gene 5 protein
(Ier5 ) [304], both showing the described abundance and synthesis dynamics.
The maintained diﬀerence in protein synthesis for these proteins again high-
lights the recent ﬁnding that many proteins involved in immune response
have instable RNA but stable proteins [21].
The overall good agreement of RNA abundance and protein synthesis
data is illustrated by only 17 proteins with opposing kinetics (category M
and N in ﬁgure 6.5). An induction of RNA expression in combination with a
reduction in protein synthesis in response to LPS stimulation was observed for
six proteins (Nfkbia, Cdc25a, Irf2bpl, Zcchc2, Glg1, Ptprs)(ﬁg. 6.5 category
N).
NF-κB inhibitor alpha (Nfkbia) inhibits dimeric NF-κB/REL complexes
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Figure 6.7: Proteins with opposing kinetics: Although RNA expression is in-
creased in response to LPS treatment a decrease in protein synthesis was measured
(category N in ﬁgure 6.5).
by trapping REL dimers in cytoplasm [305]. Activation of TLR signaling in-
duces phosphorylation of Nfkbia, followed by ubiquitinylation and its degra-
dation. Therefore, NF-κB is released and can translocate to the nucleus to
activate its transcriptional program [305]. The data suggest a constant syn-
thesis but increased degradation of Nfkbia in response to LPS stimulation
to preserve NF-κB signaling. This ensures the maintenance of high Nfkbia
RNA levels for fast suppression of NF-κB signaling if needed. Therefore,
induced RNA and/or protein synthesis in combination with induced protein
degradation possibly represents one mechanism for rapid immune response
suppression to avoid negative consequences for the system, like septic shock.
Similarly, ubiquitin mediated proteolysis of M-phase inducer phosphatase
1 (Cdc25a) in response to DNA damage, resulting in delayed cell-cycle pro-
gression, has been described [306]. The observed kinetics point to a similar
mechanism of induced protein degradation, while preserving the ability to
quickly produce Cdc25a if necessary. This observation again suggests a con-
nection between inﬂammation and reduced proliferation.
The similarity of expression and synthesis proﬁles indicates a possibly
similar mechanism for the two hardly described proteins in this category
(Zcchc2, Irf2bpl).
The remaining two proteins Glg1 and Ptprs are both transmembrane
proteins and show induced levels in the secretome after two hours. Since this
induction is seen on the RNA level, too, the reduction of protein synthesis
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could be explained by an increased cleavage and release to the extracellular
space, thereby reducing the intracellular protein levels.
The category with inverse proﬁles, exhibiting induced protein synthesis
and slightly reduced RNA abundance in response to LPS treatment, is repre-
sented by eleven proteins with diverse functions, ranging from apoptosis and
stress response to transcriptional regulation (e.g. Atf4, Chac1, Gch1, Hpgds,
Ndrg1, Sesn2 )(category M in ﬁgure 6.5). Those proﬁles could be explained
by a rapid RNA degradation.
In conclusion, the combined measurement of changes in RNA abundance
and protein synthesis over a time frame after perturbation of the system
helps to group proteins based on the mechanism regulating gene expression.
Hence, it provides starting points for the explanation of observed phenotypes
and gives ﬁrst hints how to further investigate protein expression regulation
of individual proteins.
6.2.2 Comparison of protein synthesis to total protein
abundance dynamics
The ability to investigate newly synthesized proteins separately from the
immense background of “old” proteins should on one hand increase the sen-
sitivity for the detection of changes and on the other hand reveal processes
not measurable on total protein level, like the interplay of protein synthesis
and degradation.
97 proteins are regulated either in protein synthesis or in protein abun-
dance and detected in both data sets. 26 of those exhibit the same regulation
pattern, including mostly proteins with well known functions in immune re-
sponse, such as Nfkbiz, Fos, Jun, Nlrp3, Spp1, Slfn2, Zpf36 and Irg1.
Even though a diﬀerence in protein synthesis in response to LPS stimu-
lation was detected, 69 proteins do not signiﬁcantly change in total protein
abundance. Twelve of these proteins, although not signiﬁcant, show the same
trend, being slightly induced or reduced in total abundance (e.g. Gpr84,
Oasl1, Rel, Tnfsf9, Dnajb4, Marcksl1, Hmox1, Elf2 ). Additional, 42 proteins
change in RNA abundance and protein synthesis after LPS stimulation but
not in the overall protein abundance level. Several of them are proteins with
established functions in inﬂammation (e.g. Tlr7, Tlr13, Hmga2, Pdlim5,
Zyx, Dnaja1, Hspa5, Icam1, Nfkb2, Nfkb1 ). Most probably, the detection
of the regulation was achieved for these proteins by newly synthesized pro-
tein enrichment causing increased sensitivity for measuring diﬀerences in the
proteome after stimulation. Finally, twelve proteins are induced and three
proteins are reduced in protein synthesis, while no diﬀerences on RNA or
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protein abundance was detected (ﬁg. 6.8).
−2
−1
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Hpgds
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Ndrg1
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Lyz2
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Rps27a
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Ints6
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Gclc
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Rgs3
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Gtf2b
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Brd2
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Pabpc1
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Tra2a
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
Dlgap4
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
−2
−1
0
1
2
3
4
−2
−1
0
1
2
Protein synthesis RNA abundance Secretome Protein abundance
Brd1 Spata13 No66
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
−2
−1
0
1
2
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
−2
−1
0
1
2
Time in min
lo
g2
−(
LP
S
/−
)
60 120 180
−2
−1
0
1
2
Figure 6.8: Proteins with increased or decreased protein turnover: Although
RNA and protein abundance remain constant after LPS treatment, an increase or
decrease in protein synthesis was measured.
This proﬁle could be explained by an increased or reduced protein turnover
in response to LPS stimulation. An interesting case is Ubiquitin-40S ribo-
somal protein S27a (Rps27a), since it is the precursor of two functionally
distinct proteins, ubiquitin and 40S ribosomal protein S27a, produced by
proteolytic cleavage [307]. Ubiquitinylation plays a central roll in the regu-
lation of NF-κB signaling, not only by targeting proteins for proteasomal
degradation, but also as a signaling tag [308]. Of note, only peptides matching
the 40S ribosomal protein S27a chain have been detected (ﬁg. 6.9). Hence,
an increased turnover of Rps27a could therefore provide ubiquitin, necessary
for the regulation of NF-κB signaling, while the second strain is immediately
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Figure 6.9: Sequence coverage of Rps27a: The protein is cleaved after synthe-
sis into ubiquitin (yellow) and 40S ribosomal protein S27a (gray). All detected
peptides (red) belong to the 40S ribosomal protein S27a chain.
degraded. The function of the increase or decrease in protein turnover of the
other proteins remains to be elucidated by further studies.
To summarize, the enrichment of newly synthesized proteins increases the
sensitivity for the detection of proteomic changes in response to stimulation.
Furthermore, additional insights into regulatory mechanisms can be gained
by comparing of protein synthesis diﬀerences to diﬀerences in RNA and pro-
tein abundance, e.g., elucidating proteins with increased or decreased protein
turnover in response to stimulation.
6.2.3 Comparison of protein synthesis to secretion dy-
namics
Macrophages, as the ﬁrst actors in immune response, need to communicate
with other cells of the immune system to guide them to the place of inﬂamma-
tion and activate their response programs. To achieve this, they extensively
secrete signaling proteins like cytokines. In order to not miss this important
set of proteins, secretome analysis was performed at the same time points
after LPS stimulation.
In total 107 secreted proteins showed diﬀerential secretion in response to
LPS stimulation within the ﬁrst three hours (ﬁg. 6.2a). When including the
data sets presented in chapter 5.4, i.e. including the later time points at
8 and 19 hours after LPS treatment, this number increases to 150 proteins
(ﬁg. 6.2a). The extracellular temporal proﬁles for 25 of these proteins are
similar to the detected intracellular changes in protein synthesis (ﬁg. B.7).
Most of the proteins in this group are well known to be involved in inﬂam-
matory response, including seven cytokines (ﬁg. B.7).
The set of 15 proteins with increased RNA abundance and protein se-
cretion but no intracellular protein synthesis diﬀerence or no intracellular
detection mainly contains established inﬂammatory proteins, including six
cytokines (Il6, Ccl5, Ccl2, Csf3, Ccl7, Il23a) (ﬁg. 6.10). This highlights how
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Figure 6.10: Analysis of the secretome retrieves changes not detected in cell
lysates: The abundance diﬀerences seen on RNA level can only be detected ex-
tracellular but not in cell lysate and would have been missed by approaches not
applying secretome analysis. (The numbers above the columns give the time after
LPS stimulation.)
secretome analysis can provide additional information, which would have
been missed in standard proteomic analysis. The exclusive detection of some
proteins, like IL6 and Ccl5, at prolonged times after LPS stimulation (8 or
19 hours) possibly stands for delayed regulatory eﬀects in inﬂammation as
discussed in chapter 5.4 (ﬁg. 6.10).
Approximately half of all diﬀerentially secreted proteins do not exhibit
changes in RNA abundance or intracellular protein synthesis (category L in
ﬁgure 6.5). These secretion diﬀerences could therefore be gene expression
independent. 51 of the 89 proteins (all time points including 8 and 19 h)
carry a signal peptide or are annotated to be secreted in UniProt [244] and 48
proteins are established factors in immune response. These two observations
ensure that these are not artifacts derived by increased apoptosis in the LPS
stimulated cells, although this cannot be excluded for all 89 proteins.
Unconventional secretion could be one explanation for the described pat-
tern. The four proteins not having a signal peptide but being assigned to be
secreted in UniProt [244] are Macrophage migration inhibitory factor (Mif ),
Nuclease-sensitive element-binding protein 1 (Ybx1 ) (regulation of splicing)
and the two Galectins Lgals1 and Lgals3. All four proteins are secreted by a
unconventional pathway since they do not enter the endoplasmatic reticulum
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and their secretion is not inhibited by monensin or brefeldin A [144–146].
Functional annotation enrichment revealed a functional cluster contain-
ing the terms “vesicle” and “pigment granule” with the highest enrichment
score (7.71), including proteins such as App, Capg, Cltc, Coro1a, Gpnmb,
Hsp90ab1, Hsp90b1, Prdx1, Hspd1, Hsp90aa1, P4hb, Pdia, Sdcbp, Ywhae and
Ywhaz. Therefore, increased vesicular traﬃcking in activated macrophages,
which facilitates a rapid increase of extracellular cytokine levels [309], repre-
sents one mechanism, independent of gene expression, resulting in increased
levels of (newly synthesized) vesicular proteins in the secretome.
A third mechanism of unconventional secretion is the release of exosomes.
149 proteins (34.7%) of all 429 proteins detected in the supernatant of mouse
macrophages are assigned to be released via exosomes according to the cu-
rated database ExoCarta [158]. Among them as many as 52 proteins are
induced in secretion but not in intracellular protein synthesis or RNA ex-
pression, representing 58% of the proteins with this proﬁle. An increased
release of exosomes in response to LPS stimulation could therefore explain
the observed secretion of most of the proteins in this group not bearing a sig-
nal peptide (e.g. Pkm2, Ppia, Rpl30, Rps25, Ywhae, Hist1h4a, Cct8, Capg,
Eef1a1 ).
Another enriched cluster includes proteins involved in “antigen process-
ing and presentation” (enrichment score: 1.73). Of note, all H-2 class II
histocompatibility antigens quantiﬁed in the secretome are induced only on
secretome level (ﬁg. 6.11). This group of proteins has been reported to be
released by exosomes earlier [310].
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Figure 6.11: Detected H-2 class II histocompatibility antigens
Finally, transmembrane proteins could be released to the medium by
proteolytic cleavage. Transmembrane proteins with the described proﬁles
are Sema4D which is proteolytically cleaved [311] and Ptprs, App and Lfng
that have a cleavage site assigned in UniProt [244].
The comparison of secretion kinetics to intracellular RNA and protein lev-
els reveals three proteins with reduced protein synthesis but increased levels
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of extracellular protein (ﬁg. 6.12). All three are transmembrane receptors.
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Figure 6.12: Proteins with opposing kinetics: Although RNA abundance and
protein synthesis are decreased in response to LPS treatment an increase in extra-
cellular protein levels was measured.
Interleukin-6 receptor subunit alpha (Il6ra) is the receptor for Il6, a cy-
tokine with central functionality in inﬂammatory response and exists in a
membrane bound form (IL-6RA) and a soluble form (sIL-6RA). The solu-
ble form is produced by two independent mechanisms: partial proteolysis
by metalloproteases (ADAM10 and ADAM17) [312] or alternative splicing of
mRNA [313]. Binding of the complex of Il6/sIL-6RA to the inducible core-
ceptor IL6-RB (Il6st) is necessary for the activation of Il6 signaling in cells
that do not express IL-6RA themselves [314]. The measured discrepancy of in-
tracellular and extracellular Il6ra levels could therefore be explained by the
exclusive and induced release of sIL-6RA to the extracellular space, while
the overall Il6ra expression is reduced. This expression pattern would assist
the stimulation of other cells while repressing autoinduction, which is further
supported by the slightly but not signiﬁcantly reduced levels of IL6-RB de-
tected on protein and RNA level. Unfortunately, this hypothesis could not
be conﬁrmed using the available data, since only peptides derived from the
extracellular part of Il6ra have been detected (ﬁg. B.8a).
The peptides detected for Poliovirus receptor-related protein 1 (Pvrl1 )
and Plexin-B2 (Plxnb2 ) cover their complete sequences (ﬁg. B.8b,c), while
in the secretome samples only peptides derived from the extracellular part of
the proteins were detected. Therefore, again protease shedding mechanisms
are likely causing the observed protein dynamics (ﬁg. 6.12). For both pro-
teins such mechanisms have been reported earlier: Pvrl1 is cleaved by alpha-
secretase, which is mediated by ADAM10 [315]. The single chain precursor of
Plxnb2 is proteolytically processed into a heterodimeric receptor [316]. While
the beta subunit contains the transmembrane domain, a short extracellular
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part and cytosolic domains, the alpha subunit, consisting of most of the ex-
tracellular part, remains linked to the cell surface by weak interactions to
the beta subunit [316] (ﬁg. B.8c).
In summary, adding secretome analysis too the experimental workﬂow
helped to get a deeper insight into macrophage activation, revealing proteins
that would have been missed by standard proteomic approaches and iden-
tiﬁes candidate proteins involved in gene expression-independent regulatory
mechanism in immune response.
6.3 Regulated protein classes in macrophage
activation
6.3.1 Transcription factors
Transcription factors are low-abundant proteins with spatial and temporal
restricted expression that bind DNA and induce or inhibit transcription.
Hence, they are key actors in gene expression and tightly regulated in re-
sponse to cellular perturbation. In the presented data, 59 (14%) of the pro-
teins with diﬀerential expression levels or synthesis are transcription factors
(ﬁg. 6.3). 32 of these have established functions in inﬂammation, based on
the previously mentioned criteria (ﬁg. 6.13). Among them several members of
the NF-κB and AP1 transcription factor complexes, the key regulators down-
stream of TLR4, are strongly induced after LPS stimulation of macrophages
(Rel, Nfkb1, Nfkb2, Relb, Junb, Fosl1, Fosl2, Jun, Fos, Jund, Fosb)(ﬁg. 6.13a).
Additional examples are: Atf3, which is probably a transcriptional repressor
of pro-inﬂammatory genes [317], Egr1/2/3, Ets2, Cebpd, which acts together
with NF-κB to maximize Il6 production [220], Irf7 and Irf4. Interferon reg-
ulatory factor 4 (Irf4 ) has been found to be essential for M2 macrophage
polarization [186]. Since LPS is thought to induce a M1 macrophage pheno-
type [186], the induction of Irf4 suggests the additional participation of Irf4
in the development of the M1 macrophage phenotype.
Most of the detected transcription factors known to act downstream of
LPS are induced in response to LPS stimulation (25 of 35 induced proteins),
while only 5 of 17 proteins with reduced expression or synthesis are estab-
lished inﬂammatory proteins (ﬁg. 6.13). Several of the induced transcription
factors with unknown function in immune response are involved in cellular
stress response or apoptosis, both of which are well known to be activated
by LPS [318] (e.g. Csrnp1, Csrnp2, Maﬀ, Atf4 and Plagl2 ). In contrast, sev-
eral of the transcription factors with reduced expression or synthesis inhibit
transcription (Tcfap4, E2f7, E2f8, Hbp1 and Bhlhe41 ). These proteins are
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Figure 6.13: RNA abundance and protein synthesis proﬁles for the detected
transcription factors showing either induced (a) or reduced (b) expression or pro-
tein synthesis. (Transcription factors appearing twice in the list (isoforms were
distinguished) but have not been quantiﬁed on protein level were removed. The
two transcription factors regulated on secretome level are not shown.)
probably down-regulated after LPS stimulation to allow the transcription of
genes being usually repressed under “normal” conditions.
Transcription factors often precisely concert the timing of target gene
expression. In order to ﬁnd transcription factors that regulate multiple of
the signiﬁcant proteins detected in this study, transcription factor target
enrichment was performed using MetaCore [246]. The heatmap in ﬁgure 6.14
displays the enrichment scores (z-score) for transcription factors with at least
ﬁve downstream targets and an enrichment score higher than eight at at least
one of the investigated time points. Enrichment was performed separately
for signiﬁcant RNAs and newly synthesized proteins. Not all of the retrieved
transcription factors have been identiﬁed in the presented data set, but since
these low abundant proteins could be missed in the analysis, they could still
regulate expression downstream of LPS.
The enrichment patterns on RNA level are more speciﬁc than on protein
level, which is probably caused by diﬀerent translation rates of the down-
stream proteins for individual transcription factors (ﬁg. 6.14). On RNA level
especially the members of the NF-κB family are highly enriched already one
hour after stimulation. For these transcription factors a similar strong en-
richment on protein level can be detected from two hours of stimulation on,
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Figure 6.14: Transcription factors showing an enrichment of downstream targets
among the signiﬁcant proteins. The heatmap displays the z-score provided by
MetaCore [246] after loading all signiﬁcant proteins or RNAs at the investigated
time points to the enrichment algorithm. Transcription factors with at least ﬁve
downstream targets and an enrichment score higher than eight at at least one
of the time points are shown. Furthermore the temporal dynamics measured in
this study are highlighted based on the categorization presented in section 6.2.
Members of important transcription factor families in immune response are color
coded.
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while only a moderate enrichment was detected after one hour (ﬁg. 6.14). The
members of the AP1 transcription factor family exhibit moderate enrichment
of target proteins at all time points.
Several transcription factors regulate expression of multiple proteins with
signiﬁcant diﬀerences in RNA abundance at one hour after stimulation, while
the enrichment score at later time point decreases (ﬁg. 6.14), e.g., Jun and
three members of the ATF transcription factor family. Similar patterns have
been observed by Bhatt et al. when scanning for binding motifs of transcrip-
tion factors in their RNA expression data set derived from lipid A (the active
component of LPS) stimulated mouse bone-marrow derived macrophages [223].
Similarly, the observed pattern for STAT family members, being enriched
across the complete time frame, coincides with their observations (ﬁg. 6.14).
Strong enrichment of downstream target proteins on protein level after
one hour of stimulation was found for only few transcription factors, includ-
ing Tfcap4, Myc, Srf, Elk3 and Elk4. Hence, these transcription factors
could be involved in the regulation of early responses to LPS stimulation.
ETS domain-containing protein Elk-3 (Elk3 ) and Activator protein 4 (Tf-
cap4 ) protein synthesis was reduced after three hours of LPS stimulation
(ﬁg. 6.13b). In combination, this points to a possible involvement of these
proteins in the regulation of endotoxine tolerance [192] as described in chap-
ter 2.3.
Target proteins downstream of Transcription factor E2F1 (E2f1 ) are en-
riched across the complete time frame under investigation (ﬁg. 6.14). No-
tably, Transcription factor E2F7 (E2f7 ) and Transcription factor E2F8 (E2f8 )
are reduced after three hours of LPS stimulation (ﬁg. 6.13b). Both transcrip-
tion factors inhibit E2F-dependent transcription in a synergistic fashion, re-
pressing E2f1 -dependent apoptosis [319]. Hence, down-regulation of these two
proteins could ensure ongoing E2f1 -dependent transcription. Although E2f1
itself has not been detected in the dataset, the combination of these obser-
vations points to an involvement of E2f1 in the regulation of inﬂammation.
In summary, a high number of transcription factors was found to be reg-
ulated in response to LPS stimulation of mouse macrophages. This includes
well known regulators of immune response, as well as potentially novel ones.
Among the novel candidates most of the induced transcription factors reg-
ulate stress response and apoptosis, while the down-regulation of transcrip-
tion factors seems to either repress functions not necessary for inﬂammation
or omit inhibition of the transcription of pro-inﬂammatory proteins. Target
gene enrichment analysis reveals temporal regulation pattern of transcription
factors in response to LPS stimulation. The data suggests a participation of
E2f1, a transcription factor regulating cell cycle and apoptosis [320], in immune
response.
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6.3.2 Receptors
Receptors recognize extracellular signals and transmit them by activating sig-
naling cascades leading to the induction of transcriptional response programs.
Hence, they play important roles in cell-to-cell communication and pattern
recognition, which are the key functionalities needed to react to bacterial in-
vasion. Additionally, they can function in cell migration and transmembrane
transport.
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Figure 6.15: Signiﬁcant receptors. IR: proteins involved in immune response
based on the previously deﬁned parameters (regulation downstream of LPS, AP1
or NF-κB described in the MetaCore database [246] or any GO term containing
“immune”, “defense response” or “inﬂammatory response”); F: main functionality
of the receptor based on UniProt [244]. The numbers above the columns give the
time after LPS stimulation.
In total 44 receptors with diﬀerential expression or synthesis in response
to LPS stimulation were detected (ﬁg. 6.3, ﬁg. 6.15). Most of them have
established functions in immune response (e.g. Cd14, Sdc4, Ccrl2, Icam1,
Gpr84 ). In addition, several of the detected receptors are involved in cell
adhesion (e.g. Ptprj, Itgav, Itga5, Itgax, Emr1, Pvr, Icam1, Neo1, Plxnb2 ),
low density lipoprotein binding (Msr1, Ldlr, Olr1 ) and antigen processing
and presentation (e.g. H2-L, H2-K1, H2-D1, Clec4d, Lilrb4 ) (ﬁg. 6.15),
representing processes highly regulated in inﬂammation.
27 receptors exhibit induced expression or synthesis proﬁles, including
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Cd14, a receptor for LPS that cooperates with TLR4 and MD-2 together
inducing immune response after LPS stimulation [321](ﬁg. 6.15).
Three induced receptors were detected intracellular as well as extracellu-
lar (Icam1, Sdc4 and Ldlr). While Intercellular adhesion molecule 1 (Icam1 )
and Syndecan-4 (Sdc4 ) are induced in protein synthesis intracellular and ex-
tracellular, Low-density lipoprotein receptor (Ldlr) shows only extracellular
an induced proﬁle. All three transmembrane receptors are cleaved from the
cellular surface into a soluble form in response to stimulation [322–324]. Since
the intracellular Ldlr levels remain constant, LPS seems to induce prote-
olytic Ldlr cleavage rather than Ldlr gene expression. Ldlr binds low den-
sity lipoprotein and mediates its endocytosis. Lipoproteins can bind LPS and
therefore reduce LPS mediated responses such as Tnf production [325]. The
fast (already detected at one hour) release of Ldlr may prevent inhibition of
LPS induced anti-bacterial programs by lipoproteins.
Among the nine down-regulated receptors two are toll-like receptors (Tlr7
and Tlr13)(ﬁg. 6.15). Toll-like receptor 7 (Tlr7 ) is expressed in the endo-
somes and recognizes imidazoquinolines and ssRNA [321]. The reduced ex-
pression of this protein in response to LPS stimulation has not been shown
earlier. The transcription of the relatively novel member of the toll-like re-
ceptor family Tlr13 is activated by Ets2 and inhibited by NF-κB [326], both
of which are induced in the samples.
The opposing extra- and intracellular kinetics of the three receptors Il6ra,
Plxnb2 and Pvrl1 can most probably be explained by an increase in prote-
olytic cleavage at the external side of the plasma membrane, as discussed
in section 6.2.3. Similar conclusions can be drawn for two receptors only
induced in the secretome (Sema4d, Ptprs)(ﬁg. 6.15). Notably, the soluble
form of Semaphorin-4D (Sema4d) is the ligand of Plexin-B2 (Plxnb2 ), both
of which are unconventional secreted [327] (see section 6.2.3).
Functional annotation enrichment of all regulated proteins revealed the
KEGG pathway “Cytokine-cytokine receptor interaction” (Benjamini cor-
rected p-value: 1.0x10−4), with 9 receptors of 27 proteins assigned to this
pathway (ﬁg. B.9). Interestingly, only receptors for cytokines of the TNF
family are induced while the remaining receptors show reduced proﬁles.
Thereby, a selfstimulation with these groups of secreted cytokines may be
prevented, such as for the detected cytokine receptor pairs Il6/Il6ra and
Tgfb1/Tgfbr1, arguing for a paracrine eﬀect of these cytokines. Contrarily,
Tnf /Tnfrsf1b represents a cytokine-receptor pair of the Tnf family for which
selfstimulation is promoted, representing an at least partly autocrine function
of Tnf.
In conclusion, the high number of diﬀerentially expressed, synthesized or
secreted receptors highlights their importance in the regulation of inﬂamma-
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tion. Along with functions in immune response and antigen processing and
presentation, several of them are involved in cell adhesion and low-density
lipoprotein binding, possibly representing processes regulated in response to
LPS stimulation. Gene expression-independent regulation of several recep-
tors was detected, pointing to an extensive induction of extracellular pro-
teolytic cleavage as well as exosome release. In addition, synthesis proﬁles
of receptors in combination with their ligands might be used to diﬀerentiate
between autocrine and paracrine secretion mechanisms.
6.3.3 Receptor ligands, cytokines and growth factors
Receptor ligands, especially cytokines and growth factors, possess central
functions in cell-to-cell signaling. Their binding to the corresponding recep-
tors triggers signaling cascades, resulting in the activation of transcriptional
response programs.
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Figure 6.16: Signiﬁcant signaling molecules. The numbers above the columns
give the time after LPS stimulation.
In this study 31 receptor ligands were regulated in response to LPS stim-
ulation, including 20 cytokines and 3 growth factors (ﬁg. 6.16). A very
strong and fast intra- and extracellular induction was observed for Cxcl10,
Tnf, Serpine1 and Il1rn. Interleukin-1 receptor antagonist protein (Il1rn),
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that inhibits Interleukin-1 receptor binding, is much stronger induced in the
secretome than intracellular.
A slightly delayed response to LPS stimulation can be seen for Ccl4,
Tnfsf9, Jag1, Pdgfb, Ltb, Lyz2, Ccl2 and Csf3. By including the data sets
described in chapter 5.4, receptor ligands were detected that show a very slow
response on protein level (8-19 hours), while RNA abundance was already
regulated within three hours of LPS stimulation (Spp1, Ccl9, Ccl5, Il6, Il23a,
Ccl7 ). Since many cytokines are low abundant, some of them were only
detected on RNA level (Il1a, Cxcl2, Ebi3 ).
Notably, only two signaling proteins are reduced after LPS stimulation
(Il16, Tifa). Pro-IL-16 is cleaved by caspase-3 into a secreted C-terminal
part and a N-terminal part, which is translocated into the nucleus [328]. Se-
creted Interleukin 16 (Il16 ), a ligand for CD4, stimulates migration of several
immune cells, like T cells, monocytes, eosinophils and dendritic cells [329–332],
while the C-terminal part induces G(0)/G(1) cell cycle arrest [328]. In addi-
tion, soluble Il16 desensitizes the chemokine receptors CCR5 and CXCR4 [333].
Reduction of Il16 levels in response to LPS stimulation could therefore ei-
ther prevent cell cycle arrest or the desensitization of chemokine receptors in
target cells, like CCR5 which binds the cytokines Ccl4, Ccl5 and Ccl7, being
strongly induced in the presented data set (ﬁg. B.9).
Ligands with contradicting intra- and extracellular proﬁles, such as Glg1,
are most probably externalized by an unconventional secretion pathway, as
discussed in chapter 6.2.3.
In summary, a high number of receptor ligands are regulated in response
to LPS stimulation. Most of them show induced intra- and extracellular
proﬁles with diﬀerent kinetics and strength of induction, highlighting the
tight temporal regulation of cytokine release from activated macrophages.
Il16 is one cytokine with reduced expression. Its reduction possibly prevents
cell cycle arrest or desensitization of chemokine receptors.
6.3.4 Kinases and phosphatases
The mammalian proteome contains more than 500 kinases and around 100
phosphatases [334], acting together to regulate phosphorylation dynamics in
the cell. Phosphorylation of proteins often initiates or maintains signaling
pathways. Hence, kinases and phosphatases constitute key players in the
regulation of signaling pathways activated in inﬂammation. Major changes
in phosphorylation levels in response to macrophage stimulation have been
demonstrated recently [224;225]. E.g., Weintz et al. reported 1850 phospho-
proteins, among which 24% and 9% of the phosphorylation sites were up-
or down-regulated in response to LPS stimulation of primary macrophages,
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respectivelly.
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Figure 6.17: Signiﬁcant kinases (a) and phosphatases (b).
Within the presented data sets 32 kinases and 10 phosphatases exhibit
signiﬁcant diﬀerential expression or synthesis (ﬁg. 6.17). Only twelve of these
proteins are involved in immune response based on the previously mentioned
parameters. 15 kinases are induced in response to LPS stimulation while 17
are reduced.
Polo-like kinases 2 and 3 (Plk2, Plk3 ) are the strongest induced kinases,
followed by Inhibitor of nuclear factor kappa-B kinase subunit epsilon (Ik-
bke), Choline kinase alpha (Chka) and Serine/threonine-protein kinase 40
(Stk40 )(ﬁg. 6.17). Plk2 and Plk3 do not only regulate the cell cycle, but are
also considered as stress response genes [335], possibly explaining their strong
induction in response to LPS treatment. Interestingly, although both pro-
teins are induced on the level of protein synthesis to a similar extend, the
RNA abundance diﬀerence for Plk2 is four times higher than for Plk3. This
could be explained by a higher translation rate for Plk3 compared to Plk2.
Chka, which catalyzes the ﬁrst phosphorylation reaction for the biosyn-
thesis of phosphatidylcholine, is rapidly induced after LPS addition, similarly
to Plk2 and Plk3, and contributes to the regulation of cell growth and cell
stress/defense mechanisms [336]. Notably, Chka RNA abundance is elevated
after two hours of stimulation, pointing to a negative feedback mechanism,
as described in chapter 6.2.1.
Ikbke, which is strongly induced after three hours of LPS stimulation,
phosphorylates inhibitors of NF-κB thus activating NF-κB dependent tran-
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scription [337]. Thereby it is possibly necessary for propagation of NF-κB
target gene expression. Finally the kinase Stk40, which is strongly induced
after two hours of stimulation, has been described as a possible negative
regulator of NF-κB [338].
Slightly less induction was observed for Gk, Brd2, Jak1, Jak2 and Mknk2
(ﬁg. 6.17). Induction of Glycerol kinase Gk, the key enzyme in the regu-
lation of glycerol uptake and metabolism, by LPS has been demonstrated
earlier [339]. Janus kinases (Jak1, Jak2 ), that transmit signals of cytokine
receptors without intrinsic kinase activity [340], are both induced after two
hours of LPS stimulation.
Although a signiﬁcant increase in RNA abundance was observed for Dual
speciﬁcity mitogen-activated protein kinase kinase 3 (Map2k3 ), which cat-
alyzes the phosphorylation of the MAP kinase p38, no signiﬁcant change
in protein synthesis could be determined. Mitogen-activated protein kinase
kinase kinase 1 (Map3k1 ), another component of the protein kinase signal
transduction cascade involved in NF-κB activation, shows reduced abun-
dance and synthesis after two hours of stimulation. Similar kinetics have
been observed for CapZ-interacting protein (Rcsd1 ), which has not been as-
sociated with immune response until now.
Several kinases exhibit reduced protein levels at even later times after
stimulation, including Stk38 an inhibitor of Map3k1 [341], while Chek1, Chek2,
Clk1, Mknk1, Srpk2 and Stk17b are only regulated on RNA level.
Five of the six induced phosphatases are Dual speciﬁcity phosphatases
(Dusp1, Dusp2, Dusp4, Dusp5, Dusp16 )(ﬁg. 6.17), while several additional
Dual speciﬁcity phosphatases were detected, showing no signiﬁcant regula-
tion (Dusp3, Dusp6, Dusp7, Dusp11, Dusp12, Dusp19, Dusp22 ). All reg-
ulated Dual speciﬁcity phosphatases are mitogen-activated protein kinase
phosphatases (MKPs), which can dephosphorylate MAPKs (mitogen-acti-
vated protein kinases) and therefore act as antagonists of MAPK signaling
cascades [342]. Dual speciﬁcity phosphatases can be induced by various stim-
uli. Since this induction often depends on MAPK activation, it has been
proposed to be a negative feedback mechanism for down-regulating MAPK
signaling [342].
Among the phosphatases with reduced synthesis, two M-phase inducer
phosphatases (Cdc25a, Cdc25b) were detected, both involved in the regula-
tion of cell cycle progression. Notably, several of the down-regulated kinases
contribute to cell cycle regulation (Cdk2, Mastl, Chek1, Chek2, Clk1, Nek7 ).
In summary, LPS activation of mouse macrophages results in a tight
regulation of kinases and phosphatases, representing the need for spatial
and temporal control of phosphorylation patterns to induce inﬂammatory
signaling pathways. In addition to kinases and phosphatases exhibiting well
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described functions in the regulation of immune response several proteins
involved in cell cycle control were detected. This observation could represent
on one hand parallel functions of these kinases and phosphatases but on
the other hand also a regulation of proliferation in response to macrophage
activation. Notably, ﬁve Dual speciﬁcity phosphatases were strongly induced
after stimulation, possibly enabling negative regulation of inﬂammation.
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Discussion
Diﬀerences between cellular phenotypes can be deﬁned by changes in pro-
teome composition as well as protein localization and activity. To decipher
the mechanisms driving the change from one phenotype to another, robust
methods for the investigation of protein abundance, localization and activity
regulation are necessary.
Changes in protein abundance are driven by the collective sum of syn-
thesis and degradation of proteins. Methods that investigate these processes
primarily utilize pulse labeling with radioactive or stable isotopes in cell cul-
ture to selectively label and detect newly synthesized proteins and investigate
their degradation. While labeling with radioactive isotopes allows for very
short labeling pulses, the identiﬁcation of the labeled proteins is challenging
and requires extensive protein separation to determine the protein synthe-
sis rates for single proteins. In contrast, stable isotope labeling in tandem
with mass spectrometry provides qualitative and quantitative information
for individual proteins. One of the caveats of stable isotope labeling experi-
ments is the requirement for detectable amounts of labeled proteins [9], which
is typically achieved by longer labeling periods. This limits the applicability
of these methods to the investigation of long term regulatory responses.
Other aspects are the limited scan speed and dynamic range capabilities
of current generation mass spectrometers hampering the detection of low
abundant proteins. These hurdles are particularly relevant when analyzing
the cellular secretome, where the high abundance of serum components sup-
plemented with cell growth medium limits the depth of coverage in these
samples by mass spectrometric analysis.
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7.1 Labeling, enrichment and quantiﬁcation
of newly synthesized proteins
In the course of this thesis a method was developed solving both of these
problems by pulse labeling of newly synthesized proteins with a non-canonical
azide-containing amino acid (AHA). The azide group facilitates the eﬃcient
isolation of newly-synthesized proteins from complex background via click-
chemistry. While this approach has been used for the investigation of protein
synthesis earlier [11;12;114], its application in secretome analysis is novel and
has been demonstrated in chapter 5 to outperform alternative methods in
the number of identiﬁed proteins, the applicability to complex backgrounds
and sophisticated experimental designs.
Two strategies for enrichment of AHA containing proteins are commer-
cially available. First, AHA containing proteins can be labeled with a biotin-
alkyne and enriched using NeutrAviding beads and second, the proteins can
be covalently linked to alkyne-bearing agarose beads. The advantage of the
biotin-alkyne is the possible detection of newly synthesized proteins using
western blotting with anti-biotin antibodies. Thus, the labeling eﬃciency
can be evaluated prior to the work intensive enrichment and mass spectro-
metric measurement and the enrichment procedure can be monitored, as
demonstrated in section 4.1. Since this reagent does not contain a cleavable
linker, as the one used by Dieterich et al. [11], a high background of NeutrA-
vidin derived peptides in the samples after release from the beads cannot be
prevented, which represents the major disadvantage of this reagent.
Therefore, covalent coupling of newly synthesized proteins to the alkyne-
bearing agarose resin is advantageous, because contamination-free samples
are produced by on-bead digestion. This was demonstrated by the detection
of more than 2000 additional proteins (section 4.2). Furthermore, due to
the ability of loading higher initial total protein amounts and since newly
synthesized proteins are covalently bound to the resin, the alkyne-bearing
agarose is the ideal choice for secretome analysis if protein concentrations are
high and extensive washing is necessary to remove contaminating proteins.
In addition to the simple detection of newly synthesized proteins, the
processes that drive the changes in cellular phenotypes need to be quantita-
tively compared under multiple conditions and in dependence of time. First
attempts in this direction have been made by Kramer et al. combining AHA
with iTRAQ labeling of peptides in order to investigate changes in protein
synthesis of Escherichia coli upon perturbing the growth conditions [114;115].
For protein quantiﬁcation, only peptides containing AHA were used to ensure
that they are newly synthesized. As only methionine containing peptides can
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be labeled with AHA, the number of peptides to be submitted to quantita-
tive analysis is relatively low, resulting in low numbers of quantiﬁed proteins
(394).
In this thesis a diﬀerent quantitative method was combined with AHA
labeling, since the metabolic nature of the AHA approach makes it very
amenable to the combination with SILAC methods. Two diﬀerent labeling
protocols that combine AHA with SILAC were tested: complete labeling with
SILAC amino acids before AHA incorporation or the combination of AHA
with pSILAC labeling, a method which has been used earlier for the com-
parison of protein synthesis under diﬀerent experimental conditions. Both
methods allowed the reproducible detection of thousands of newly synthe-
sized proteins.
Complete SILAC labeling has the advantage that part of the sample can
be used for the quantiﬁcation of changes in global protein expression in par-
allel. In contrast to pSILAC labeling, ideally 100% of the amino acids used
have to be replaced by stable isotope labeled amino acids, which necessitates
several cell duplications. Due to the requirement for high amounts of stable
isotope labeled amino acids and special cultue medium, the cost of an ex-
periment can be high. Furthermore, suﬃcient incorporation of the isotopic
label needs to be validated experimentally.
An additional advantage of pSILAC is its ability to discriminate new from
pre-existing proteins. Test experiments using samples not labeled with AHA
for protein enrichment with NeutrAvidin as well as agarose beads revealed
that despite the use of very stringent washing conditions, relatively high
numbers of non-speciﬁc protein identiﬁcations were made. This was likely
caused by side reactions with thiol groups of cysteines catalyzed by the highly
reactive Cu(I), since no background was detected when excluding Cu from the
same test experiment. These side reactions are negligible if a good labeling
eﬃciency with AHA is achieved (e.g. by applying extended labeling times).
Since high eﬃciencies are not achievable in applications with short labeling
times or high protein background, like in secretome samples, the combination
of AHA with pSILAC is the ideal approach to circumvent those problems.
The SILAC label is then used to distinguish between background binding and
newly synthesized proteins. Alternatively, Cu(I) can be excluded when using
cyclic alkynes in a ring strain supported 1,3-cycloaddition [121] as performed
by Nessen et al. with a non-commercial alkyne-bearing resin [12].
In mouse macrophages the incorporation of AHA was detectable after
only ﬁve minutes of treatment (section 4.1). As many as 4852 newly synthe-
sized proteins were quantiﬁed after 20 minutes of pulse labeling with AHA
and SILAC amino acids comparing LPS stimulated to unstimulated mouse
macrophages (section 6.1.2). Thereby, the number of newly synthesized pro-
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teins quantiﬁed by Kramer et al. was exceeded more than ten times, applying
a labeling pulse of similar length [114;115]. It should be noted that they used a
less complex model system and no enrichment with the alkyne-agarose resin,
which represents an additional advantage of the method presented in this
thesis.
Pulsed SILAC labeling alone can be used to compare protein synthesis
under two conditions [112]. For the detection of protein synthesis diﬀerences
in mouse macrophages after LPS stimulation for two or three hours, this
method showed poor correlations between biological replicates, which com-
plicated the detection of changing proteins (section 4.2). In contrast, using
a combination of AHA and pSILAC labeling enabled, after enrichment, the
detection of hundreds of signiﬁcantly changing proteins with very good cor-
relations between biological replicate samples (section 4.2). Therefore, the
reduction of signal-to-noise ratios due to depletion of “old” proteins repre-
sents the major advantage of the described method. Hence, the described
method facilitates the investigation of newly synthesized proteins using sta-
ble isotope labeling on the labeling time scale similar to radioactive isotope
labeling techniques.
Moreover, due to the high background of serum proteins, the results ob-
tained by secretome analysis without enrichment were even worse. Here,
the detection of secreted proteins was nearly impossible, while high numbers
were detected using the presented approach (section 5.1).
7.1.1 Impact of AHA on protein synthesis and secre-
tion
Since the incorporation of AHA into newly synthesized proteins is disfavored
in comparison to methionine [117], the described approach is limited to either
naturally or genetically manipulated methionine auxotrophic organisms, like
mammals. In addition, AHA carries a novel functional group that can po-
tentially inﬂuence the structure, stability, functionality and even subcellular
location of labeled proteins. Hence, before applying this approach, the impact
of AHA on the system of interest needs to be investigated and experimental
conditions have to be optimized.
In this study this question was addressed by measuring the viability and
translation rate of AHA treated mouse macrophages. While no inﬂuence on
cell viability was observed after up to four hours of AHA treatment, the global
translation rate was reduced by approximately 25% after two hours. This is
likely caused by the decreased activity of methionine-tRNA synthetase to-
wards AHA in comparison to methionine [117]. Since the aim of this thesis was
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to compare protein synthesis under two diﬀerent conditions, this reduction
in global protein synthesis should have a similar eﬀect on the compared cells
and should therefore not inﬂuence the results of the experiment. This hy-
pothesis was tested by comparing the protein synthesis ratios retrieved by the
described method to ratios measured using pSILAC without AHA treatment.
Protein synthesis diﬀerences in AHA treated but not in untreated samples
were only detected for four and seven proteins of about 5000 proteins after
two and three hours LPS stimulation, respectively (section 4.2). Therefore,
a major impact of AHA on the measured diﬀerences in protein synthesis can
be excluded.
To ascertain that AHA does not inﬂuence protein secretion, the secre-
tomes of treated and untreated cells were compared. No signiﬁcant diﬀerence
in protein secretion for cells grown in the presence of AHA was observed.
One of the potential limitations of this method is that the replacement
of methionine by AHA restricts the pool of detectable proteins to those that
contain methionine. Only 106 of 53623 proteins in the mouse fraction of the
UniProt database [244] do not contain methionine. Additional 2430 proteins
contain only an N-terminal methionine which is often cleaved directly after
protein synthesis. Therefore, 4.7% of all mouse proteins are not detectable
with the described method. In addition to this limitation the use of AHA for
tagging could potentially introduce a detection bias for proteins with speciﬁc
characteristics, such as methionine rich sequences. However, this possibility
was excluded by comparing various protein properties such as methionine
numbers, protein lenght, isoelectric point and hydrophobicity of the proteins
detected in AHA treated samples to all proteins in the complete proteome
or secretome and samples not labeled with AHA (section 4.2, 5.5).
7.2 Secretome analysis
The selective enrichment of secreted and newly synthesized proteins addresses
a major challenge in secretome analysis, this being the abundant background
of serum proteins. It is common to perform these types of analyses using
serum-free medium based approaches. However, the method facilitates the
detection of hundreds of secreted proteins including proteins of diverse func-
tionalities in the presence of serum.
When used in combination with pSILAC labeling, the method was applied
to in-depth quantitative comparison of secretome composition. It has been
demonstrated that quantiﬁcation by pSILAC is highly reproducible between
biological replicates (correlation routinely >0.85), allowing rigorous statis-
tical evaluation. Combining AHA labeling and pSILAC, limited amounts
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of cells suﬃced to identify multiple low-abundant secretory proteins, includ-
ing several that are rarely seen in proteomic studies (cytokines, some of the
growth factors).
Comparison to published data sets revealed that the method identiﬁes
lower numbers of contaminating proteins (section 5.1.1). This additional
beneﬁt can be explained by the use of pSILAC to “mark” newly synthesized
proteins. These proteins represent a minor fraction of all contaminating
proteins released by, e.g., dying cells.
The detection of contaminations can be further reduced by applying short
collection times, being facilitated by enrichment. Hence, the optimization of
collection times can balance between the identiﬁcation of high numbers of
secreted proteins and the reduction of contaminations. In addition, pSILAC
aids in discriminating between peptides derived from secreted proteins and
their homologous within serum (section 5.3).
In addition, the method facilitated examination of secretome changes
induced within a very short time window. It has been shown that the deter-
mined secretion proﬁles can be used to explain diﬀerences in diverse pheno-
types.
Alternative enrichment approaches primarily focus on subpopulations of
secreted proteins, such as those that are glycosylated [175], which were pre-
dicted to constitute 66% of all secreted proteins. Therefore, these alternative
approaches will miss 34% of the secreted proteins. However, the present ap-
proach will only miss 5% of proteins based on the absence of methionine in
the amino acid sequence.
Vast diﬀerences were detected when comparing secretion proﬁles of cancer
and non-cancer cells, reﬂecting diﬀerences in metastatic properties. The
diﬀerential secretion of several proteases and metalloproteases, as well as
their targets, illustrates the extensive processing of extracellular and cell
surface bound proteins. Proteins with well described functionalities in cancer
progression were detected, as well as several with potentially novel roles in
cancer progression, such as PLOD1/2/3, TNC and SDC4 (section 5.1.1).
To evaluate these proteins as cancer biomarkers, comparative analysis of
multiple patient speciﬁc cancer and non-cancer cell lines is needed, followed
by extensive conﬁrmation of the observations in vivo.
The ﬁnding that the method presented here is readily applicable to pri-
mary cells is highly relevant, indicating that patient- or tissue-derived cells
are directly accessible to secretome analysis. This type of study would per-
mit bypassing of artifacts that may be introduced by the use of cell lines.
This undervalued problem was clearly demonstrated by the vast diﬀerences
between primary hepatocytes compared to hepatoma cell lines (section 5.3).
The scope of another commonly overlooked aspect of secretome analysis,
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namely the impact of serum starvation that is routine applied in the large ma-
jority of secretome studies, was also determined. Cell type independent star-
vation responses, as well as cell type dependent ones were demonstrated. Nu-
merous biologically important proteins, including multiple cytokines, whose
secretion was found to be induced or reduced upon starvation, emphasizes
the need for careful evaluation of biomarkers to conﬁrm that they are not
a consequence of culture conditions (section 5.2). Here, RAW 267.4 mouse
macrophages were extremely sensitive towards serum starvation, explaining
the lack of secretome studies in this cell line up to now.
A particularly powerful and unique application of the presented method is
in studying the kinetics of secretory activity, as demonstrated for stimulation
of macrophages by LPS. In addition to the successful identiﬁcation of sev-
eral known LPS eﬀector proteins (Tnf, Il6, Vegf, several of the chemokines),
many others were found that had not been seen in the context of LPS stimu-
lation before. Furthermore, the ability to derive temporal proﬁles for each of
them has added novel insights to this heavily studied system. Therefore, the
combination of in-depth proteome proﬁling with time-resolved protein secre-
tion provides a powerful and unique application of the method. This will be
helpful to study cellular responsiveness to speciﬁc stimuli, including drugs
and growth factors and may provide important clues to their mechanism of
action.
Finally, all secreted proteins were combined in a compendium revealing
cell speciﬁc functionalities for proteins exclusively secreted by one cell type.
The addition of further experiments will provide more speciﬁc classiﬁcations
of protein functions.
In addition to the presented experiments, this method could also be ap-
plied to alternative approaches in secretome analysis, such as secretory vesicle
or exosome enrichment, 3D cell culture, patient derived cell cultures, cellu-
lar co-culturing systems, or the investigation of secretory pathways using
inhibitors. Moreover, due to the recent success in labeling zebraﬁsh larvae
with AHA [128], there is potential for future application in whole organism
studies.
7.3 Activation of mouse macrophages
Having developed the method for deep investigation of newly synthesized and
secreted proteins, valuable clues into the mechanism deﬁning the phenotype
of a cell or organism can be retrieved. However, a really profound view on a
system will be reached when combining these data sets with the investigation
of RNA and total protein expression changes. The integration of these data
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permits to distinguish between transcriptional, translational and localization
regulation.
Hence, a combination of RNA and protein quantiﬁcation approaches were
applied to study the activation of mouse macrophages with LPS in a time-
course experiment, facilitating the examination of early mechanisms that
regulate innate immune responses. This process involves rapid changes of
the transcriptional program. Although this model system has been exten-
sively studied, a comprehensive investigation of LPS stimulated macrophages
combining RNA and protein expression data along with temporal changes in
protein synthesis and secretion is currently unavailable.
Combined across all data sets, it was observed that 782 RNAs and pro-
teins were diﬀerentially expressed or synthesized. Approximately half of these
changes were detected on the proteome level (section 6.1.2). The number of
detected changing proteins exceed previous proteomic studies of this system,
with the exception of the study by Du et al. [222]. However, this previous study
employed a fold-change cut oﬀ of >1.2 and <0.8 to deﬁne expression diﬀer-
ences [222]. These represent extremely relaxed fold-change cut oﬀs, resulting
in an artiﬁcially large data set.
Investigating newly synthesized proteins had the main impact for the
detection of diﬀerences between treated and untreated cells at the proteome
level in this study. This is highlighted by the observation that few proteins
were diﬀerentially expressed when examining total protein abundances.
In conclusion, enrichment of newly synthesized proteins increases the sen-
sitivity for the observation of minor changes due to reduction of complexity
and interference from preexisting proteins. Additionally, deeper proteome
coverage, achieved by enrichment, led to the detection of numerous low abun-
dant proteins.
This study covers 38% of the proteins with established transcriptional
regulation downstream of LPS stimulation (section 6.1.2). Improvements of
this value could be achieved by the extension of the study towards diﬀer-
ent amounts of LPS used for stimulation, longer stimulation times or the
combined stimulation with LPS and LPS-binding protein (LBP), since it
was previously shown that LPS binds to LBP prior to TLR4 binding [197].
Moreover, under in vivo conditions direct or indirect interactions with other
cell types can inﬂuence stimulation response programs. The use of primary
macrophages would be a small step into the direction of in vivo conditions.
Notably, it has been demonstrated that the analysis of secreted proteins
increases the detection of established proteins in inﬂammatory response and
has a higher relative contribution towards their detection than analysis of
the intracellular proteome. This is not a standard approach in proteomics
and its application to the very same cell culture conditions was extremely
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challenging without the developed method.
One of the primary beneﬁts of the presented data results form the combi-
natory and time-resolved detection of RNA and protein expression changes
in combination with changes in protein synthesis and secretion to group pro-
teins based on mechanism regulating their abundance in the cell. Thereby,
starting points for further investigation of regulatory mechanisms can be
proposed. One example is the detection of possible negative feedback mech-
anisms for several proteins (mainly transcription factors) (ﬁg. 6.6). These
observations are partially validated by previous reports suggesting that the
detected proteins are regulated by similar mechanisms.
An additional example for insights gained by the integration of the diﬀer-
ent data sets is the elucidation of 15 proteins exhibiting increased or decreased
protein turnover in response to LPS treatment (ﬁg. 6.8).
Moreover, based on the observed secretion proﬁles, an induction in vesic-
ular traﬃcking and exosome release in response to LPS treatment can be
proposed, as well as the cleavage of transmembrane proteins, pointing to an
increase of extracellular proteolytic cleavage mediated by LPS (section 6.3.2).
The recent view on this system is biased towards results derived by RNA
expression measurements due to the lack of proteomic studies. The new
data set helps to distinguish between regulated RNA species being truly
transcribed and those that do not yield to changes in protein abundance.
E.g., several proteins with reduced RNA levels in response to stimulation
did not change on protein level. Here, post-translational mechanisms estab-
lish protein synthesis and abundance. Conversely, minor diﬀerences in RNA
abundance levels yielded signiﬁcant changes in protein synthesis for several
proteins (section 6.2). This could be achieved by an increase or reduction in
translation rate, which could be evaluated by ribosome occupancy proﬁling.
Notably, the set of proteins with reduced RNA abundance but no change in
protein synthesis is enriched in proteins involved in cell cycle as well as those
having GTPase regulator activity (section 6.2).
An additional aspect of the presented data set is the temporal resolution,
which allows to distinguish between early and late responses to LPS stimu-
lation. These temporal proﬁles in combination with established knowledge
on protein functionality allowed the prediction of novel mechanisms involved
in innate immune response, speciﬁcally the induction of E2F-1-dependent
genes (section 6.3.1), the NF-κB dependent reduction of Toll-like receptor
13 synthesis (section 6.3.2), the inhibition of autocrine stimulation by cer-
tain cytokines due to the reduced synthesis of the corresponding receptor
(section 6.3.2), the omission of cell cycle arrest or CCR-5 inhibition by IL-
16 (section 6.3.3) as well as a possibly higher translation rate for PLK-3
compared to PLK-2 (section 6.3.4).
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7.4 Conclusion
In the course of this thesis, two novel methods addressing challenges in the
ﬁeld of proteome research have been presented.
First, the unbiased identiﬁcation of speciﬁc and combinatorial binding of
proteins to long DNA-sequences (in the range of CRMs) using in vitro en-
richment and mass spectrometry can complement current methods in gene
expression research. While the detection of DNA-binding sites of estab-
lished transcription factors is achieved using ChIP-approaches, the detection
of unknown DNA-binding proteins has not been possible for these kind of
regulatory sequences yet.
The method was applied to the comparison of proteins binding to three
CRMs active at diﬀerent times and in diﬀerent tissues during Drosophila
melanogaster development. In total 72 potential regulators of these CRMs
have been detected, of which some bound to the expected CRM, thereby
conﬁrming the presented method. In vivo validation of selected candidates is
in progress. This method will help to elucidate how transcriptional networks
are orchestrated by interlacing signals from multiple transcription factors.
Second, a novel method combining pulsed metabolic labeling with the
non-canonical amino acid AHA with pSILAC has been developed. The use
of this technique permitted highly reproducible and selective relative quan-
tiﬁcation of newly synthesized proteins in response to cellular perturbation
with a deep proteome coverage.
Adaption of this method for secretome analysis addresses one of the ma-
jor challenges in this ﬁeld. In doing so, this methodology opens up new
avenues towards novel applications of mass spectrometry based proteomics
for the study of the secretome. The application of this approach in various
experimental setups and cellular systems as presented here has demonstrated
its broad applicability. Moreover, the integration of the developed methods
with RNA and protein expression measurements is a valuable tool to uncover
mechanisms regulating protein abundance and localization in LPS-induced
cells mimicking innate immunity.
The high temporal resolution is the major advantage of this method and
should be exploited in further applications. This includes temporal secretome
analysis as presented in this thesis, but also the time-resolved analysis of, e.g.,
protein degradation or protein modiﬁcation. Here, processes only targeting
new proteins could be determined.
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Methods
If not stated reagents and chemicals are purchased from Sigma Aldrich and
mass spectrometry grade solvents and acids are purchased from Biosolve.
Iodoacetamide (IAA), Dithiothreitol (DTT), Acetamide, Sodium dodecyl sul-
fate (SDS), Ammonium Persulfate (APS), Tetramethylenediamine (TEMED)
were retrieved from Bio-Rad Laboratories. Antibodies were purchased from
abcam. Trypsin (Gold, mass spectrometry grade) was recieved from Promega.
8.1 Sample preparation
8.1.1 Cell culture and collection of conditioned media
PC3 and WPMY-1 cells were grown in 10-cm cell culture dishes at 37 ◦C,
5% CO2 in DMEM (GIBCO), supplemented with 10% FBS (GIBCO) until
50% and 70% conﬂuency, respectively (WPMY-1 ∼2x106 cells, PC3 ∼2.5x106
cells). RAW 264.7 macrophages were grown at 37 ◦C, 5% CO2 in DMEM
(GIBCO) with 10% FBS (GIBCO), 100 mg/L Primocin (InvivoGen) and
4 mM/L L-Glutamin (GIBCO) added until ∼70% conﬂuency (∼1x107 cells
for pSILAC experiments and ∼0.5x106 cells for full SILAC experiments).
Hepa1c1 and Hepa1-6 cells were grown in 10 cm cell culture dishes at 37 ◦C
and 5% CO2 in DMEM with 10% FBS and 1x Penicillin/Streptomycin (P/S;
P.: 100 U/mL ; S: 100 μg/mL; GIBCO) until ∼80% conﬂuency (∼4x106
cells). Primary mouse hepatocytes (PHC) were isolated and cultured as
described elsewhere [343]. Viability of cells was determined by trypan blue
staining and 6x106 living cells were seeded on collagen I-coated 10 cm cell
culture dishes. After 4 h of incubation, hepatocytes were attached to the col-
lagen coat and dead cells were washed away. Adherent hepatocytes (>90%
conﬂuence) were incubated for additional 18 h in Williams’ Medium E (sup-
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plemented with 10% FBS, 1x P/S, 2 mM Glutamin).
8.1.2 Pulse-labeling of cells with AHA and SILAC
For complete SILAC labeling RAW 264.7 cells were grown in SILAC medium
(DMEM non-GMP formulation without methionine, arginine and lysine,
GIBCO) supplemented with 100 mg/L Primocin, 4 mM/L L-Glutamine,
10% dialysed fetal bovin serum (GIBCO), 30 μg/mL methionine and sta-
ble isotope labeled amino acids (84 μg/mL [13C6]L-arginine and 146 μg/mL
[13C6,15N2]L-lysine (Cambridge Isotope Laboratories, Inc) or the natural ver-
sions of this amino acids). Labeling eﬀeciency was determined by mass spec-
trometry after each round of splitting until labeling was complete. Then cells
were grown up and frozen in liquid nitrogen.
To deplete cells from methionine, lysine and arginine, the cells were
incubated for 30 min (RAW 264.7, Hepa1c1, Hepa1-6 and primary hepa-
tocytes) or one hour (PC3 and WPMY-1) in depletion medium (DMEM
non-GMP formulation without methionine, arginine and lysine, GIBCO)
with 10% dialysed fetal bovin serum (GIBCO), 4 mM/L L-Glutamine and
100 mg/L Primocin, before incubation in the same medium supplemented
with 0.1 mM L-azidohomoalanine (AnaSpec, Inc) and in case of pSILAC
either 84 μg/mL [13C6,15N4]L-arginine and 146 μg/mL [13C6,15N2]L-lysine
or 84 μg/mL [13C6]L-arginine and 146 μg/mL [4,4,5,5-D4]L-lysine (Cam-
bridge Isotope Laboratories, Inc). RAW 264.7 cells were stimulated with
100 ng/mL lipopolysaccharides (Escherichia coli O111:B4; Sigma) for the
indicated times. All assays were performed as independent biological dupli-
cates with reversed SILAC labels. Collected media was centrifuged (5 min at
1,000 x g) COMPLETE, EDTA free protease inhibitor (Roche) added and
frozen at -80 ◦C. The protein concentration of the collected media determined
with a NanoDrop (Thermo Fisher Scientiﬁc) was 3 mg/mL in all experiments
with serum containing medium.
Cells were washed three times with warm PBS, detached using a cell
scraper and centrifuged (5 min at 1,000 x g). After removal of PBS the cell
pellets were frozen at -80 ◦C or directly subjected to cell lysis.
The accuracy of quantiﬁcation (ﬁg. 5.3) was tested using medium of LPS
stimulated RAW 264.7 cells (0-2 hours).
Viability test
Viability was determined with trypan blue staining in independent biological
triplicates. Therefore, cells were detached with a cell scraper and transferred
to an eppendorf tube. After appropriate dilution with Trypan Blue Stain
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0.4% (GIBCO 15250-061) the solution was transfered to a Neubauer hema-
cytometer and alive and death cells (blue) were counted. Viability was calcu-
lated as the ratio of alive cells devided by total number of cells. For statistical
analysis of the results a Student’s t-test was applied. Experiments with p-
values below 0.01 were regarded as being statisticaly signiﬁcant diﬀerent in
viability.
8.1.3 Enrichment of newly synthesized proteins and
on-bead digestion using biotin-alkyne and Neu-
trAvidin beads
Cell lysis
Cells were suspended in 150 μL 1% SDS in 50 mM Tris-HCl, pH 8.0 supple-
mented with COMPLETE, EDTA free protease inhibitor (Roche) and lysed
for 15 min on ice. After sonication (3 times 10 seconds; 1 min on ice in be-
tween), the lysate was agitated for 5 min on maximum speed and centrifuged
at 13,000 x g (5 min 4◦C). The supernatant was transferred to a clean tube
and the protein concentration determined using a NanoDrop (Thermo Fisher
Scientiﬁc). The sample was either directly labeled with the biotin-alkyne or
precipitated and stored at -20 ◦C.
Labeling of newly synthesized proteins with biotin-alkyne
Labeling with alkyne-biotin was performed using the Click-iTTM Biotin Pro-
tein Analysis Detection Kit (Invitrogen C33372) applying the vendors pro-
tocol. Shortly, up to 200 μg azide-labeled protein in a maximum volume of
50 μL in 1% SDS, 50 mM Tris-HCl, pH 8.0 were combined with 100 μL of 2X
Click-iTTM Reaction Buﬀer containing the alkyne detection reagent and the
suﬃcient volumn of 18 megaOhm water for a ﬁnal volume of 160 μL. The so-
lution was agitated for 5 seconds at maximum speed followed by addition of
10 μL of CuSO4 (Component C) and agitating for 5 seconds. After addition
of 10 μL of Click-iTTM Reaction Buﬀer Additive 1, agitating for 5 seconds
and 2-3 min pausing, 20 μL of reconstituted Click-iTTM Reaction Buﬀer Ad-
ditive 2 were added followed by agitation. The bright orange solution was
rotated end-over-end for 20 min.
To remove reaction reagents the sample was precipitated by methanol-
chloroform precipitation. Brieﬂy, 600 μL of methanol, 150 μL chloroform
and 400 μL megaOhm water were added subsequently and agitated between
each addition. After centrifugation for 5 min at 13,000 x g the upper aqueous
phase was removed. To wash the protein pellet, 450 μL of methanol were
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added, followed by agitating and centrifugation (5 min at 13,000 x g). This
step was performed twice. Now the pellet was air-dried for at least 15 min
and frozen or directly subjected to newly synthesized protein enrichment,
western blotting or dot blotting.
Enrichment and of newly synthesized proteins and on-bead diges-
tion using NeutrAvidin beads
The protein pellets were diluted in 50 μL 1% SDS in PBS, followed by adjust-
ment to 1% (v/v) NP-40 and 0.05% (w/v) SDS in PBS to a concentration of
25 μg/mL of biotinylated proteins, as determined by dot blotting (see sec-
tion 8.2.1). For each 25 μg of biotinylated proteins, 200 μL of NeutrAvidin
resin slurry (Thermo Scientiﬁc) were washed three times with ten bed vol-
umes of NeutrAvidin-binding buﬀer (1% NP-40, 0.05% SDS in PBS, pH 7.5).
Next, the sample solution was added and binding of biotinylated protein was
allowed by agitating overnight at 4 ◦C. Resin was centrifuged at 2,000 x g
for 5 min at 4 ◦C and the supernatant removed. The resin was washed with
ten bed volumes of NW-A buﬀer (1% NP-40, PBS, pH 7.5) for 10 min at
RT with constant agitation, centrifuged (2,000 x g for 5 min at 4 ◦C) and
the supernatant discarded. This was repeated two more times, followed by
washing two times with NW-B buﬀer (50 mM ammonium bicarbonate), two
times with PBS and two times with NW-B buﬀer in the same manner as
above.
For on-bead digestion for each initial 100 μL of NeutrAvidin slurry the
resin was resuspended in 87 μL 50 mM ammonium bicarbonate and heated
for 10 min at 70 ◦C under agitation. A ﬁnal concentration of 2-3 M urea was
achieved by adding 10 μg of urea for each initial 100 μL of NeutrAvidin slurry.
After cooling down to room temperature TCEP was added to a ﬁnal concen-
tration of 3.125 mM and incubated for 30 min at room temperature under
constant agitation. Next, after adjusting to a ﬁnal iodoacetamide concentra-
tion of 11.2 mM, the resin was incubated for 30 min at room temperature in
the dark under constant agitation. 0.1 μg endoproteinase Lys-C (Wako) per
100 μL of suspension was added and incubated for 4 h at 37 ◦C under agi-
tation. After addition of calcium chloride to a ﬁnal concentration of 0.1 mM
the sample was trypsinized overnight at 37 ◦C under agitation with 1 μg
trypsin per 100 μL suspension. The suspension was transferred to an empty
spin column in a microcentrifuge tube and the supernatant containing the
tryptic peptides was separated by brief pulsed centrifugation. The sample
was acidiﬁed with formic acid and subjected to desalting (see section 8.1.6).
At each step during enrichment small aliquots of resin or sample were kept
for subsequent western blot analysis.
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8.1.4 Enrichment of newly synthesized proteins and
on-bead digestion using agarose beads
Newly synthesized proteins from concentrated media (Amicon Ultra R© Cen-
trifugal Filters 3 kDa cut oﬀ, Millipore) (250 μL) or cell lysates were enriched
using the Click-iT R© Protein Enrichment Kit (Invitrogen C10416), applying
the vendor’s protocol with slight modiﬁcations. For enrichment form media
100 μL agarose resin slurry was used and the volumes of all reagents were
divided by two. After washing the resin with 900 μL water, medium sam-
ple, diluted in 250 μL urea buﬀer (supplemented with the kit) and catalyst
solution were added and incubated for 16 to 20 hours at room temperature.
Alternatively cells were lysed in urea buﬀer for 15 min followed by sonication,
5 min agitating and centrifugation and then subjected to the catalytic reac-
tion using 200 μL of agrose resin slurry. After washing the resin with 900 μL
water, 0.5 mL or 1 mL SDS buﬀer (supplied with the kit) and 0.5 μL or 1 μL
1M DTT were added and agitated at 70 ◦C for 15 min. The supernatant was
aspirated and 3.7 mg iodoacetamide in SDS washing buﬀer was added and
incubated for 30 min in the dark. The resin was transferred to a spin-column
and washed with 20 mL of SDS buﬀer, 20 mL of 8 M urea/100 mM Tris
pH 8, 20 mL of 20% isopropanol (only medium samples) and 20 mL of 20%
acetonitril. After dissolving the resin in digestion buﬀer (100 mM Tris pH 8,
2 mM CaCl2, 10% acetonitrile), 0.5 μg trypsin were added and incubated
over-night at 37 ◦C. The peptide solution was collected and the resin was
washed with 500 μL water. Both solutions were combined and acidiﬁed with
20 μL 10% CF3COOH.
8.1.5 Enrichment of DNA-binding proteins
Drosophila melanogaster embryo collection
Embryo collection was performed from in-house wild-type Drosophila mela-
nogaster population. Before starting the collection three prelay periods of
30 min with subsequent exchange of plates were performed. Then new plates
were placed for 10 hours. After additional 2 hours, the embryos were washed
oﬀ the collection plates through sieves and transfered to 50% bleach (approx-
imately 5% NaOCl) and stirred for 2 minutes. After extensive washing with
water they were transfered to nitrile mesh on paper towels, blotted with light
pressure to dry followed by ﬂash-freezing and storage at -80 ◦C until further
use.
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Nuclear extracts
During the preparation of nuclear extracts the samples were constantly kept
at 4 ◦C. For one nuclear extract around 30-40 grams of embryos were used.
Isolation of nuclei was achieved by dissolving the embryos in buﬀer NU1 using
2 mL per gram embryos (Nu1: 15 mM HEPES pH 7.6, 10 mM KCl, 5 mM
MgCl2, 0.1 mM EDTA pH 7.9, 0.5 mM EGTA pH 7.9, 350 mM Sucrose,
2 mM DTT, 0.2 mM Phenylmethylsulfonylﬂuorid (PMSF)). The suspension
was homogenized and ﬁltered through Miracloth. The cloth was rinsed with
2-3 volumes of buﬀer NU1. From the ﬂow-through the nuclei were pelleted
for 15 minutes at 13k x g. The lipid layer was removed and the supernatant
discarded. For lysis, nuclei were resuspended in 0.5 mL LS buﬀer (low salt)
per gram starting material (LS buﬀer: 15 mM HEPES pH 7.6, 20% Glycerol,
20 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA pH 7.9, 1 mM DTT). An equal
volume of HS buﬀer (high salt) was added and the suspension rotated for
20 min at 4 ◦C (HS buﬀer: 15 mM HEPES pH 7.6, 20% Glycerol, 800 mM
KCl, 1.5 mM MgCl2, 0.2 mM EDTA pH 7.9, 1 mM DTT). Soluble nuclear
material was separated from insoluble chromatin and lipids by centrifugation
(1 hour at 38k rpm). The supernatant was dialyzed against NE200 buﬀer
overnight using Spectra/Por Membrane with 3kDa cut oﬀ (NE200 buﬀer:
15 mM HEPES pH 7.6, 20% Glycerol, 200 mM KCl, 1.5 mM MgCl2, 0.2 mM
EDTA pH 7.9, 1 mM DTT). The total protein concentration of the nuclear
extract was detemined using a NanoDrop (Thermo Fisher Scientiﬁc).
Preparation of biotinylated dsDNA
500 base pair long biotinylated double stranded DNA (dsDNA) was prepared
by PCR ampliﬁcation using biotinylated forward primer bearing a SmaI re-
striction site. For the PCR reaction genomic DNA, PCR buﬀer, 2.5 μM of
CRM forward primer reverse primer
tinC cgtagaaCCCGGGtgaaatattagcctttgcccgatgg aagatcaatcagaatttcagcttgg
633 cgtagaaCCCGGGaaccgaaaacgatgaaagcgtgagg gcctgcgagagcaggatggactgag
bap3 cgtagaaCCCGGGagcaatgatcagtcgatcagtcgac atctggcggatgagggcctcgagatg
Table 8.1: Primers used for the preparation of dsDNA by PCR. (Sequences in
capital letters are the restriction site for SmaI)
each dNTP (dNTP mix from Bioron 11001) and DSF-Taq DNA Polymerase
(Bioron 101005) were mixed and biotinylated forward and reverse primer
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(MWG) added to a ﬁnal concentration of 0.5 μM. PCR cycler (Biorad) was
set up to heat the samples to 94 ◦C within 2 minutes (step 1) and hold this
temperature for 30 seconds (step 2), followed by a decrease to 55 ◦C withing
30 seconds (step 3). After ﬁnal heating of the sample for one minute to 72 ◦C
(step 4), step 2 to 4 were performed for 35 cycles. Finally the temperature
was kept at 72 ◦C for 3 minutes, followed by a temperature decrease to 4 ◦C.
The purity of PCR products was tested using 1.5% agarose gels and
visualized using ethidiumbromide.
DNA extraction was performed using phenol-chloroform precipitation.
Therefore, 100 μL PCR reaction mixture was adjusted to 200 μL using TE
buﬀer (10 mM Tris pH 8.0, 1 mM EDTA) and mixed with 300 μL buﬀer-
saturated phenol. Organic and aqueous phases were separated using gel sepa-
ration tubes by centrifugation at maximum speed for 5 min. After chloroform
addition (300 μL), mixing and additional centrifugation, the top aqueous
phase was transfered to a new tube. 3 volumes ethanol, 1/10 volume of 3 M
sodium acetate and 10 μL glycogen were added, mixed and frozen at -80 ◦C
over night. DNA pellets were separated for the solution by centrifugation at
maximum speed at 4 ◦C, washed with 200 μL 70% cold ethanol and again
centrifuged. The pellets were dried and resuspended in 30 μL of buﬀer EB
(QIAquick PCR Puriﬁcation Kit, Quiagen). The concentration of DNA was
determined using a NanoDrop (Thermo Fisher Scientiﬁc).
DNA aﬃnity pull-down
For DNA aﬃnity pull-down the protocol by Mittler et al. was modiﬁed [8].
The biotinylated dsDNA (∼250 pmol) was diluted in buﬀer DW (20 mM
Tris-HCl, pH 8.0, 2 M NaCl, 0.5 mM EDTA, 0.03% NP-40) to give a ﬁnal
volume of 0.4 mL. 1 mg of Dynabeads MyONe Streptavidin C1 (Invitrogen)
was equilibrated with two washes of buﬀer TE (0.01% (v/v) NP40) (0,4 mL
each) and two washes of buﬀer DW (0.75 mL each) followed by incubation
of the biotinylated dsDNA (rotary wheel, 3 h, room temperature) with the
equilibrated magnetic beads. Wasching of the beads was performed one time
in 0.4 mL TE (containing 0.02% NP40) and three times in 0.4 mL DW buﬀer,
followed by resuspension in 0.1 mL of buﬀer DW and storrage at -20 ◦C until
further use.
The beads harboring the immobilized dsDNA were incubated for one hour
in blocking buﬀer (20 mM Hepes, pH 7.9, 0.05 mg/mL BSA, 0.05 mg/mL
glycogen, 0.3 M KCl, 0.02% NP40, 2.5 mM DTT, 5 mg/mL polyvinylpyrroli-
done) at RT on a rotary wheel using 1.3 mL buﬀer per mg beads. Excess
blocking buﬀer was removed by washing the beads with 1.3 mL (per mg
beads) restriction endonuclease buﬀer (New England Biolabs (NEB) buﬀer
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3) containing 0.02% NP40 and two times with 2.67 mL buﬀer G (20 mM Tris-
HCl, pH 7.3, 10% (v/v) glycerol, 0.1 M KCl, 0.2 mM EDTA, 10 mM potas-
sium glutamate, 0.04% NP40, 2 mM DTT, 0.4 mM PMSF and 0.005 mg/mL
each of aprotinin, leupeptin and pepstatin A) per mg beads.
Nuclear extracts (stored at -80◦C) were cleared for insoluble matter by
centrifugation at 15,000 x g for 20 min at 4 ◦C and adjusted to 10 mM
potassium glutamate, followed by quick dilution with one volume of buﬀer
G containing 0.2 mg/mL of poly dAdT. Insoluble matter was removed by
centrifugation at 15,000 x g for 10 min at 4 ◦C. Preclearing of the nuclear
extracts was performed by incubation with MyOne streptavidin magnetic
beads at a ﬁnal concentration of 1.5 mg/mL for one hour at 4 ◦C, that have
been washed with buﬀer TE supplemented with 0.02% NP40, buﬀer DW
and equilibrated in buﬀer G. After removal of the beads using a magnetic
separator the nuclear extracts were mixed with the blocked DNA bearing
beads at a ﬁnal concentration of 0.7 mg/mL and incubated for 3 hours at
4 ◦C. Recovered beads were washed four times with buﬀer G (1.8 mL per mg
beads) and ones with restriction endonuclease buﬀer (NEB buﬀer 3; adjusted
to 0.02% (v/v) NP40, 2.5% (v/v) glycerol, 1 mM DTT, 0.2 mM PMSF and
0.005 mg/mL each of aprotinin, leupeptin and pepstatin A). The last washing
step was omited in the ﬁnal experiments as described in chapter 3.
For elution using DNases the beads were dissolved in 266 μL of DNAse
buﬀer, enzyme added and agitated for the depicted times (DNase I: Turbo
TM DNase (Applied Biosystem Ambion), SmaI (New England Biolabs)).
Elution with SDS was performed by heating a suspension of the beads in
1% or 0.1% SDS in 0.1 mM Tris pH 6.8 to 95 ◦C for 3 min.
8.1.6 Sample preparation for mass spectrometry
Media not submitted to the enrichment procedure were concentrated using
Amicon Ultra R© Centrifugal Filters (15 mL 3 kDa cut oﬀ, Millipore) at 4 ◦C
and 6000 rpm and washed with 50 mM ammonium bicarbonate until the solu-
tion was clear. In-solution reduction, alkylation and digestion was performed
by adding 10 mM DTT and incubation at 65 ◦C for 30 min, followed by the
addition of 5 mM iodoacetamide and incubation in the dark for 60 min. For
digestion, 0.5 μg of trypsin was added and incubated at 37 ◦C over night.
Digestion of DNA-binding proteins and total cell lysates was performed
according to a previously published protocol [229] with slight modiﬁcations.
The concentration of DTT was adjusted to 0.1 M. After heating to 95 ◦C
for 5 min the samples were cooled to room temperature and concentrated
using Amicon Ultra R© Centrifugal Filters (0.5 mL 3 kDa cut oﬀ, Millipore).
200 μL 8 M urea in 0.1 M Tris/HCl pH 8.5 were added and concentrated.
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After addition of 100 μL iodoacetamide the samples were mixed at 600 rpm
for one minute and incubated without mixing for 5 min followed by the
concentration of the sample. The buﬀer was exchanged by adding 100 μL
8 M urea in 0.1 M Tris/HCl pH 8.0 followed by concentration of the sample
for three times. After addition of 0.5 μg of endoproteinase Lys-C (Wako)
in 40 μL 8 M urea in 0.1 M Tris/HCl pH 8.0 and mixing at 600 rpm for
one minute, the ﬁlter units were incubated at room temperature overnight.
120 μL 50 mM ammonium bicarbonate with 0.5 μg trypsin were added and
incubated at room temperature for four hours.
The acidiﬁed samples (10% CF3COOH) as well as the samples prepared
by on-bead digestion were desalted using Sep-Pak R© cartridges (Vac 1cc
(50 mg) tC18, Waters) as described elsewhere [10]. The desalted peptide sam-
ples were either directly analyzed by nano-LC-MS/MS or fractionated using
isoelectric focusing or strong-anion-exchange chromatography. For isoelec-
tric focusing an Agilent 3100 OFFGEL Fractionator was used in combination
with ImmobilineTM DryStrips (ph 3-10 NL, 13 cm, GE Healthcare). Dried
samples were resuspended in 360 μL H2O and diluted in 1.44 mL 1.25 x IEF
stock solution (6% glycerol, 2% Ampholytes pH 3-10 (1:50) (BioRad)). Fo-
cusing was performed at a constant current of 50 mA with a maximum Volt-
age of 4000 V. After reaching 20 kVh the samples were collected, acidiﬁed
with CF3COOH and desalted using StageTips [344]. For medium samples 12
fractions were combined to 6 fractions. The peptide samples were dried and
dissolved in 4% acetonitrile, 0.1% formic acid. Alternatively, strong anion
exchange was used for the fractionation of the samples into 6 fractions, as
described elsewhere [345] with minor adaptions. Brieﬂy, desalted peptide sam-
ples were dissolved in 200 μL Britton & Robinson Universal Buﬀer pH 2 and
loaded on the anion exchange stage tip which was placed into a C18-stage tip.
Peptides were successively eluted to new C18-stage tips each with Britton
& Robinson Universal Buﬀer pH 12, pH 8, pH 6, pH 4 and pH 2. The ﬂow
through was reloaded to the C18-stage tips and desalted as described above.
8.1.7 Sample preparation for mRNA expression mea-
surement
Approximately 1x106 RAW 264.7 cells were prepared for mRNA expression
measurements and stimulated for one , two and three hours with 100 ng/mL
LPS in DMEM (GIBCO) with 10% FBS (GIBCO), 100 mg/L Primocin (In-
vivoGen) and 4 mM/L L-Glutamin (GIBCO) (∼70% conﬂuency) or left un-
treated. Each experiment was performed in triplicate. For RNA puriﬁcation
the RNeasy Plus Mini Kit (Quiagen) was used according to vendors protocol
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with cell lysis directly in the cell plates and homogenization using QIAshred-
der (Quiagen). For the elution of bound mRNA two times 50 μL water were
used and the ﬁnal concentration was determined using NanoDrop (Thermo
Fisher Scientiﬁc).
8.2 Measurement
8.2.1 Dot blot/ Western blot/ Silver staining
Dot blot
For dot blot the sample pellets were diluted in 50 μL 1%SDS in PBS. 200 μL
of sample dilutions in PBS and a BSA dilution series were prepared. Ni-
trocellulose membrane was equilibrated in PBS and the the dot blot was
assembled according to the manufacturer’s recommendation. The wells were
washed ones with PBS before duplicate application of 100 μL of sample di-
lutions. Samples were removed from wells by the application of vacuum
followed by one washing step with PBS.
Western blot
Samples were mixed with 4x loading buﬀer (1% SDS, 40% glycerol, 20% beta-
Mercaptoethanol, 150 mM Tris pH 6.8, 0.004% Bromphenolblue) and heated
for 5 min at 95 ◦C. Protein separation was performed using 12% SDS-Page
gels with 4% stacking gel (table 8.2) at a constant voltage of 140 V.
Stock running gel stacking gel
H2O 4.5 mL 2.65 mL
30% Acrylamide 5 mL 1 μL
1.5M Tris-HCl pH 8.8 3.25 mL 1.25 mL
10% SDS 130 μL 50 μL
10% APS 60 μL 30 μL
TEMED 20 μL 10 μL
Table 8.2: Composition of SDS-Page gels.
For blotting the gels were incubated in transfer buﬀer (20% methanol,
20mM Tris, 153 mM Glycin, 0,2% SDS) for 10 min. The semi-dry blotting
system (Biorad) was assembled according to vendors directions. Blotting
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was performed at maximum 50 V and a maximum current of 80% of the
membrane area for one hour. The membrane was washed three times with
deionisized water and stained with Ponceau red followed by antibody stain-
ing.
Visualization
Blocking of non-speciﬁc protein binding to the membrane was achieved by
placing the membrane in 5% dry milk in PBS supplemented with 1% Tween20
(PBS-T) for 45 min at RT with gentle agitation on a rocking plate. The
membrane was incubated with the primary antibody in the desired dilution
in 5% dry milk in PBS-T for 1 h at RT with gentle agitation. Next, the
membrane was washed three times with PBS-T for 10 min each, followed by
incubation with the secondary antibody dilution (1:10,000 in 5% dry milk in
TBS-T) for 45 min at RT with gentle agitation. The membrane was washed
three times with PBS-T for 10 min each. Proteins were detected using the
western blotting detection system Immobilon TM Western Chemiluminescent
HRP Substrat (Millipore) in combination with an imaging ﬁlm BioMax MR
ﬁlm from KODAK according to the manufacturer’s instructions. For dot
bots the amount of biotinylated, that is, newly synthesized proteins in the
samples, was estimated by comparing the intensity of the sample dots with
the intensity of biotinylated BSA standard dots.
Silver staining
Samples were mixed with 4x loading buﬀer (1% SDS, 40% glycerol, 20%
beta-Mercaptoethanol, 150 mM Tris pH 6.8, 0.004% Bromphenolblue) and
heated for 5 min at 95 ◦C. Protein separation was performed using 12%
SDS-Page gels with 4% stacking gel (table 8.2) at a constant voltage of
140 V. The gel was rinsed with water followed by ﬁxation for 45 minutes
(H2O:methanol:acetic acid 50:40:10). After washing with water for 1.5 hours
(multiple times exchanged), the gels were incubated in 0.2% (w/v) sodium
thiosulfate for 3 min, followed by two times washing with water, 1 min each.
Next, the gels were incubated with 0.1% (w/v) silvernitrate at 4 ◦C for
30 min. 0.04% formaldehyde in 2% (w/v) sodium carbonate (one exchange)
were added until staining was complete and stopped with 5% acetic acid,
followed by washing with water.
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8.2.2 LC-MS/MS
Peptides were separated using a nanoAcquity UPLC system (Waters) ﬁtted
with a trapping (nanoAcquity Symmetry C18, 5 μm, 180 μm x 20 mm) and an
analytical column (nanoAcquity BEH C18, 1.7 μm, 75 μm x 200 mm). The
outlet of the analytical column was coupled directly to an LTQ Orbitrap Velos
or Orbitrap Velos Pro (Thermo Fisher Scientiﬁc) using a Proxeon nanospray
source (solvent A: 0.1% formic acid, solvent B: acetonitrile, 0.1% formic acid).
The samples were loaded with a constant ﬂow of solvent A at 15 μL/min onto
the trapping column. Peptides were eluted via the analytical column at a
constant ﬂow of 0.3 μL/min. During the elution step, the percentage of
solvent B increased in a linear fashion from 3% to 25% in 40 min, 110 min
or 210 min followed by an increase to 40% in 4 min, 10 min or 5 min and an
increase to 85% in 0.1 min, 1 min or 1 min for the diﬀerent gradient lengths.
The peptides were introduced into the mass spectrometer via a Pico-Tip
Emitter 360 μm OD x 20 μm ID; 10 μm tip (New Objective). Full scan
MS spectra with mass range 300-1700 m/z were acquired in proﬁle mode in
the FT with resolution of 30000. The ﬁlling time was set at maximum of
500 ms with limitation of 106 ions. The most intense ions (up to 15) from
the full scan MS were selected for fragmentation in the LTQ. Normalized
collision energy of 40% was used and the fragmentation was performed after
accumulation of 3 x 104 ions or after ﬁlling time of 100 ms for each precursor
ion (whichever occurred ﬁrst). MS/MS data was acquired in centroid mode.
Only multiply charged (2+, 3+) precursor ions were selected for MS/MS. The
dynamic exclusion list was restricted to 500 entries with maximum retention
period of 30 s and relative mass window of 10 ppm. Lock mass correction
using a background ion (m/z 445.12003) was applied.
8.2.3 mRNA expression measurement
The mRNA expression measurement was performed using GeneChip R©Whole
Transcript (WT) Sense Target Labeling Assay from Aﬃmetrix. All sample
preparation and measurement procedures were performed according to the
vendors protocol. The consequent preparation procedures performed were:
cDNA synthesis and ampliﬁcation (several rounds), sample clean up, termi-
nal labeling, hybridization and washing and staining. Aﬃmetrix exon ex-
pression chip (MoGene-1_0-st-v1) was used for hybridization and expression
measurement.
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8.3 Data analysis
8.3.1 Data processing
The mass spectrometric raw data was processed using MaxQuant (version
1.2.2.5 or version 1.2.0.18 for Drosophila melanogaster) [1] and MS/MS spec-
tra were searched using the Andromeda search engine [346] against either
human (69906 entries), mouse (53623 entries) or drosophila melanogaster
(18797 entries) proteins in UniProt [244], to which 265 frequently-observed
contaminants as well as reversed sequences of all entries had been added. For
growth medium samples each of these databases had been concatenated to
bovine-speciﬁc part of UniProt (26526 entries) (all downloaded 21.06.2011).
Enzyme speciﬁcity was set to trypsin/P and a maximum of two missed cleav-
ages were allowed. Cysteine carbamidomethylation was used as ﬁxed modi-
ﬁcation and methionine oxidation, protein N-terminal acetylation, as well as
replacement of methionine by AHA (in case of AHA treatment experiments)
were used as variable modiﬁcations. The minimal peptide length was set to
6 amino acids. Initial maximal allowed mass tolerance was set to 20 ppm
for peptide masses, followed by 6 ppm in the main search and 0.5 Dalton for
fragment ion masses. False discovery rates for peptide and protein identiﬁ-
cation were set to 1%. At least one unique peptide was required for protein
identiﬁcation. The protein identiﬁcation was reported as an indistinguish-
able “protein group” if no unique peptide sequence to a single database entry
was identiﬁed.
For protein quantiﬁcation a minimum of two ratio counts was set and the
“requantify” and “match between runs” function enabled (exception: “match
between runs” not enabled for Drosophila melanogaster data set). For pSI-
LAC samples a protein group was kept for the further analysis, if it contained
at least one mouse or human sequence and the number of identiﬁed peptide
species carrying an medium-heavy or heavy label divided by the total number
of peptide species detected in the complete experimental setup was higher
than 0.2. For all other samples proteins assigned to contaminants or reverse
sequences were removed. Average protein ratios were reported, if they were
quantiﬁed in both replicates each based on at least two ratio counts.
8.3.2 Compendium of secreted proteins
To assemble the compendium all detected mouse proteins were mapped to
their human homologue in the human UniProt database based on gene names.
Only one protein per gene name was kept in the database and proteins with-
out gene name were removed, resulting in 20695 remaining entries. Proteins
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were regarded as identiﬁed in one cell type if at least 3 assigned MS/MS spec-
tra summed over all experiments of one cell type were detected. The theo-
retical human secretome was deﬁned to include all proteins with the UniProt
keyword “Signal” or “Secreted” [244] or reaching the signiﬁcance threshold in
SignalP4.0 [245], producing 3831 proteins. For theoretical cleavage of the sig-
nal peptide, 22 amino acids were removed from the N-terminus of the protein
sequence, if a signal peptide was predicted by SignalP 4.0 or the UniProt key-
word “Signal” was assigned.
8.3.3 Statistical analysis
Mass spectrometry
Statistical analysis was performed using the Limma package in R/Biocon-
ductor [347]. After ﬁtting a linear model to the data, an empirical Bayes
moderated t-test was used and p-values were adjusted for multiple testing
with Benjamini and Hochberg’s method. If not stated otherwise, proteins
with an adjusted p-value lower than 0.01 and exhibiting a minimum fold
change of 2 were considered to be diﬀerentially synthesized or secreted. For
analysis of LPS-time course experiments prior to statistical test values with
high standard deviations were removed if the standard deviation of biological
replicates was higher than 1.2 (or 1.8 for pSILAC without AHA) or the
standard deviation was higher than the absolute log2-fold-change for fold-
changes higher than 0.6 (or 1.2 for pSILAC without AHA). Correlations
between replicates were calculated in R using pearson correlation.
Statistical signiﬁcance in the Drosophila melanogaster data sets was de-
termined using Signiﬁcance A test [1] in Perseus (written by Jürgen Cox; MPI
of Biochemistry Martinsried) independent for the biological replicates. Pro-
teins signiﬁcant in both biological replicates were considered as candidates
for further analysis.
mRNA expression
mRNA expression values were analyzed using Gene Spring GX Software (Ag-
ilent). An unpaired t-test with asymptotic p-value calculation followed by
Benjamini-Hochberg p-value correction for multiple testing was used to deﬁne
statistical signiﬁcant changes in mRNA expression comparing LPS treated
samples against untreated sample. After background determination all RNAs
with expression values below 50 were excluded from the analysis. Only RNAs
with a adjusted p-value higher than 0.01 and a minimum fold-change of 2
were considered as signiﬁcantly changing.
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8.3.4 Bioinformatical analysis
Functional annotation enrichment was performed using DAVID [230]. Meta-
Core (GeneGo Inc.) [246] was used for pathway map enrichment, transcrip-
tion factor target gene enrichment and network analysis. The network in
section 5.1.1 was visualized in Cytoscape [348]. Functional classiﬁcation was
performed using either MetaCore (individual datasets) or PANTHER clas-
siﬁcation system [288;289] (secretome compendium). Default parameters were
used in all analysis. In the LPS-time course dataset a connection to immune
response was assigned if any of the following criteria was fulﬁlled: the pro-
tein is downstream of LPS, NF-κB or AP1 based on the curated GeneGo
database or GO annotations contain any term with “immune”, “inﬂamma-
tory response” or “defense response”.
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Figure B.1: Examples of MS-spectra for peptides detected with (panels a and c)
and without enrichment (panels b and d). The mass range for the SILAC triplets
used for quantiﬁcation is shown. Red lines highlight the masses of diﬀerentially
labeled peptides. The lower signal-to-noise in the spectra without enrichment
complicates recognition of isotope envelopes and accurate peptide quantiﬁcation.
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Figure B.2: Secretion proﬁles of cells grown in methionine- or AHA-containing
media. Displayed are log2-fold-changes (AHA/methionine) for diﬀerent collection
times (3, 6 and 24 h) and cell lines (PC3 and WPMY-1) indicating all quantiﬁed
proteins (panels in 1st and 3rd row) or only truly secretory proteins (panels in 2nd
and 4th row).
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Figure B.3: Distribution of protein length (panels a and b) and methionine
frequencies (panels c and d) in the theoretical secretome (3831 proteins, black
lines) and experimentally detected proteins (665 proteins, red lines)Frequencies
are plotted for complete protein sequences (panels a and c) and after cleavage of
the N-terminal signal peptide and start-methionine (panels b and d).
159
APPENDIX B. SUPPLEMENTARY FIGURES AND TABLES
−2 −1 0 1 2 3 4
−
2
−
1
0
1
2
3
4
log2(LPS/−) PS 120 min
lo
g2
(L
P
S
/−
) R
N
A
 6
0 
m
in
R=0.57
−1 0 1 2 3 4
−
2
−
1
0
1
2
3
4
log2(LPS/−) PS 60 min
lo
g2
(L
P
S
/−
) R
N
A
 6
0 
m
in
R=0.47
−2 −1 0 1 2 3 4
−
2
−
1
0
1
2
3
4
log2(LPS/−) PS 180 min
lo
g2
(L
P
S
/−
) R
N
A
 6
0 
m
in
R=0.61
−2 −1 0 1 2 3 4
−
2
−
1
0
1
2
3
4
log2(LPS/−) PS 480 min
lo
g2
(L
P
S
/−
) R
N
A
 6
0 
m
in
R=0.51
−2 −1 0 1 2 3 4
−
2
0
2
4
6
log2(LPS/−) PS 120 min
lo
g2
(L
P
S
/−
) R
N
A
 1
20
 m
in
−2 −1 0 1 2 3 4
−
2
0
2
4
6
log2(LPS/−) PS 180 min
lo
g2
(L
P
S
/−
) R
N
A
 1
20
 m
in
−2 −1 0 1 2 3 4
−
2
0
2
4
6
log2(LPS/−) PS 480 min
lo
g2
(L
P
S
/−
) R
N
A
 1
20
 m
inR=0.44 R=0.56 R=0.61
−2 −1 0 1 2 3 4
−
2
0
2
4
6
log2(LPS/−) PS 180 min
lo
g2
(L
P
S
/−
) R
N
A
 1
80
 m
in
−2 −1 0 1 2 3 4
−
2
0
2
4
6
log2(LPS/−) PS 480 min
lo
g2
(L
P
S
/−
) R
N
A
 1
80
 m
inR=0.50 R=0.59
Protein synthesis
60 min
Protein synthesis
120 min
Protein synthesis
180 min
Protein synthesis
480 min
R
N
A abundance
60 m
in
R
N
A abundance
120 m
in
R
N
A abundance
180 m
in
Figure B.4: Comparison of log2-fold-changes of newly synthesized proteins to
log2-fold-changes of RNA at diﬀerent times after LPS stimulation. The correlation
between data sets increases slightly when comparing RNA expression changes to
changes of protein synthesis at a later time point. (PS: protein synthesis)
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Figure B.7: Similar protein kinetics were measured intracellular and extracellu-
lar: The observed protein synthesis dynamics show the same trend for cell lysates
and secretome. (The numbers above the columns give the time after LPS stimu-
lation.)
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Figure B.8: Sequence coverage for three proteins with contradicting kinetics
when comparing secretome and intracellular results. (red: detected peptides in-
tracellular; blue: detected peptides intracellular and extracellular; orange: trans-
membrane domain; green: methionine; The cleavage site of Plxnb1 is highlighted
in light green.)
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1 2 3 4 5 16
Figure B.10: Puriﬁed 500 base pair DNA sequences after PCR ampliﬁcation and
phenol-chloroform extraction: No contamination with longer or shorter DNA can
be detected. (1: 100 kB marker; 2: tinC, 3: tinD, 4: sns, 5: CRM 663, 6: bap3)
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Functional Term Score Functional Term Score
non-membrane-bounded organelle 60.59 transcription activator activity 11.23
mitotic cell cycle 51.80 Zinc ﬁnger, C2H2-like 11.16
transcription regulation 50.62 DNA replication 10.61
nucleotide-binding 45.05 zinc-ﬁnger 10.27
nuclear lumen 29.34 female gamete generation 10.08
chromosome 28.52 endocytosis 9.68
chromosome organization 24.82 protein localization 9.19
ribonucleoprotein 24.44 negative regulation of gene expres-sion 8.78
regulation of RNA splicing 22.12 neuron diﬀerentiation 8.52
helicase 20.11 nuclear chromosome 8.37
DNA metabolic process 19.15 translation factor activity, nucleicacid binding 8.24
RNA processing 17.26 kinase 7.99
positive regulation 15.74 posttranscriptional regulation ofgene expression 7.90
cell cycle 15.54 regulation of cell cycle 7.19
mRNA binding 15.07 WD40 repeat, conserved site 7.06
ribonucleoprotein complex bio-
genesis 14.99 K Homology 6.65
Zinc ﬁnger, PHD-type 12.50 tissue morphogenesis 6.59
DNA helicase activity 11.30 chromatin assembly or disassem-bly 6.27
Table B.1: Functional annotation clustering for all quantiﬁed proteins. (The
score is the enrichment score for each cluster provided by DAVID [230]. the func-
tional terms were chosen to represent most of the clustered terms.)
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Abbreviation Description
CRM cis-regulatory module
AHA azidohomoalanine
HPG homopropargylglycine
HAG homoallylglycine
Met methionine
LPS lipopolysaccharides
ncAAS non-canonical amino acids
SILAC stable isotope labeling with amino acids in cell culture
pSILAC pulsed SILAC
iTRAQ isobaric tags for relative and absolute quantiﬁcation
COPII coat protein complex II
COPI coat protein complex I
OFF-Gel IEF oﬀ-gel isoelectric focusing
fullSILAC near 100% labeling with stable isotope labeled amino acids
NSP newly synthesized proteins
nanoLC-MS/MS nano-ﬂow liquid chromatography coupled to two dimensional massspectrometry
FDR false discovery rate
GO gene ontology
PHC primary hepatocytes
iBAQ intensity based absolute quantiﬁcation
ECM extracellular matrix
TSS transcription start site
ChIP chromatin immunoprecipitation
BONCAT bioorthogonal non-canonical amino acid tagging
PAMPs pathogen associated molecular patterns
TAMs tumor-associated macrophages
DAPI 4’,6-diamidino-2-phenylindole
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PROTEIN NAMES
Protein short name Protein name
ADAMs A sisintegrin and metalloproteinases
AP1 Transcription factor activator protein 1
ARE Antioxidant responsive elements
ARG1 Arginase 1
ATF Cyclic AMP-dependent transcription factor
C/EBP CCAAT/enhancer-binding protein
CCL Chemokine ligand
CD14 Monocyte diﬀerentiation antigen CD14
COX2 Cyclo-oxygenase 2
CREB Cyclic AMP-responsive element-binding protein
CXCL Chemokine CXC motif ligand
FIZZ1 Found in inﬂammatory zone 1
GR Galactose receptor
HO1 Heme-oxygenase 1
IKK Inhibitor of nuclear factor kappa-B kinase
IL Interleukin
IL1ra Interleukin 1 receptor antagonist
ILR2 Interleukin 1 receptor type II, decoy receptor
iNOS Inducible nitric oxide synthase
IRAK Interleukin-1 receptor-associated kinase
IRF IFN regulatory factor
JNK Mitogen-activated protein kinase JNK
LBP LPS-binding protein
Mal MyD88 adaptor-like protein
MAPK Mitogen-activated protein kinase
MD2 Lymphocyte antigen 96
MKK Dual speciﬁcity mitogen-activated protein kinase kinase
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PROTEIN NAMES
Protein short name Protein name
MMPs matrix metalloproteases
MyD88 Myeloid diﬀerentiation primary response protein MyD88
NEMO NF-kappa-B essential modulator
NRF2 Nuclear factor erythroid 2-like 2
p38 Mitogen-activated protein kinase p38
PPAR Peroxisome proliferator-activated receptor
RIP1 Receptor-interacting serine/threonine-protein kinase 1
SR Scavenger receptor
STAT Signal transducer and activator of transcription
TAB TGF-beta-activated kinase 1 and MAP3K7-binding protein
TAK1 Nuclear receptor subfamily 2 group C member 2
TANK TRAF family member-associated NF-kappa-B activator
TBK Serine/threonine-protein kinase TBK
TLR4 Toll-like receptor 4
TNF Tumor necrosis factor
TRAF Tumor necrosis factor receptor-associated factor
TRAM TRIF-related adaptor molecule
TRIF TIR domain-containing adapter molecule 1
Ym1 Chitinase 3-like 3 lectin
HUMAN
Gene name Protein name
ALAD Delta-aminolevulinic acid dehydratase
ALCAM CD166 antigen
APP Amyloid beta A4 protein
AREG Amphiregulin
BCAM Basal cell adhesion molecule
COL Collagen
CSF1 Macrophage colony-stimulating factor 1
CTGF Connective tissue growth factor
CYR61 Protein CYR61
DKK Dickkopf-related protein
ERP44 Endoplasmic reticulum resident protein 44
FGFBP1 Fibroblast growth factor-binding protein 1
GDF15 Growth/diﬀerentiation factor 15
GLG1 Golgi apparatus protein 1
GPC Glypican
HS3ST1 Heparan sulfate glucosamine 3-O-sulfotransferase 1
HSP90B1 Endoplasmin
HSPA Heat shock 70 kDa protein
IL1RN Interleukin-1 receptor antagonist protein
IL4L1 L-amino-acid oxidase
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HUMAN
Gene name Protein name
IL6ST Interleukin-6 receptor subunit beta
INHBA Inhibin beta A chain
KITLG Kit ligand
L1CAM Vascular cell adhesion protein 1
LAM Laminin
LDLR LDL receptor
LOX Lysyl oxidases
LTBP Latent-transforming growth factor beta-binding protein
LY6E Lymphocyte antigen 6E
NUCB2 Nucleobindin-2
PCSK9 Proprotein convertase subtilisin/kexin 9
PLAT Tissue-type plasminogen activator
PLAU Urokinase-type plasminogen activator
PLOD Procollagen-lysine,2-oxoglutarate 5-dioxygenases
PPIA Peptidyl-prolyl cis-trans isomerase A
PSAP Proactivator polypeptide
ROBO1 Roundabout homolog 1
SDC Syndecan
SERPINE1 Plasminogen activator inhibitor
SLIT2 Slit homolog 2 protein
SPP1 Osteopontin
TGFB Transforming growth factor beta
THBS Thrombospondin
TIMP3 Metalloproteinase inhibitor 3
TNC Tenascin
TNF Tumor necrosis factor
TXN Thioredoxin
VEGFA Vascular endothelial growth factor A
MOUSE
Gene name Protein name
Adam Disintegrin and metalloproteinase domain-containing protein
Ahsg Alpha-2-HS-glycoprotein
Anln Actin-binding protein anillin
Apo Apolipoprotein
App Amyloid beta A4 protein
Arl5b ADP-ribosylation factor-like protein 5B
Arsb Arylsulfatase B
Atf3 Cyclic AMP-dependent transcription factor ATF-3
Atf4 Cyclic AMP-dependent transcription factor ATF-4
B2m Beta-2-microglobulin
Bcam Basal cell adhesion molecule
Bhlhe41 Class E basic helix-loop-helix protein 41
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MOUSE
Gene name Protein name
Brd2 Bromodomain-containing protein 2
Btg2 Protein BTG2
C2 Complement C2
C9 Complement component C9
Capg Macrophage-capping protein
Ccl C-C motif chemokine
Ccnd1 G1/S-speciﬁc cyclin-D1
Ccrl2 C-C chemokine receptor-like 2
Ccrl2 C-C chemokine receptor-like 2
Cct8 T-complex protein 1 subunit theta
Cd14 Monocyte diﬀerentiation antigen CD14
Cd44 CD44 antigen
Cd83 CD83 antigen
Cdc25a M-phase inducer phosphatase 1
Cdc25b M-phase inducer phosphatase 2
Cdk2 Cyclin-dependent kinase 2
Cebpd CCAAT/enhancer-binding protein delta
Chac1 Cation transport regulator-like protein 1
Chek1 Serine/threonine-protein kinase Chk1
Chek2 Serine/threonine-protein kinase Chk2
Chka Choline kinase alpha
Clec4d C-type lectin domain family 4 member D
Clk1 Dual speciﬁcity protein kinase CLK1
Cltc Clathrin heavy chain 1
Coro1a Coronin-1A
Cpe Carboxypeptidase E
Cpeb4 Cytoplasmic polyadenylation element-binding protein 4
Csf1r Macrophage colony-stimulating factor 1 receptor
Csf3 Granulocyte colony-stimulating factor
Csrnp1 Cysteine/serine-rich nuclear protein 1
Csrnp2 Cysteine/serine-rich nuclear protein 2
Cst Cystatin
Cts Cathepsin
Ctsc Dipeptidyl peptidase 1
Cxcl C-X-C motif chemokine
Dag1 Dystroglycan
Dnaja1 DnaJ homolog subfamily A member 1
Dnajb4 DnaJ homolog subfamily B member 4
Dsn1 Kinetochore-associated protein DSN1 homolog
Dusp Dual speciﬁcity phosphatase
E2f1 Transcription factor E2F1
E2f7 Transcription factor E2F7
E2f8 Transcription factor E2F8
Ebi3 Interleukin-27 subunit beta
Ect2 Protein ECT2
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MOUSE
Gene name Protein name
Edil3 EGF-like repeat and discoidin I-like domain-containing protein 3
Eef1a1 Elongation factor 1-alpha 1
Egr Early growth response protein
Ehd1 EH domain-containing protein 1
Elf2 ETS-related transcription factor Elf-2
Elk3 ETS domain-containing protein Elk-3
Elk4 ETS domain-containing protein Elk-4
Ell2 RNA polymerase II elongation factor ELL2
Emr1 EGF-like module-containing mucin-like hormone receptor-like 1
Ets2 Protein C-ets-2
Fgd4 FYVE, RhoGEF and PH domain-containing protein 4
Flnb Filamin-B
Fn1 Fibronectin
Fos Proto-oncogene c-Fos
Fosb Protein fosB
Fosl1 Fos-related antigen 1
Fosl2 Fos-related antigen 2
Gc Vitamin D-binding protein
Gch1 GTP cyclohydrolase 1
Gk Glycerol kinase
Glg1 Golgi apparatus protein 1
Gpnmb Transmembrane glycoprotein NMB
Gpr84 G-protein coupled receptor 84
H1f0 Histone H1.0
H2-D1 H-2 class I histocompatibility antigen, D-D alpha chain
H2-K1 H-2 class I histocompatibility antigen, K-D alpha chain
H2-L H-2 class I histocompatibility antigen, L-D alpha chain
H2-T23 H-2 class I histocompatibility antigen, D-37 alpha chain
Hbp1 HMG box-containing protein 1
Hexim1 Protein HEXIM1
Hist1h1a Histone H1.1
Hist1h2bf Histone H2B type 1-F/J/L
Hist1h4a Histone H4
Hist2h2aa1 Histone H2A type 2-A
Hist2h2ab Histone H2A type 2-B
Hist2h3b Histone H3.2
Hmga2 High mobility group protein HMGI-C
Hmha1 Minor histocompatibility protein HA-1
Hmox1 Heme oxygenase 1
Homer1 Homer protein homolog 1
Hpgds Hematopoietic prostaglandin D synthase
Hsp90aa1 Heat shock protein HSP 90-alpha
Hsp90ab1 Heat shock protein HSP 90-beta
Hsp90b1 Endoplasmin
Hspa5 78 kDa glucose-regulated protein
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MOUSE
Gene name Protein name
Hspd1 60 kDa heat shock protein, mitochondrial
Hspg2 Basement membrane-speciﬁc heparan sulfate proteoglycan core protein
Icam1 Intercellular adhesion molecule 1
Ier3 Radiation-inducible immediate-early gene IEX-1
Ier5 Immediate early response gene 5 protein
Iﬁ30 Gamma-interferon-inducible lysosomal thiol reductase
Igfbp4 Insulin-like growth factor-binding protein 4
Ikbke Inhibitor of nuclear factor kappa-B kinase subunit epsilon
Il Interleukin
Il1rn Interleukin-1 receptor antagonist protein
Il6ra Interleukin-6 receptor subunit alpha
Irf2bpl Interferon regulatory factor 2-binding protein-like
Irf4 Interferon regulatory factor 4
Irf7 Interferon regulatory factor 7
Irg1 Immune-responsive gene 1 protein
Itga5 Integrin alpha-5
Itgav Integrin alpha-V
Itgax Integrin alpha-X
Itih4 Inter alpha-trypsin inhibitor, heavy chain 4
Itpkb Inositol 1,4,5-trisphosphate 3-kinase B
Jag1 Protein jagged-1
Jak1 Tyrosine-protein kinase JAK1
Jak2 Tyrosine-protein kinase JAK2
Jun Transcription factor AP-1
Junb Transcription factor jun-B
Jund Transcription factor jun-D
Kif11 Kinesin-like protein KIF11
Lam Laminin
Lamc1 Laminin subunit gamma-1
Ldlr Low-density lipoprotein receptor
Lfng Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe
Lgals Galectin
Lilrb4 Leukocyte immunoglobulin-like receptor subfamily B member 4
Ltb Ltb protein
Lyz2 Lysozyme C-2
Maﬀ Transcription factor MafF
Map2k3 Dual speciﬁcity mitogen-activated protein kinase kinase 3
Map3k1 Mitogen-activated protein kinase kinase kinase 1
Marcksl1 MARCKS-related protein
Mastl Serine/threonine-protein kinase greatwall
Mdm2 E3 ubiquitin-protein ligase Mdm2
Mif Macrophage migration inhibitory factor
Mknk1 MAP kinase-interacting serine/threonine-protein kinase 1
Mknk2 MAP kinase-interacting serine/threonine-protein kinase 2
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MOUSE
Gene name Protein name
Mmp13 Collagenase 3
Mpeg1 Macrophage-expressed gene 1 protein
Msr1 Macrophage scavenger receptor types I and II
Myc Myc proto-oncogene protein
Ncapd3 Condensin-2 complex subunit D3
Ndrg1 Protein NDRG1
Nek7 Serine/threonine-protein kinase Nek7
Neo1 Neogenin
Nfkb1 Nuclear factor NF-kappa-B p105 subunit
Nfkb2 Nuclear factor NF-kappa-B p100 subunit
Nfkbia NF-kappa-B inhibitor alpha
Nfkbib NF-kappa-B inhibitor beta
Nfkbiz NF-kappa-B inhibitor zeta
Nlrp3 NACHT, LRR and PYD domains-containing protein 3
Notch1 Neurogenic locus notch homolog protein 1
Nrp2 Neuropilin-2
Oasl1 2’,5’-oligoadenylate synthetase-like 9
Olr1 Oxidized low-density lipoprotein receptor 1
Orc5 Origin recognition complex subunit 5
P4hb Protein disulﬁde-isomerase
Pdgfb Platelet-derived growth factor subunit B
Pdia Protein disulﬁde-isomerase
Pdlim5 PDZ and LIM domain protein 5
Phlda1 Pleckstrin homology-like domain family A member 1
Pkm2 Pyruvate kinase isozymes M1/M2
Plagl2 Pleomorphic adenoma gene like 2
Plat Tissue-type plasminogen activator
Plau Urokinase-type plasminogen activator
Plk2 Polo-like kinase 2
Plk3 Polo-like kinase 3
Plxnb2 Plexin-B2
Ppia Peptidyl-prolyl cis-trans isomerase A
Prdx1 Peroxiredoxin-1
Prim1 DNA primase small subunit
Ptprj Receptor-type tyrosine-protein phosphatase eta
Ptprs Receptor-type tyrosine-protein phosphatase S
Pvr Poliovirus receptor-related protein 2
Pvrl1 Poliovirus receptor-related protein 1
Racgap1 Rac GTPase-activating protein 1
Rasa3 Ras GTPase-activating protein 3
Rassf2 Ras association domain-containing protein 2
Rbl1 Retinoblastoma-like protein 1
Rcsd1 CapZ-interacting protein
Rel Proto-oncogene c-Rel
Relb Transcription factor RelB
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MOUSE
Gene name Protein name
Rfc4 Replication factor C subunit 4
Rgl1 Ral guanine nucleotide dissociation stimulator-like 1
Rpl30 60S ribosomal protein L30
Rps25 40S ribosomal protein S25
Rps27a Ubiquitin-40S ribosomal protein S27a
Sdc4 Syndecan-4
Sdcbp Syntenin-1
Sema4d Semaphorin-4D
Serpina Serine protease inhibitor
Sesn2 Sestrin-2
Sil1 Nucleotide exchange factor SIL1
Slc4a7 Sodium bicarbonate cotransporter 3
Slfn2 Protein Slfn2
Sparc Secreted acidic cysteine rich glycoprotein
Spp1 Osteopontin
Srf Serum response factor
Srpk2 SRSF protein kinase 2
Stk17b Serine/threonine-protein kinase 17B
Stk38 Serine/threonine-protein kinase 38
Stk40 Serine/threonine-protein kinase 40
Sumf1 Sulfatase-modifying factor 1
Tfcap4 Activator protein 4
Tgfb1 Transforming growth factor beta-1
Tgm2 Protein-glutamine gamma-glutamyltransferase 2
Timp2 Metalloproteinase inhibitor 2
Tinagl1 Tubulointerstitial nephritis antigen-like
Tlr13 Toll-like receptor 13
Tlr3 Toll-like receptor 3
Tlr7 Toll-like receptor 7
Tnf Tumor necrosis factor
Tnfsf9 Tumor necrosis factor ligand superfamily member 9
Vav3 Guanine nucleotide exchange factor VAV3
Vegfa Vascular endothelial growth factor A
Vps37c Vacuolar protein sorting-associated protein 37C
Wdr67 WD repeat-containing protein 67
Xpo1 Exportin-1
Ybx1 Nuclease-sensitive element-binding protein 1
Ywhae 14-3-3 protein epsilon
Ywhaz 14-3-3 protein zeta/delta
Zcchc2 Zinc ﬁnger CCHC domain-containing protein 2
Zfp36 Tristetraprolin
Zyx Zyxin
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DROSOPHILA MELANOGASTER
Gene symbol Protein name
baf Barrier-to-autointegration factor
bigmax BHLHZip transcription factor BIGMAX
bin Protein Biniou
CG2990 LD18775p
CG32772 CG32773
Chi CHIP
CrebB-17A Cyclic-AMP response element binding protein B at 17A
DAPI 4’,6-diamidino-2-phenylindole
Eip75B Ecdysone-induced protein 75B
esg Escargot
ewg DNA-binding protein Ewg
hang Zinc ﬁnger protein hangover
hb Protein hunchback
Hrb27C Heterogeneous nuclear ribonucleoprotein 27C
Hrb87F Heterogeneous nuclear ribonucleoprotein 87F
Kr-h1 Krueppel homologous protein 1
lark RNA-binding protein lark
lin-52 Lin-53
Mef2 Myocyte-speciﬁc enhancer factor 2
mod(mdg4) Modiﬁer of mdg4
nub Protein nubbin
pdm2 POU domain protein 2
pnr Protein Pannier
Rbf2 RB-related protein RBF2
Rox8 Rox8
snail Protein snail
so Protein sine oculis
sqz Zinc ﬁnger protein squeeze
Ssb-c31a RNA polymerase II transcriptional coactivator
Su(H) Suppressor of hairless protein
vvl POU domain protein CF1A
wor Worniu
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